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Hospital acquired infections (HAIs) are an important cause of morbidity and mortality 
following paediatric cardiac surgery. 
Aim: 
To determine the incidence, risk factors for and outcome of postoperative HAIs in the 
Paediatric Intensive Care Unit (PICU) of the Red Cross War Memorial Children’s Hospital 
(RCWMCH) in Cape Town. 
Methods:  
A prospective observational study of all postoperative cardiac patients admitted to PICU 
from September 2011 to March 2012. The definitions of laboratory confirmed blood stream 
infections (BSI), urinary tract infections (UTI), and surgical site infections were based on the 
Centres of Disease Control criteria. Ventilator associated pneumonia (VAP) was diagnosed 
using a modification of the Clinical Pulmonary Infection Score (CPIS). 
Results:  
110 patients (median age 19 months; 43% male) undergoing 126 surgical procedures were 
enrolled. Sixty HAIs occurred in 43 (39%) patients (68.3% pulmonary; 13.3% blood; 11.7% 
wound; 3.3% urine; 3.3% tissue).  Nine (8.2%) patients died and their deaths were not 
related to HAIs. 
Causative organisms for HAIs were gram negative isolates (57.3%), viral isolates (22.7%), 
gram positive isolates (16%) and fungal isolates (2.7%). The median (IQR) day 
postoperatively of first organism detected from any specimen was 3 (2 – 5) days. 36% of 
isolates were detected within 48 hours postoperatively.  
Being underweight for age (adjusted odds ratio, OR: 2.77; 95% CI 1.04 – 7.36, p = 0.04), 




0.04) and increased duration of arterial lines (OR 1.47; 95% CI 1.21 – 1.78; p = 0.0001) 
were identified as being independently associated with acquiring HAI on multivariate 
analysis.    
 Patients with HAI spent median (IQR) 6 (4 – 13) and 21 (9 – 38) days in PICU and hospital 
compared to 3 (2 – 5) and 9 (7 – 13) days in uninfected patients (p < 0.0001).                                                                                                            
Conclusions: 
The incidence of HAI in this population was high with identified associations and significant 
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BACKGROUND OF PAEDIATRIC CARDIAC SERVICES IN SOUTH AFRICA, A 
DEVELOPING COUNTRY’S PERSPECTIVE 
There is a significant burden of paediatric cardiac disease in South Africa (Hoosen, Cilliers 
et al. 2011). The population of South Africa is approximately 51 million (Statistics South 
africa 2011) and the prevalence of congenital cardiac disease is approximately 4-6 per 1000 
live births. Thus approximately 11 000 children with congenital heart disease (CHD) are 
born every year (Hoosen, Cilliers et al. 2010). With appropriate care, the prognosis for most 
of these children is excellent, with at least 85% expected to survive to adulthood (Hoosen, 
Cilliers et al. 2011). 
 
In 2006, approximately 1 300 patients were operated on for CHD in South Africa, 800 of 
them in the public service hospitals, which serve close to 85% of the population. This means 
that less than 25% of the children in South Africa with CHD who rely on the public health 
services received the care they needed (Hoosen, Cilliers et al. 2011). 
 
Thus the burden of paediatric cardiac disease is not being addressed. There are eight South 
African units (five major public sector centres and three private sector centres) available for 
paediatric cardiac surgery (Hewitson, Brink et al. 2002) and there are long waiting lists for 
most elective surgeries at these units (Saxena 2009). In addition, the rest of Africa cannot 
really access this system. 
 
According to an editorial published in the South African Medical Journal, the reasons 
contributing to this resource limited situation are threefold (Hoosen, Cilliers et al. 2011). 
Firstly, paediatric cardiac services are unable to meet the demand due to a paucity of trained 
paediatric cardiologists (Hoosen, Cilliers et al. 2011). Secondly, the capacity to successfully 
manage the full patient load in public sector hospitals is limited by the scarcity of adequately 
trained and experienced paediatric cardiothoracic surgeons, limited theatre availability and 
postoperative intensive care, which requires highly specialised nursing and medical 




misdiagnosed or identified too late. This is most important, because as many as 20% of CHD 
cases present with life-threatening illness in the neonatal period, where survival depends on 
timely diagnosis, management and referral (Hoosen 2011). 
 
Survivors of CHD without surgical intervention require frequent hospital visits and repeated 
admissions for the complications of unoperated CHD. This continued need for highly 
specialized medical treatments places a significant financial and emotional burden on already 
impoverished caregivers and families (Hoosen 2011). Timely diagnosis and surgical 
management of CHD is thus an obvious financial benefit for both the families and health 
systems in resource poor settings. 
 
IMPACT OF HOSPITAL ACQUIRED INFECTION (HAI) ON PAEDIATRIC CARDIAC 
PATIENT AFTER SURGERY 
A HAI is a localised or systemic condition resulting from an adverse reaction to the presence 
of an infectious agent(s) or its toxin(s) that was not present on admission to the hospital. An 
infection is considered to be hospital acquired if all elements of Centres for Disease Control 
(CDC) site-specific infection criteria were not present during the first 48 hours of hospital 
admission but were all present on or after the 3rd calendar day of admission to the hospital 
(the day of hospital admission is calendar day 1) (Centers for Disease Control and 
Prevention 2014). 
 
HAIs represent a major complication in paediatric intensive care unit (PICU) patients 
undergoing cardiac surgery and are associated with significant morbidity and mortality 
(Levy, Ovadia et al. 2003, Grisaru-Soen, Paret et al. 2009, Pasquali, He et al. 2013). HAIs 
contribute to prolonged duration of hospital and ICU stays (Levy, Ovadia et al. 2003, 
Grisaru-Soen, Paret et al. 2009, Pasquali, He et al. 2013). As noted previously, cost-
containment is highly relevant to performing congenital heart surgeries in developing 
countries. Prolonged durations of stay in the intensive care unit (ICU) due to HAIs could 
inflate costs after cardiac surgery (Pasquali, He et al. 2013). Every effort needs to be made to 
prevent the causes of increased duration of ICU and hospital stay in order to contain costs 
(Rao 2007). 
 
HAIs therefore represent a major complication and a considerable clinical, emotional and 




Ovadia et al. 2003, Abou Elella, Najm et al. 2010). Identifying and instituting measures to 
prevent and manage these HAIs in a resource-limited setting are clinically and financially 








OBJECTIVES OF THE LITERATURE REVIEW 
The objectives of the literature review were to determine the epidemiology, aetiology and 
described incidence of HAIs in postoperative cardiac patients in paediatric intensive care 
units (PICU); to define the patients at risk for developing HAIs and to describe the morbidity 
and mortality associated with HAIs. 
 
METHODS 
CRITERIA FOR CONSIDERING STUDIES FOR THIS REVIEW 
Study design: Any study design was considered for inclusion. 
Participants: neonates, infants and children (0 -18 years) admitted to PICU following cardiac 
surgery.  
Outcome measures: Epidemiology, incidence, cause and outcome of HAI in terms of 
duration of hospital and PICU stay and mortality. Measures of risk associated with HAIs 
included delayed sternal closure, surgical complexity scoring systems, use of corticosteroids, 
cardiopulmonary bypass factors, staffing in an ICU, inflammatory markers of infection and 
genetic factors. 
Exclusion criteria: articles published in a language other than English, studies including 
animal models. 
 
LITERATURE SEARCH STRATEGY 
The following databases were searched for English articles published up until 25 May 2014: 
PubMed, University of Cape Town Libraries search engine and Journal publication sites: 
Pediatric Critical Care Medicine, Intensive care Medicine, The New England journal of 
medicine, The Journal of thoracic and cardiovascular surgery, The Annals of Thoracic 
Surgery, Annals of Pediatric Cardiology, Anesthesiology, Critical Care Medicine and 
Pediatric cardiology. The search terms used were: postoperative infections OR cardiac 
surgery OR postoperative cardiac surgery infections OR PICU infections OR hospital 
acquired infections post cardiac surgery OR cardiac surgery infections OR nosocomial 
infections post cardiac surgery OR bloodstream infections post cardiac surgery OR 






Reference lists of identified articles were scanned for papers relevant to the objectives of the 
literature review.   
 
Abstracts of identified articles were reviewed and relevant articles identified which focussed 
on the terms: hospital acquired infections, nosocomial infections, blood stream infections, 
urinary tract infections, surgical site infections, ventilator associated pneumonia and devise 
associated infections in paediatric patients in an intensive care unit following cardiac 
surgery. Results were synthesised narratively. 
 
RESULTS OF THE LITERATURE SEARCH 
4125 articles were initially identified, of which 1636 articles were identified as relevant (see 
above); and 113 articles were included in the review (Appendix 1). 
 
SCOPE OF THE PROBLEM 
Hospital acquired infection is defined as a localised or systemic condition that 1) results 
from adverse reaction to the presence of an infectious agent(s) or its toxin(s) and 2) was not 
present or incubating at the time of admission to the hospital. The presence and classification 
of the HAI is based on clinical findings, laboratory evidence and clinical judgment of the 
attending physician (Garner, Jarvis et al. 1996). 
 
HAIs are thought to be an important cause of morbidity and mortality in paediatric patients 
following cardiac surgery, although epidemiological information regarding acquired 
infections following paediatric cardiac surgery is limited (Wheeler, Jeffries et al. 2011, 
Tantawy, Seliem et al. 2012, Barker, O'Brien et al. 2010, Algra, Driessen et al. 2012, 
Grisaru-Soen, Paret et al. 2009, Levy, Ovadia et al. 2003). Specifically, no published data is 
available for the South African population. It is important to obtain data in this population in 
order to accurately identify patients at risk for postoperative HAI, and to suggest strategies 
for preventing infections and optimising patient management and outcome. 
 
The morbidity associated with HAIs includes prolonged antibiotic usage, increased 
resistance of microorganisms to antimicrobials, reoperation, prolonged hospital and ICU 




al. 2010, Tantawy, Seliem et al. 2012). The development of these infections has 
overwhelming emotional and financial impacts (Abou Elella, Najm et al. 2010) for patients 
and their family (Tantawy, Seliem et al. 2012). 
 
The most common HAIs previously reported in postoperative cardiac PICU patients are: 
bloodstream infections (BSIs), including catheter-related BSIs (CRBSIs) (2.6% -68.2%) 
(Grisaru-Soen, Paret et al. 2009, Levy, Ovadia et al. 2003, Abou Elella, Najm et al. 2010, 
Bezzio, Scolfaro et al. 2009, Barker, O'Brien et al. 2010, Mastropietro, Barrett et al. 2013, 
Bakshi, Vaidyanathan et al. 2007, Alvarez, Fuentes et al. 2012); lower respiratory tract 
infections (LRTIs) including ventilator associated pneumonia (VAP) (1% – 51.2%) (Grisaru-
Soen, Paret et al. 2009, Siddiqui, Mir et al. 2011, Tan, Sun et al. 2004, Shi, Zhao et al. 2008, 
Algra, Driessen et al. 2012, Rosanova, Allaria et al. 2009, Alvarez, Fuentes et al. 2012); 
urinary tract infections (UTIs) (<1% - 17.2%) (Grisaru-Soen, Paret et al. 2009, Levy, Ovadia 
et al. 2003, Siddiqui, Mir et al. 2011, Algra, Driessen et al. 2012, Mastropietro, Barrett et al. 
2013) and surgical site infections (SSIs) (1.53% -25%)(Barker, O'Brien et al. 2010, Grisaru-
Soen, Paret et al. 2009, Levy, Ovadia et al. 2003, Allpress, Rosenthal et al. 2004, Hafez, 
Saied et al. 2012, Nateghian, Taylor et al. 2004, Chaudhuri, Shekar et al. 2012, Woodward, 
Son et al. 2011, Tantawy, Seliem et al. 2012, Harder, Gaies et al. 2013). 
 
Identification of risk factors for HAI is important because if patients at risk can be identified 
prior to surgery, procedures may be adjusted to reduce further risk and necessary 
interventions may be implemented postoperatively to reduce the overall risk of acquiring 
HAIs. 
 
Bloodstream infection (BSI) and other Hospital acquired infection (HAI): incidence 
and risk factors in postoperative cardiac patients. 
The incidence of BSI and other HAI rates with associated factors are presented in Table 1. 
The reported incidence of hospital acquired infections (HAIs) in a paediatric ICU  (PICU), in 
paediatric cardiovascular surgery patients specifically, ranges from 2.6% - 68% (Tantawy, 
Seliem et al. 2012, Siddiqui, Mir et al. 2011, Barker, O'Brien et al. 2010, Algra, Driessen et 
al. 2012, Grisaru-Soen, Paret et al. 2009, Levy, Ovadia et al. 2003, Bakshi, Vaidyanathan et 
al. 2007, Rosanova, Allaria et al. 2009, Mastropietro, Barrett et al. 2013, Alvarez, Fuentes et 
al. 2012, Sarvikivi, Lyytikainen et al. 2008, Pasquali, He et al. 2013). The incidence of HAI 




Urrea, Pons et al. 2003, Singh-Naz, Sprague et al. 1996), which is markedly lower than may 
be expected in postoperative cardiac PICU patients, and is presumed to be due to immune 
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 Paediatric cardiac intensive care unit 
 
All studies reportedly used the CDC definitions for HAIs. Interpretation of CDC criteria is open to 
variation, and strict and consistent adherence to definitions has not been verified in these studies. 
Further limitations of these studies include variability in patient profiles, differing surgical 
complexities, differing study designs, retrospective nature of the studies and the variability in patient 
treatments and infection control protocols between the institutions. Some studies tried to overcome 
the limitations by conducting prospective studies with a cohort of comparable paediatric cardiac 
surgery patients (Grisaru-Soen, Paret et al. 2009, Bezzio, Scolfaro et al. 2009, Levy, Ovadia et al. 
2003, Rosanova, Allaria et al. 2009, Abou Elella, Najm et al. 2010, Tantawy, Seliem et al. 2012). 
These studies have small sample sizes and the interventions and outcomes investigated differed 
between the studies. The incidence of bacteraemia and fungaemia associated with HAIs was the focus 
in a number of studies (Levy, Ovadia et al. 2003, Abou Elella, Najm et al. 2010, Rosanova, Allaria et 
al. 2009) with few reporting on viral aetiologies of HAIs (Grisaru-Soen, Paret et al. 2009). 
 
It is clear that there is marked variation in the incidence of HAIs amongst various studies. This is 
evident in the difference in BSI rate in developing country studies such as Pakistan (34.6%) (Siddiqui, 
Mir et al. 2011) and Egypt (40%) (Tantawy, Seliem et al. 2012) reporting high HAI rates compared to 
an Argentinian study (5%) (Rosanova, Allaria et al. 2009). The Argentinian study (Rosanova, Allaria 
et al. 2009) was conducted at a tertiary referral institution with patients cared for in a general 
paediatric ICU setting similar to this study population. It is interesting to note that Siddiqui et al 
(Siddiqui, Mir et al. 2011) commented on a strict institutional infection control policy with 1:1 nurse-
to-patient ratio in their dedicated paediatric cardiac intensive care unit (PCICU) resulting in a low 
overall HAI rate (7.7%) compared to a high HAI rate reported by Tantawy et al (68%) in their PCICU 
with nurse-to-bed ratio 1:3 or 1:4.  This institution has a similar 1:1 nurse-to-patient ratio to the study 
conducted in Pakistan.  
 
Developed countries reported marked variation in BSI rates ranging from low rates in the PCICUs of 
Saudi Arabia (8.6%) (Abou Elella, Najm et al. 2010) and Israel (10%) (Levy, Ovadia et al. 2003) 
compared to Grisaru-Soen et al (Grisaru-Soen, Paret et al. 2009) reporting a high BSI rate (65.8%) in 
their study population. The study setting and workload was similar in the two previous studies 
conducted in Saudi Arabia and Israel as each had nine and 12 bed units respectively and admitted 
about 350 patients annually. The distribution of HAIs is not only affected by the affluence of the 
country but also institutional policies and protocols such as nurse-to-patient ratio and institutional 





Various patient, environmental and interventional procedures contribute to the risk of developing 
HAIs. Identified factors contributing to risk include high surgical complexity score, neonatal age, 
prolonged ICU stay, and open chest postoperatively (Abou Elella, Najm et al. 2010, Algra, Driessen 
et al. 2012). Prolonged duration of ventilation and PICU stay have repeatedly been identified as risk 
factors, but further studies are needed to determine whether these are cause or consequence of HAI 
(Barker, O'Brien et al. 2010, Rosanova, Allaria et al. 2009, Alvarez, Fuentes et al. 2012, Mastropietro, 
Barrett et al. 2013, Pasquali, He et al. 2013). 
 
The implementation of and adherence to institutional infection prevention and control policies, 
including strict hand hygiene, and adequate nurse-patient ratio have been shown to reduce the 
incidence of HAIs in paediatric ICU patients post cardiac surgery (Siddiqui, Mir et al. 2011, Grisaru-
Soen, Paret et al. 2009). The absence of specific policies has been reported as a risk factor for the 
development of HAIs (Siddiqui, Mir et al. 2011, Grisaru-Soen, Paret et al. 2009). To understand the 
reasons for this variation in incidence of HAIs amongst various studies one has to look at the risk 
factors for developing HAIs within specific patient groups. 
 
Risk factors for bloodstream infections such as high surgical complexity score, prolonged ICU stay, 
open chest postoperatively, younger age (< 2 months) and undernutrition overlap with risk factors for 
other HAIs (Abou Elella, Najm et al. 2010, Rosanova, Allaria et al. 2009). Longer duration of central 
lines (> 7 days) is a risk factor specific to BSI (Abou Elella, Najm et al. 2010, Bezzio, Scolfaro et al. 
2009) 
 
An Italian study conducted by Bezzio et al. (Bezzio, Scolfaro et al. 2009) reported that infants and 
children with central venous catheter (CVC) insertion in the subclavian vein after cardiac surgery 
were almost five times more likely to develop a catheter related bloodstream infection (CRBSI) than 
patients who had an insertion in another vein. The authors were unable to provide reasons for this 
result. Abou Elella et al. (Abou Elella, Najm et al. 2010) identified high surgical complexity score and 
prolonged PICU and hospital stay as risk factors for the development of BSIs. Genetic factors may 
play an important role as well, and there are several gene polymorphisms that have been linked with 
an increased susceptibility to sepsis (Wheeler, Jeffries et al. 2011). 
 
It is known that the risk of BSI is reduced by adequate antiseptic skin preparation immediately before 
central venous catheter insertion and by keeping microbial density at the insertion site low while the 




BSIs result from contamination of the catheter by bacteria residing on patients’ skin at the time of 
device insertion, later from microorganisms migrating from the skin to catheter tip, or after catheter 
hub contamination, and often also by patients’ own skin flora (Safdar, Maki 2004, Levy, Katz et al. 
2005). There is a strong correlation between the number of organisms colonising the insertion site of 
the CVC and the risk of BSI (Levy, Katz et al. 2005).  Chlorhexidine gluconate (CHG), which has 
broad antimicrobial activity, prolonged residual effect, and superiority over iodophor skin 
preparations, is the recommended agent for disinfecting skin before catheter insertion in surgical 
patients (Bleasdale, Trick et al. 2007, Safdar, Maki 2004, O'Grady, Alexander et al. 2011). 
 
Risk factors for surgical site infections (SSIs) after paediatric cardiovascular surgery 
The reported incidence of SSIs in postoperative cardiac patients ranges from 26% - 27% in studies 
conducted in the Netherlands (Algra, Driessen et al. 2012) and Egypt (Hafez, Saied et al. 2012) to 1% 
- 7.5% in studies conducted in USA (Woodward, Son et al. 2011) and Israel (Grisaru-Soen, Paret et 
al. 2009) respectively. Similar to this study, Algra et al (Algra, Driessen et al. 2012) had an 
institutional prophylactic antibiotic policy perioperatively, compared to the Egyptian authors (Hafez, 
Saied et al. 2012) who reported no uniform guidelines were in place guiding antibiotic prophylaxis to 
prevent SSIs.  The patient setting for the study conducted by Grisaru et al (Grisaru-Soen, Paret et al. 
2009) was similar to our institution, admitting about 380 postoperative cardiac patients annually to the 
general PICU, however the study patient population was significantly younger (52% < 2 months of 
age). Various risk factors for SSIs after paediatric cardiovascular surgery have been reported and are 
outlined in Table 2. 
 
Preoperative risk factors include: Younger age, previous sternotomy and prolonged preoperative 
hospital / ICU stay. Patients with a higher preoperative leukocyte count had an increased risk for SSIs 
(Levy, Ovadia et al. 2003, Ben-Ami, Levy et al. 2008, Costello, Graham et al. 2010, Sohn, Schwartz 
et al. 2010). Intraoperative factors include: longer duration of surgery, use and duration of CPB, use 
of deep hypothermia and intraoperative blood transfusions (Nateghian, Taylor et al. 2004, Costello, 
Graham et al. 2010). Postoperative factors include: delayed sternal closure, prolonged ventilation, low 
cardiac output, prolonged use of central vascular catheters (CVC), prolonged ICU stay and elevated 
leukocyte count (Allpress, Rosenthal et al. 2004, Nateghian, Taylor et al. 2004, Ben-Ami, Levy et al. 
2008, Alvarez, Fuentes et al. 2012).  
 
A recurring factor identified as contributing to increased risk was younger age (< 2 months) (Allpress, 




postulated that this population group inherently has an increased risk for HAIs post cardiac surgery 
since the surgeries are expected to be complex and high risk with patients having prolonged hospital 
and ICU stays (Pollock, Ford-Jones et al. 1990, Mrowczynski, Wojtalik et al. 2002). 
 
Sohn et postulated that the complexity of congenital cardiac defects and the aggressive medical 
management required to support patients through their recovery placed children at high risk for SSI 
(Sohn, Schwartz et al. 2010). The authors concluded that the use of perioperative medical 
interventions increased the risk of SSI in young children after cardiac surgery. However, the study 
also concluded that multiple severity of illness scores [Pediatric risk of Mortality III (PRISM III), 
Neonatal Therapeutic intensity scoring system (NTISS), Therapeutic intensity scoring (TISS-76)], the 
Risk Adjustment for Congenital Heart Surgery (RACHS-1) category, and longer duration of 
postoperative antimicrobials were not associated with SSI. 
 
A study conducted by Woodward et al, (Woodward, Son et al. 2011) aimed to determine the incidence 
of, and preventative practice regarding paediatric surgical site infections. A 31-question on-line 
survey regarding paediatric SSIs was sent to 89 congenital heart programs. The study concluded that 
neither program size nor delayed sternal closure were associated with increased incidence of SSIs and 
that variations in preoperative measures, antibiotic regimens, and wound care did not statistically 
impact the incidence of SSI. Programs with protocols to monitor and control blood glucose levels 
postoperatively had statistically lower infection rates (1.04 vs. 2.35, P  = 0.03). A limitation to the 
study is the level of non-responders to the online and mailed surveys. Thirty-eight (43%) of the 89 
programs responded which the authors acknowledged was a concerning source of bias. They argued 
that despite this limitation the data reflected valuable new information about the institutional protocols 
and policies of a large number of paediatric cardiac surgery programs. One has to challenge the data 
obtained from this study due to the low response rate and the inherent biased nature of questionnaire-
based studies that rely on the individual responder’s perception of their clinical practice.  
 
As with other HAIs in postoperative paediatric cardiac patients, various prevention strategies such as 
antibiotic prophylactic regimes and infection control policy implementation have been used to reduce 
the incidence of SSIs. Skin decontamination as part of an infection control policy with 4% 
Chlorhexidine gluconate pre-operative bathing has been shown to reduce microbial counts on the 
skin, including gram negative and gram positive organisms, and reducing incidence of SSIs 
(Bleasdale, Trick et al. 2007). Antimicrobial prophylaxis using Cefazolin has been shown to be 






Higher risk severity scores are associated with developing HAI, and specific risk factors such as 
prolonged ventilation, prolonged use of central vascular access may in turn contribute to prolonged 
ICU stay. However, it is unclear what the primary risk factor would be e.g. prolonged CVC use occurs 
in a patient with BSI to administer antibiotics versus the child developed a BSI due to prolonged use 
of CVC due to prolonged ICU stay? Teasing out specific risk factors and the overlapping effect of 
each is why more studies are needed into HAIs in this population group.  
 
In review, unfortunately, the majority of these studies have small sample sizes. The protocols for 
preoperative care, prophylactic antibiotics, wound care and follow up after surgery differ between the 
studies. This makes it difficult to compare findings and relate these findings to the wider population of 
paediatric cardiac surgery patients. It becomes evident that multiple factors contribute to increasing 
risk of SSIs in postoperative cardiac patients with younger age (< 2 months) being a consistent risk 
factor. This suggests that infection prevention strategies should be directed particularly at ways to 
reduce risk of acquiring HAIs in this vulnerable group of younger patients.
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Impact of delayed sternal closure on HAIs after paediatric cardiovascular surgery 
Delayed sternal closure (DSC) may be required in the care of paediatric patients who have 
undergone cardiac surgery to minimise postoperative respiratory and hemodynamic instability (Jogi, 
Werner 1985, Gangahar, McGough et al. 1981, McElhinney, Reddy et al. 2000, Ozker, Saritas et al. 
2012). 
 
Although necessary for the treatment of certain unstable patients, DSC may expose patients to an 
increased risk of HAIs, including bloodstream (Das, Rubio et al. 2011) and surgical site infections 
(SSIs) (Shin, Jhang et al. 2011) (Table 3). Ozker et al (Ozker, Saritas et al. 2012) significantly 
associated an increased mortality rate with increased cross clamp time (CCT) and DSC in 
postoperative paediatric cardiac patients. The limitations of these studies include their retrospective 
nature, small sample size, variability in antibiotic treatment and prophylaxis protocols, and variability 
in patient profiles. DSC is frequently used in more complex surgical cases as indicated by the high 
mean comprehensive Aristotle score (13.2 ± 3.1) in the study conducted by Shin et al. Johnson et al 
(Johnson, Jaggers et al. 2010) and Das et al (Das, Rubio et al. 2011) tried to overcome the limitations 
by choosing a specific comparable cohort of neonatal patients with hypoplastic left heart syndrome 
(HLHS) after cardiac surgery. Johnson et al (Johnson, Jaggers et al. 2010) suggested that more 
frequent use of delayed sternal closure is associated with longer length of stay and higher 
postoperative infection rates. Das et al (Das, Rubio et al. 2011) reported that their neonatal study 
population, undergoing stage 1 Norwood procedure, with DSC had a fourfold increased risk of 
developing bloodstream infection in-hospital. 
 
In contrast to this study’s patient population, the study populations’ of Johnson et al (Johnson, Jaggers 
et al. 2010), Das et al (Das, Rubio et al. 2011) and Shin et al (Shin, Jhang et al. 2011) were limited to 
DSC following palliative cardiac procedures in neonatal patients. Similar to this study’s patient 
profile DSC was performed following various cardiac conditions in the studies conducted in Turkey 
(Ozker, Saritas et al. 2012), USA (Harder, Gaies et al. 2013) and Canada (Bowman, Rebeyka et al. 
2013). 
 
Maintenance of sternal opening care also varied between the studies e.g. Shin et al (Shin, Jhang et al. 
2011) applied sternal traction sutures to increase the volume of the thoracic cavity and irrigated the 
mediastinal space with a crystalloid solution every two days from the day of sternal opening (Shin, 
Jhang et al. 2011). Ozker et al (Ozker, Saritas et al. 2012) used a rigid plastic material to keep the 




was sutured to the skin with running polypropylene sutures. The dressing was changed in ICU daily in 
an aseptic manner. In some cases sterna were left open but skins were closed primarily. Their study 
patients were evaluated for sternal closure on a daily basis and taken to theater for closure trial when 
ready. 
 
Shin et al (Shin, Jhang et al. 2011) reported that prolonged ventilator support and complexity of the 
cardiac anomaly increase the risk of adverse outcomes after procedures to repair congenital cardiac 
anomalies. After adjusting for these variables, duration before DSC did not appear to be a risk factor 
for surgical mortality, postoperative infection, or wound dehiscence. Strategies to prevent BSIs in 
paediatric postoperative cardiac patients therefore could be directed at reducing duration of ventilator 
support rather than focussing on factors associated with delayed sternal closure. Harder et al and 
Bowman et al also concluded that the duration of DSC was not a significant risk factor for SSI 
(Harder, Gaies et al. 2013, Bowman, Rebeyka et al. 2013).  
 
These studies do not provide a clear consensus of whether delayed sternal closure is a risk factor for 
SSIs and rather indicate that multiple strategies may be needed to reduce the risk for HAIs in 
postoperative cardiac patients. Recurring at risk groups identified within postoperative cardiac 
patients are younger age (neonatal age) and increased severity of cardiac condition. The risk factor 
may well be neonatal age more than actual DSC, thereby, suggesting this group of cardiac patients be 
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Risk factors for nosocomial pneumonia including ventilator associated pneumonia (VAP) after 
paediatric cardiovascular surgery 
Nosocomial pneumonia has been defined according to criteria of the Centers for Disease Control and 
Prevention (CDC) (Centers for Disease Control and Prevention 2014). VAP is defined as nosocomial 
pneumonia developing 48 hours or more after initiation of mechanical ventilation (Roeleveld, Guijt et 
al. 2011). Nosocomial pneumonia (NP) represents an important cause of morbidity and mortality in 
postoperative paediatric cardiac patients and increases hospital costs (Tan, Sun et al. 2004). 
 
General risk factors for NP in ICU patients include the prior administration of broad spectrum 
antibiotics (e.g. third generation cephalosporins) (Tan, Sun et al. 2004), duration of mechanical 
ventilation, severity of illness, reintubation, transport out of the ICU and the use of histamine-2 
blockers (Chastre, Fagon 2002, Alvarez, Fuentes et al. 2012). Nosocomial pneumonia, including 
VAP, in postoperative paediatric cardiac patients has frequently been associated with complex CHD 
compared to simple CHD (see Table 4) (Tan, Sun et al. 2004).  Roeleveld et al (Roeleveld, Guijt et al. 
2011) associated VAP development with transfusion of fresh frozen plasma (FFP) and high patient 
mortality risk scores (Roeleveld, Guijt et al. 2011). Patients with VAP in this population group have 
been shown to have longer duration of ventilation and longer ICU stay (Roeleveld, Guijt et al. 2011, 
Rosanova, Allaria et al. 2009). 
  
Duration of mechanical ventilation (MV) has become a critically important issue for resource 
allocation and is correlated with postoperative morbidity and mortality. Prolonged mechanical 
ventilation (PMV) after cardiac surgery in children has been associated with postoperative morbidity 
and mortality, as well as increased ICU and hospital resource utilisation. Shi et al (Shi, Zhao et al. 
2008) also reported that independent risk factors for prolonged mechanical ventilation in infants and 
neonates were higher RACHS-1 (risk adjustment for surgery for congenital heart disease (P = 0.041), 
nosocomial pneumonia (P = 0.001), low cardiac output syndrome (P = 0.001), postoperative 
cumulative positive fluid balance (P = 0.032), and extubation failure (Shi, Zhao et al. 2008). 
Extubation failure was defined as the reinstitution of mechanical ventilator support (including non-
invasive mechanical support) within 24 hours after extubation (Shi, Zhao et al. 2008). Their study 
population was much younger (≤ 3 months) yet mechanically ventilated shorter durations (median 48 
hours) compared to Fischer et al  (median age 1.3 years; median MV duration 3 days) who reported a 
lower VAP rate (9.6%) and did not associate rate of VAP with increased complexity of surgery.  
Fisher et al reported a 3.7 days median delay of extubation in children following surgery for CHD 
attributable to VAP (Fischer, Allen et al. 2000). This study’s population age was similar to Fischer et 




surgeries admitted annually to their PICU compared to approximately 300 admitted annually 
postoperatively to this institution. 
 
Siddiqui et al (Siddiqui, Mir et al. 2011) and Tantawy et al (Tantawy, Seliem et al. 2012) are two 
studies with similar study populations and settings, both reporting a high VAP rate (38.5% and 35% 
respectively) with significant differences in nurse-to-patient ratios (1:1 and 1:3-4 respectively). This 
may once again reflect the importance of strict implementation and adherence to the institutional 
Infection Control policy. This study’s staffing setting was similar to Siddiqui et al (Siddiqui, Mir et al. 
2011) with a nurse-to-patient ratio of 1:1 and their study population similarly included patients 
ventilated preoperatively. 
 
Nosocomial pneumonia and prolonged duration of ventilation are inherently linked and each is a risk 
factor for the other. The risk factors contributing to NP and PMV thus have to be identified and 
effective preventive measures adhered to such as infection control policies and early extubation from 
mechanical ventilation.  
 
These study findings are limited by small sample size, retrospective nature of the studies and 
differences in patient and cardiac surgery profiles. However, it is important to note that recurring risk 
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Incidence and risk factors of urinary tract infections (UTIs) in postoperative paediatric cardiac 
patients 
Incidence and risk factors of urinary tract infections (UTIs) in postoperative cardiac patients are 
presented in Table 5. Incidence varies from 1% to 17.2% with identified risk factors being younger 
age, poor hand hygiene, prolonged duration of hospital stay and prolonged use of urinary catheter 
device (Tantawy, Seliem et al. 2012, Siddiqui, Mir et al. 2011, Algra, Driessen et al. 2012, Grisaru-
Soen, Paret et al. 2009, Dudeck, Horan et al. 2011, Rosanova, Allaria et al. 2009, Mastropietro, 
Barrett et al. 2013). Mastropietro et al (Mastropietro, Barrett et al. 2013) reported the highest rate 
(17.2%) in their cohort of patients limited to younger age (≤ 5yrs), higher duration of ICU stay (≥ 7 
days) and higher basic Aristotle score (≥ 7). Despite the increased cardiac disease severity score (ASA 
score ≥ 3) reported in the Argentinian study (Rosanova, Allaria et al. 2009) the reported incidence of 
UTI in this population group was the lowest.  
 
This study’s setting was similar to Rosanova et al (Rosanova, Allaria et al. 2009) with approximately 
350 postoperative cardiac patients admitted annually to the PICU, however our population group was 
younger and had a lower cardiac disease severity scoring. Strategies adopted by Tantawy et al 
(Tantawy, Seliem et al. 2012) in their PCICU to reduce UTI and overall HAI rates included specific 
urinary catheter care supervision modules and random unplanned observations of hand washing 
between patients of attending nurses. Adherence to infection control policies has emerged as an 
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Immune and inflammatory responses after cardiopulmonary bypass (CPB) 
Some patients require cardiac surgery with CPB. In addition to the other factors associated with HAI, 
CPB induces immune responses that contribute to relative immunosuppression and may predispose 
to HAI (Wheeler, Jeffries et al. 2011, Fuhrman, Zimmerman et al. 2011). CPB in combination with 
ischemia-reperfusion injury, hypothermia, and surgical trauma, elicits a complex, systemic 
inflammatory response syndrome (SIRS) that is characterized by activation of the complement, 
coagulation and fibrinolytic pathways, release of endotoxin, activation of leukocytes and the vascular 
endothelium, and release of pro-inflammatory cytokines (Wheeler, Jeffries et al. 2011, Fuhrman, 
Zimmerman et al. 2011). Collectively, these pathways result in endothelial damage, capillary leak and 
organ dysfunction (Fuhrman, Zimmerman et al. 2011). The magnitude of this response varies 
(Gravlee 2008, Raja, Dreyfus 2005). SIRS in its most severe form may include one or more of the 
following clinical manifestations: pulmonary, renal, gut, central nervous system, and myocardial 
dysfunction; coagulopathy; vasoconstriction; capillary permeability; vasodilatation; accumulation of 
increased interstitial fluid; haemolysis; pyrexia; and increased susceptibility to infections and 
leucocytosis (Gravlee 2008).  
 
Efforts to limit inflammation include design of smaller circuits to reduce requirements for blood in the 
prime, the use of biocompatible circuits, the addition of steroids to the prime, and the use of modified 
ultrafiltration at the termination of bypass (Fuhrman, Zimmerman et al. 2011). Lowering the 
temperature of the patient has also been shown to reduce adherence of neutrophils to the endothelium 
(Gravlee 2008). These manoeuvres are intended to limit blood-circuit interactions, decrease the 
production of mediators, and filter inflammatory mediators out of the circulation (Fuhrman, 
Zimmerman et al. 2011). CPB temperature has been considered but not proven to have an effect on 
HAI (Stocker, Shekerdemian et al. 2011). 
 
CPB affects both the innate and adaptive immunity systems. CPB generates an unphysiologic 
(detrimental) innate immune response manifested as a whole body SIRS. At the same time, CPB 
induces the cellular and humoral constituents of the adaptive immune system to undergo quantitative 
and qualitative changes, leading to a temporary immunodeficiency. The degree of immunosuppression 
is directly related to the magnitude and duration of the surgical procedure, to the volume of transfused 
blood and duration of CPB (Gravlee 2008).  
 
Longer durations of surgery and CPB time have previously been identified as independent risk 




Nateghian, Taylor et al. 2004). The authors (Allpress, Rosenthal et al. 2004) postulated that the 
reasons for this risk association included: possible increased bacterial contamination of the operative 
site with increased duration of surgery, and cellular damage resulting from drying and handling of 
tissues. Longer procedures are also a marker for more complex procedures, which is another variable 
that may contribute to risk of infection (Allpress, Rosenthal et al. 2004). Nahum et al reported longer 
duration of CPB had been associated with bacterial infection in febrile postoperative paediatric 
cardiac patients (Nahum, Schiller et al. 2012). An Egyptian study (Tantawy, Seliem et al. 2012) 
reported a significant mortality risk amongst postoperative cardiac patients who had prolonged CPB 
and ischemic times, and developed HAIs. 
 
 Bayer et al (Bayer, Dogan et al. 2009) demonstrated that CPB produced an absolute decrease in the 
number of circulating cells in most lymphocyte subsets. The most profound decreases were seen in 
the absolute numbers of all lymphocyte subsets in the early postoperative period (Table 6). This state 
of immune suppression may result in an increased risk of sepsis in children undergoing cardiac 
surgery for palliation or repair of CHD.  
 
In addition, there are likely several reasons that children with CHD are at a particularly increased risk 
of HAIs. CPB together with several other predisposing factors may increase the risk and severity of 
infection in postoperative cardiac paediatric patients. These include chronic hypoxia and other co-
morbid conditions associated with cyanotic CHD likely affecting the host immune response, as well 
as the need for invasive supportive devices and technology may also increase the risk of HAI in this 
population (Wheeler, Jeffries et al. 2011). Importantly, sepsis is a significant and independent risk 
factor for increased duration of mechanical ventilation, cardiac intensive care unit (CICU) LOS, 
healthcare costs, and mortality in children with CHD (Wheeler, Jeffries et al. 2011). Further factors 
associated with risk are genetic factors (e.g. 22g11 deletion or DiGeorge sequence), age (increased 
mortality at younger age) (Wynn, Cornell et al. 2010) and nutritional state (increased morbidity with 
malnutrition)(Carcillo 2005, Nguyen, Nguyen et al. 2005). 
 
Genetic and malformation syndromes 
There are several well described genetic and malformation syndromes (e.g., 22q11 deletion or 
DiGeorge sequence and Trisomy 21) that are associated with congenital heart malformations and 
defects in immunity (Wheeler, Jeffries et al. 2011). McDonald (McDonald, Dodgen et al. 2012) 
reported on the impact of 22q11.2 deletion on the postoperative course of children after cardiac 




del22q11 group, and prolonged BSIs and UTIs. Genetic and malformation syndromes may influence 
the clinical and surgical outcomes of congenital heart defects, both because of peculiar anatomic 
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Use of corticosteroids in postoperative paediatric cardiac patients 
Children undergoing congenital heart surgery often receive corticosteroids with the aim of reducing 
the inflammatory response after cardiopulmonary bypass (Graham, Atz et al. 2011). Glucocorticoids 
modulate the inflammatory response, stimulate release of anti-inflammatory cytokines, and play a role 
in limiting capillary leak (Suominen, Dickerson et al. 2005, Kilger, Weis et al. 2003).  
 
 Studies have reported that corticosteroids are effective at reducing levels of certain inflammatory 
markers in this setting). However, mounting evidence questions the benefit of corticosteroids in 
relation to clinical outcomes (Robertson-Malt, Afrane et al. 2007, Graham, Atz et al. 2011, Pasquali, 
Hall et al. 2010) (Table 7).  
 
Some studies have failed to demonstrate a significant clinical benefit associated with corticosteroids 
and found that corticosteroids may be associated with increased morbidity and HAIs (Pasquali, Hall et 
al. 2010, Pasquali, Li et al. 2012). Pasquali et al. published a study in 2010 concluding that 
corticosteroids were associated with longer hospital and ICU length of stay and greater infection rates. 
The same authors published a neonatal study in 2012 and reported no significant mortality or length-
of-stay benefit associated with any methylprednisolone regimen versus no steroids, and no difference 
in postoperative infection. Graham et.al (Graham, Atz et al. 2011) reported on the combined 
preoperative and intra-operative use of glucocorticoids in neonatal cardiac surgery. They concluded 
that steroid use did not favourably affect early clinical outcomes (inotrope support, mechanical 
ventilation, hospital stay). 
 
A study conducted by Clarizia et al 2011 (Clarizia, Manlhiot et al. 2011) found that intra-operative 
steroid use in children (0 – 18 years) was associated with lower chest tube volume loss in the first 24 
postoperative hours, shorter durations of stay in ICU and hospital. Use of an additional preoperative 
dose resulted in further improvements, especially in reducing duration of mechanical ventilation. 
Patients in the cohort who received steroids were younger, had longer CPB and aortic cross-clamp 
times, and had higher incidence of delayed sternal closure. Their findings suggested that targeted use 
of steroids for younger, more complex patients may provide the most benefit. 
 
However Mastropietro et al concluded that for children undergoing complex cardiac surgery, greater 
cumulative duration of corticosteroid exposure was independently associated with postoperative 
infection (Mastropietro, Barrett et al. 2013).
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It is important to note that these studies differ in patient and surgical characteristics (age, surgical 
complexity) and that the administration of steroids differs in terms of time of administration and type 
of steroid used. Retrospective data review is subject to the limitations of the available data in medical 
records or databases. There may be other unmeasured patient or center factors that affect the receipt of 
corticosteroids and / or outcome. These may include, among others, those relating to cardiopulmonary 
bypass protocols, which may vary from center to center, such as the use of modified ultrafiltration 
(Elliott 1993, Andreasson, Gothberg et al. 1993). It is possible that some of these factors may be 
confounding factors not accounted for in the analyses (Pasquali, Hall et al. 2010). 
 
Clarizia et al admitted that the retrospective nature of their study meant that selection bias could not 
be entirely excluded regarding which patients received steroids despite the use of a propensity score to 
adjust for nonrandom assignment. Secondly, while reporting beneficial effects of combined 
preoperative and intraoperative dosing, they were unable to assess outcomes associated with 
preoperative administration alone, or infer an optimal timing for administration of both the 
intraoperative and preoperative dose (Clarizia, Manlhiot et al. 2011). 
 
These studies do not provide a clear consensus of whether corticosteroid use reduces risk of acquiring 
HAIs in this population group. The studies rather suggest that emphasis should be on reducing 
cumulative corticosteroid exposure in postoperative cardiac surgery patients in order to reduce risk of 
developing HAIs. 
 
Red blood cell (RBC) transfusion in paediatric cardiac surgery patients 
Costello et al reported that younger patients undergoing longer surgical procedures and those 
requiring more postoperative blood transfusions were at greatest risk for SSI (Costello, Graham et al. 
2010). These findings were supported by a study done by Salvin et al. (Salvin, Scheurer et al. 2011) 
who reported that patients requiring RBC transfusion were younger, more likely to have single 
ventricle physiology, required more complicated cardiac surgery, and were more acutely ill than those 
in the low transfusion (< 15ml/kg) or non-transfusion groups. RBC transfusion was associated with 
longer hospital length of stay, and the strongest association was found in the high transfusion group (> 
15ml/kg). 
 
These authors suggested that further investigation is required into whether additional preventive 




Perioperative antibiotic use in paediatric cardiac surgery patients 
Prophylactic antibiotics (Table 8) are routinely given to patients undergoing cardiac surgery to 
prevent the occurrence of nosocomial infections. Prolonged maintenance of therapy seems to increase 
the incidence of multiresistant strains, whereas limitation thereof does not seem to lead to a greater 
incidence of nosocomial infection (Kato, Shime et al. 2007). Kato et al further recommended that the 
implementation of a protocol of perioperative antimicrobial prophylaxis in pediatric cardiac surgery, 
supervised by an infection control expert, might reduce rates of postoperative infection, development 
of resistant pathogens, and lower antibiotic-related costs. 
 
Guidelines by the Society of Cardiothoracic Surgeons recommend that antibiotic use be limited to 48 
or even 24 hours (Bratzler, Houck et al. 2005, Edwards, Engelman et al. 2006). A study conducted by 
Alvarez et al (Alvarez, Fuentes et al. 2012) reported that prolonged antibiotic prophylaxis increased 
the infection rate in postoperative cardiac patients. The study findings supported the statement that 
limiting antibiotic prophylaxis to ≤ 48 hours post surgery does not increase the HAI rate. 
 
Postoperative administration of antibiotics is thus an effective prophylaxis strategy to reduce the risk 
of acquiring HAI in postoperative cardiac patients. It is recommended that duration of use be limited 
to ≤ 48 hours to reduce risk of developing resistant organisms. 
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Diagnosis and treatment of HAIs 
As mentioned above, cardiac surgery with extracorporeal circulation (CPB) often evokes a systemic 
inflammatory response syndrome (SIRS). Fever is the main symptom, and intervention is usually not 
necessary. However, sometimes fever following cardiac surgery is a sign of early bacterial infection 
warranting antibiotic therapy (Nahum, Schiller et al. 2012). Sensitive and specific markers of 
infection are, therefore, needed to distinguish patients with systemic infection from unwell patients 
who are not septic or those infected with viruses. A summary of studies identifying reliable septic 
markers in postoperative cardiac patients is presented in Table 9. 
 
Among several inflammatory markers used are procalcitonin (PCT), C-reactive protein (CRP) and 
immature leukocytes (bands) (McMaster, Park et al. 2009). SIRS also causes increases in these 
inflammatory markers, which may make the accurate clinical and laboratory diagnosis of infection in 
the post-CPB patient difficult (McMaster, Park et al. 2009). Appropriate treatment of sepsis relies 
on early and accurate diagnosis and contributes to reduced morbidity and mortality (Hatherill, Tibby 
et al. 1999). Conversely, more accurate diagnosis of sepsis will reduce unnecessary antibiotic use and 
hence reduce the risk of selecting out resistant organisms.  
 
Procalcitonin (PCT) has relatively recently been considered to be one of the best markers of bacterial 
infection with many advantages. It is an indicator that arises early, with a peak 6 -12 hours after 
bacterial stimulus, and a half-life of 24 - 30 hours (unlike CRP). It is considered to offer greater 
sensitivity and specificity for both invasive and non-invasive infection and allows better 
differentiation between viral and bloodstream infections than C-reactive protein (Nahum, Schiller et 
al. 2012, Garcia, Gargallo et al. 2012). The value of PCT may be uncertain after surgery since it may 
increase moderately in the case of SIRS, as a result of surgical stress due to CPB, without the 
presence of infection. There are limited and conflicting data on the value of PCT in the postoperative 
period in children and regarding its superior discriminatory power compared to other markers of 
infection after CPB (Garcia, Gargallo et al. 2012, Beghetti, Rimensberger et al. 2003, Rey, Los Arcos 
et al. 2007). 
 
Nahum et al. 2012 (Nahum, Schiller et al. 2012) conducted a study of 665 patients following 
paediatric cardiac surgery and reported significantly higher PCT levels in febrile patients with proven 
bacterial infection (median 5.9 ng/ml vs. median 0.85 ng.ml (P = 0.04). Garcia 2012 (Garcia, Gargallo 




study found the optimal cut off for procalcitonin was > 2 ng/mL at day 1 and > 4 ng/mL at day 2. 
There was a greater sensitivity and specificity than with CRP as an infection predictor. 
 
A combined UK / Australian study (McMaster, Park et al. 2009) compared PCT versus C-reactive 
protein and immature-to-total neutrophil ratio (ITR) as markers of infection after CPB in children. 
This study confirmed in children the findings from adults that PCT concentrations may increase after 
CPB even in the absence of infection.  CRP was found to be a poor marker of sepsis in this study and 
children with a PCT < 2.2 ng/mL or ITR < 0.08 were unlikely to have definite or probable sepsis. The 
authors suggested that an increase in the marker is more likely to suggest infection than a single value, 
particularly in the first days post-bypass. This study supported findings by Celebi et al that daily PCT 
measurements in patients might help identify postoperative infections (Celebi S, Koner O, et al, 
2006). 
 
Seguela (Seguela, Joram et al. 2011) conducted a French study to evaluate the diagnostic value of 
PCT as a marker of infection after CPB in children The study reported that the best cut-off value to 
differentiate infected children from healthy children was 13 ng/mL with 100% sensitivity and 85% 
specificity, before the third postoperative day. The authors suggested that a PCT done earlier during 
the postoperative period avoided unnecessary treatment or non-initiation of treatment of infections. In 
addition, the authors commented that McMaster et al (McMaster, Park et al. 2009) were interested 
only in overall PCT values until the fifth postoperative day and that no distinction had been made 
according to the normal PCT rise in the immediate 2–3 days after cardiopulmonary bypass (Seguela, 
Joram et al. 2011). Seguela suggested therefore that high PCT values of the initial postoperative days, 
before the third postoperative day, might have been reduced enabling earlier detection of infection. 
The authors further recommended the PCT measurement be repeated during the postoperative period 
(Seguela, Joram et al. 2011) to guide the clinician regarding antibiotic treatment duration. 
 
A study conducted by Nguyen-Vermillion et al (Nguyen-Vermillion, Juul et al. 2011) showed that the 
perioperative patterns of CRP differed by diagnosis and inflammatory state. The authors concluded 
that serial measurements might be more informative than CRP magnitude. This was supported by a 
study done by Nahum et al (Nahum, Livni et al. 2012) who reported on serial measurements of C-
reactive protein (CRP) and whether CRP velocity (rate of the change in CRP from the morning after 
surgery to fever day) after cardiac surgery in children may assist clinicians in differentiating 
postoperative fever due to bacterial infection from fever due to non-infectious origin. The authors 
reported a highly significant change in CRP over time among febrile patients with proven bacterial 




CRP / CRP velocity should not serve as the sole tool for this purpose, and it should be combined with 
other clinical and laboratory data and good clinical judgment (Nahum, Livni et al. 2012). 
 
These studies differ in sample size, population characteristics, institutional infection rates, 
postoperative management protocols and antibiotic protocols. These factors limit the extrapolation of 
their findings to other institutions and population groups. An important point to note from the studies 
is the trend of changes over time rather than an absolute value when using these markers to diagnose 
infection in postoperative cardiac patients. A second important point is that in children who develop 
proven or suspected bacterial sepsis, PCT has been found to be a more useful marker than CRP or 
ITR, where these values are more affected by CPB. PCT changes more quickly than ITR, and the test 
is more reproducible resulting in the earlier initiation of antibiotic therapy. PCT and ITR had good 
negative predictive power, meaning that a child with a normal test was unlikely to have sepsis so that 
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NEEDS FOR FUTURE RESEARCH 
Studies detailing the epidemiology of HAIs in postoperative cardiac patients have identified various risk factors and suggested many 
management strategies for preventing and treating infections in this population group. Presently there are no South African paediatric 
studies of HAIs in cardiac surgery patients. The studies thus far have been limited by various factors that prevent the extrapolation of 
findings to this institution and the subgroups of postoperative cardiac patients.  
 
Future studies need to be more homogenous in terms of: 
 Study type: prospective randomised controlled studies or cohort studies are required 
 Study population: age groups such as the high risk neonatal group, adequately powered study 
 Associated co morbidities: genetic and malformation syndromes, nutrition state 
 Surgical complexity category 
 Infection control practices: preoperative, intraoperative and postoperative including: chlorhexidine body washing protocols, 
antimicrobial prophylaxis, antibiotic treatment, wound care, management of catheter device associated infection protocols, 
infection surveillance protocols 
 Preoperative care: duration of hospital stay preoperatively, infection surveillance protocols 
 Intraoperative care: CPB and surgical practices including sternal closure policies 
 Postoperative care: duration of mechanical ventilation, use of blood and blood product protocols, staff to patient ratios, glucose 
control protocols 
 
Recurring risk factors within the studies are younger age especially the neonatal age group and age < 2months, low birth weight, 
increased surgical complexity, increased duration of ICU and hospital stays, prolonged ventilation, prolonged use of catheter devices 
and adherence to infection control and prevention policies. 
 
Factors not clearly associated as risk factors were: corticosteroid use perioperatively, open chest postoperatively, hyperglycaemia 
postoperatively, presence of genetic abnormality and previous cardiothoracic surgery. The questions still to be answered include: 
 What are the specific risk factors for HAI for the individual postoperative cardiac paediatric patient and how are these to be 
addressed? 
 Does reducing specific risk factors have a clinically relevant implication on outcome for HAIs, in reducing associated 
morbidity and mortality? 
 
It is evident that the associated factors contributing to the risk for HAIs are multifactorial. Further studies are needed to identify 
modifiable factors such as presence of a viral or bacterial infection in the preoperative period, anemia, increased duration of 
hospitalisation prior to surgery, prolonged use of intravascular catheters, staffing resources. Currently, inconsistencies in information 
exist within these identifiable risk factors, methods to reduce infection rates and how these methods affect clinical outcomes in the post 
surgical cardiac paediatric patient. It is noticeable that studies investigating the role of viruses in perioperative HAIs in paediatric 
cardiac patients have been limited and this needs to be addressed. 
 
The aim of identifying these risk factors in the cardiac surgery patient and rectifying inconsistencies in information would be to develop 






The aim of the study was to determine the incidence of HAIs in postoperative cardiac patients admitted to the PICU at the Red Cross 
War Memorial Children’s Hospital (RCWMCH). 
 
OBJECTIVES 
 To describe risk factors associated with HAIs in all children following cardiac surgery  
 To describe morbidity associated with HAIs versus uninfected patients 
 To describe the outcomes of patients (mortality, duration of PICU and hospital stay) with HAI compared to those who did not 
develop HAI 
 To identify possible strategies for preventing infections and optimising clinical management 
 
The information collected from this study could highlight the impact of acquired infections in post cardiac surgery patients. Measures 
can be identified to reduce and prevent resulting morbidity and mortality in this group of patients. This study will provide the baseline 
against which future practice improvement initiatives can be compared and benchmarked.  
 
MATERIALS AND METHODS 
 RCWMCH is a tertiary academic hospital affiliated with the University of Cape Town, South Africa.  It has a multidisciplinary twenty 
bed PICU that admits approximately 1200 patients per year, of which 250 – 300 are admitted postoperatively following cardiac 
surgeries. 
This was a prospective observational study of all patients admitted to the PICU at RCWMCH following cardiac surgery during the 
period 19 September 2011 to 19 March 2012. There were no exclusion criteria. 
Ethics approval was obtained from Faculty of Health Sciences Human Research Ethics Committee, University of Cape Town 
(Appendix 2). 
Admitting wards were defined as the ward the patient was admitted from > 24 hours prior to going to theater. When a patient was 
admitted to a hospital ward on the morning of surgery, the patient was accepted as an admission from home. Some patients stayed with 
their mothers in the mother’s accommodation (usually shared accommodation with parents of other children in the hospital) and were 
defined as being admitted from the Mother’s room. 
All children were weighed in their admitting wards prior to surgery by the nursing staff present on the patient’s admission. Height 
(standing in toddler or older child) and length (neonate / infant) were documented in the admitting wards on the day of admission or 
checked by the principal investigator if not previously documented.  
Daily data were collected, using a standardised data collection form, by the principal investigator (Appendix 3). Demographic, clinical, 
procedural and microbiological data were collected from the patients’ medical records; and haematology, chemical pathology and 
microbiology laboratory records. Each patient was evaluated daily for evidence of a HAI. Data collected included: 
a) Date / time of hospital and PICU admission and discharge. 
b) Patient characteristics: age, growth parameters (height / length and weight data were collected and then expressed as a 
proportion of expected weight for age and expected height for age using World health organisation (WHO) standards), cardiac 
defect type, previous cardiac surgery details, preoperative medications.  
c) Surgical information: type of surgical procedure and operation details. 
d) Markers of inflammation: temperature, PCT, WCC, bands, haemoglobin, platelet count, glucose readings, pulmonary 
secretions, PaO2 / FiO2 ratio, chest radiography findings. The worst values over the preceding 24 hours were recorded. Data 




e) Identification of positive cultures including the identification of the pathogen and the infection source (wound, urine, chest, 
blood, CRBSI etc.). 
f) Opinion of physician treating the patient whether the infection required treatment. 
g) Antibiotics provided. 
h) Details of events postoperatively: Bleeding, reintubation, cardiac arrest, chest-reopened, organ failure.  
 
OPERATIVE MANAGEMENT OF PAEDIATRIC CARDIAC PATIENTS 
In our institution different anaesthetists and five cardiothoracic surgeons shared the surgical work list. All patients undergoing cardiac 
surgery had percutaneously placed intravascular central lines before or at the time of surgery. Plain uncoated catheters were used as 
intravascular central lines in all patients. Anaesthetists generally placed the catheters at the time of surgery or the physician in the PICU 
before surgery placed the catheters. Atrial and ventricular pacing wires were placed by the cardiothoracic surgeons as well as 
transthoracic and transatrial lines if required.  
 
The standard protocol in place during the study period was that all patients undergoing cardiac surgery received intravenous cefazolin 
50 mg/kg/dose at the start of surgery and 6 hourly thereafter until the completion of surgery. A minimum of two doses were given, the 
second dose in PICU if operation duration was less than six hours. The patients with an open chest postoperatively were intended to 
receive 6 hourly doses of cefazolin until the chest was closed. “Adequate antibiotics given” was defined as complying with the above 
regimen. “Inadequate antibiotics” was defined as poor adherence to correct dosing, incorrect timing of antibiotic prophylaxis and doses 
not being prescribed. 
 
Steroids were not administered according to a standard protocol during the study period. Intraoperatively, steroids were given at the 
discretion of the attending anaesthetist who decided on dosage, frequency and type of steroid if administered.  
 
Patients who underwent cardiac surgery with CPB had CPB commenced using a Kids Infant oxygenator (Sorin® / KiDS®) together with 
a standard in-line filter. The priming solution consisted of packed red blood cells or stabilised human serum (SHS). Intermittent 
antegrade infusion of cold crystalloid St. Thomas solution No. 2 (Plegisol®, MMCTSLink 87) was administered as cardioplegia. The 
degree of hypothermia used (moderate – deep) and the use of ultrafiltration during rewarming was based on cardiothoracic surgeon / 
anaesthetic opinion.  
 
The indication for delayed sternal closure was decided by the cardiothoracic surgical team and usually included the more complex 
surgical cases. Chest closure was done in the PICU within 48 hours post surgery unless further complications arose preventing chest 
closure (e.g. massive fluid overload, cardiovascular instability). 
 
PROTOCOLS FOR THE CARE OF POSTOPERATIVE CARDIAC PATIENTS ADMITTED TO THE PICU 
Four paediatric intensivists led PICU management with consultation from the cardiothoracic surgery team. Analgesia was sustained 
with continuous infusions of morphine and, if deemed necessary by the attending PICU physician, midazolam infusion and / or oral 
clonidine was added.  
 
All catheters and skin sites were checked routinely as part of daily nursing care. The catheters were covered with sterile transparent 
adhesive cover after initial insertion. Routine change of central lines has not been adopted as a policy in our unit. Central lines are 




infection control measures in the PICU stipulated that each time a central intravascular line was accessed, a sterile gauze pack with 
0.5% chlorhexidine gluconate in 70% alcohol was used to clean the line port and to provide a sterile working surface. 
 
On admission to the PICU postsurgery the patient had routine bloods taken, including arterial blood gas, full blood count, electrolytes, 
urea, creatinine and a coagulation profile. Thereafter the full blood count, arterial blood gas and renal markers were repeated four 
hourly for 24 hours. The coagulation profile was repeated if clinically indicated (signs of bleeding) or previously abnormal. All patients 
had routine chest radiography on admission to ICU following cardiac surgery. Radiography was repeated based on clinical assessment 
and physician decision. 
 
Fever (>38°C) within the immediate 24 hour postoperative period was only investigated further if clinically indicated by increased 
inflammatory markers (increased WCC, immature leukocyte count or leucopaenia / neutropaenia) on routine bloods taken postsurgery, 
increasing organ dysfunction (hypotension, hypothermia, apnoea, vomiting, bradycardia, increased or altered pulmonary secretions) 
and criteria meeting the definitions of HAIs. The investigation guidelines used when an infection was suspected in the postoperative 
cardiovascular patients are shown in Appendix 4. The flow diagram was developed by consensus through a working group in the PICU. 
According to the guidelines for infection investigation all patients would have a blood culture done under sterile conditions when 
infection was suspected. One or more blood cultures were taken using a sterile technique via intravascular central lines or peripherally 
when clinically indicated for suspected BSI. Blood cultures were taken from the arterial catheter when available. If the arterial catheter 
could not be accessed to withdraw blood then the central venous catheter was used. If no central intravascular lines were accessible 
then a sterile peripheral blood culture was done. Urine dipstick via sterile urinary catheter collection was checked for nitrates / 
leukocytes and if positive was sent to the laboratory for microscopy, culture and sensitivities (MCS).  
 
All wound sites were reviewed for pain, tenderness, localised swelling, redness, heat and pus. If any of these were present a pus swab 
was collected using an aseptic technique and sent for microscopy, culture and sensitivity investigation (MCS). Patients were not 
routinely screened for resistant organisms (MRSA) pre- or postoperatively. 
 
Clinical signs and laboratory markers of infection appearing within 48 hours after cardiac surgery were considered to indicate infection 
acquired prior to surgery.  The increasing trend of PCT, leukocyte count and immature leukocyte count or the presence of leucopoenia / 
neutropaenia were used as indicators of infection within the clinical context of signs of suspected infection. In accordance with the 
CDC definitions for diagnosing HAIs and CPIS criteria for diagnosing VAP during this study total leukocyte count and immature 
leukocyte count were used. In addition the physician treating the patient used these markers with trend of increasing PCT as indicators 
of infection. According to the the study protocol, specimens were to be collected on patients when an infection was suspected and 
required further investigation. Due to this study being observational I did not intervene in patient management by dictating to the 
attending physician when to collect or not collect the specimens. I recorded the results of all specimens collected from the study 
patients during their PICU admission. 
 
 For the purposes of this study, PICU hospital acquired infection (related to cardiac surgery) was defined as an infection not present or 
incubating at the time of PICU admission after cardiac surgery, with an onset of at least 48 hours postoperatively. Patients with an 
infection or on antimicrobials prior to surgery were not excluded from the study. Patients who developed infection within 48 hours after 
cardiac surgery and had not been in a hospital facility were defined as having a community-acquired infection. Patients who developed 
infection within 48 hours after cardiac surgery and had been in a hospital facility (ward other than PICU, mother’s room area, other 
hospital) were defined as HAI outside PICU.   
 
The definitions of Laboratory confirmed blood stream infections (BSI), urinary tract infections (UTI), and surgical site infections were 




CDC definition of BSI: 
 Patient has a recognised pathogen cultured from one or more blood cultures and organism cultured from blood is not related to 
an infection at another site 
or 
 Patient has at least one of the following signs or symptoms: fever (>38oC), chills, or hypotension and positive laboratory results 
are not related to an infection at another site 
or 
 Patient ≤ 1 year of age has at least one of the following signs or symptoms: fever (> 38oC core), hypothermia (< 36oC core), 
apnea, or bradycardia and positive laboratory results are not related to an infection at another site 
 
CDC definition of UTI: 
 Patient had an indwelling urinary catheter in place for >2 calendar days, with day of device placement being Day 1, and 
catheter was in place on the date of event and at least 1 of the following signs or symptoms: fever (> 38°C); suprapubic 
tenderness*; costovertebral angle pain or tenderness*  and a positive urine culture of ≥ 105 colony-forming units (CFU)/ml 
with no more than 2 species of microorganisms. Elements of the criterion must occur within a timeframe that does not exceed a 
gap of 1 calendar day between two adjacent elements  
or 
 Patient had an indwelling urinary catheter in place for > 2 calendar days and had it removed the day of or the day before the 
date of event  and at least 1 of the following signs or symptoms: fever (> 38°C); urgency*; frequency*; dysuria*; suprapubic 
tenderness*; costovertebral angle pain or tenderness* and a positive urine culture of ≥105 colony-forming units (CFU)/ml with 
no more than 2 species of microorganisms. Elements of the criterion must occur within a timeframe that does not exceed a gap 
of 1 calendar day between two adjacent elements  
*With no other recognised cause 
 
CDC definition of SSI: 
Deep incisional SSI:  
 Infection occurs within 30 or 90 days after the operative procedure (where day 1 = the procedure date) and  
involves deep soft tissues of the incision (e.g., fascial and muscle layers) and patient has at least one of the following:  
a.) purulent drainage from the deep incision b.) a deep incision that spontaneously dehisces or is deliberately opened by a surgeon, 
attending physician** or other designee and is culture-positive or not cultured and patient has at least one of the following signs or 
symptoms: fever (>38°C); localised pain or tenderness. A culture-negative finding does not meet this criterion. c.) an abscess or 
other evidence of infection involving the deep incision that is detected on direct examination, during invasive procedure, or by 
histopathologic examination or imaging test.  
Organ/Space SSI: 
 Infection occurs within 30 or 90 days after the operative procedure (where day 1 = the procedure date) and 
infection involves any part of the body, excluding the skin incision, fascia, or muscle layers, that is opened or manipulated during 
the operative procedure and patient has at least 1 of the following: 
a.) purulent drainage from a drain that is placed into the organ/space b.) organisms isolated from an aseptically obtained culture of 
fluid or tissue in the organ/space c.) an abscess or other evidence of infection involving the organ/space that is detected on direct 
examination, during invasive procedure, or by histopathologic examination or imaging test and meets at least one criterion for a 
specific organ/space infection site.  




Infection occurs within 30 days after any operative procedure (where day 1 = the procedure date), and involves only skin and 
subcutaneous tissue of the incision and patient has at least 1 of the following: 
a.) purulent drainage from the superficial incision b.) organisms isolated from an aseptically obtained culture of fluid or tissue 
from the superficial incision c.) superficial incision that is deliberately opened by a surgeon, attending physician or other 
designee and is culture-positive or not cultured and patient has at least one of the following signs or symptoms of infection: 
pain or tenderness; localised swelling; redness; or heat. A culture negative finding does not meet this criterion d.) diagnosis of 
superficial incisional SSI by the surgeon or attending physician or other designee. 
 
CDC Definition for pneumonia 
Radiology 
 Two or more serial chest radiographs with at least one of the following: a.) New or progressive and persistent infiltrate b.) 
Consolidation c.) Cavitation d.) Pneumatoceles, in infants ≤1 year old  
NOTE: In patients without underlying pulmonary or cardiac disease (e.g., respiratory distress syndrome, bronchopulmonary dysplasia, 
pulmonary edema, or chronic obstructive pulmonary disease), one definitive chest radiograph is acceptable. 
Signs / Symptoms  
At least one of the following: a.) Fever (>38°C or >100.4°F) b.) Leukopenia (<4000 WBC/mm3) or leukocytosis (≥12,000 WBC/mm3)  
For adults ≥70 years old, altered mental status with no other recognized cause and at least one of the following: c.) New onset of 
purulent sputum, or change in character of sputum, or increased respiratory secretions, or increased suctioning requirements d.) New 
onset or worsening cough, or dyspnea or tachypnea e.) Rales or bronchial breath sounds f.) Worsening gas exchange (e.g., O2 
desaturations [e.g., PaO2/FiO2 ≤240], increased oxygen requirements, or increased ventilator demand 
Laboratory 
At least one of the following: a.) Positive growth in blood culture not related to another source of infection b.) Positive growth in 
culture of pleural fluid c.) Positive quantitative culture from minimally contaminated LRT specimen (e.g., BAL or protected specimen 
brushing) d.) ≥5% BAL-obtained cells contain intracellular bacteria on direct microscopic exam (e.g., Gram’s stain) f.) Histopathologic 
exam shows at least one of the following evidences of pneumonia:  
 Abscess formation or foci of consolidation with intense PMN accumulation in bronchioles and alveoli  
 Positive quantitative culture of lung parenchyma  
 Evidence of lung parenchyma invasion by fungal hyphae or pseudohyphae  
 
All patients suspected of UTI had a urinary dipstick done on urine obtained from a urinary catheter checking for leukocyte esterase 
and/or nitrate. If the dipstick was positive for nitrates / leukocytes then urine was sent to the microbiology laboratory for microscopy, 
culture and sensitivity testing. Due to limitations in follow up of the patients the investigation for surgical site infection was confined to 
acute infections presenting during the admission to the intensive care unit, infections reported during the postoperative stay in the 
cardiology ward and if a patient was readmitted to the PICU. 
 
 Considering that routine daily chest radiography is not practiced in this PICU, VAP was diagnosed using a modification of the Clinical 
Pulmonary Infection Score (CPIS), which has been found to be an effective and appropriate diagnostic system in this study site 
(Morrow, Argent et al. 2009, Morrow, Mowzer et al. 2012). The CPIS (Appendix 3) was calculated daily and assessed for development 
of VAP, as indicated by a score of ≥ 6 or an increase of  > 2 from the previous score.  
 
When ventilator associated pneumonia was suspected, a nonbronchoscopic bronchoalveolar lavage (BAL) or tracheal aspirate, white 




attending PICU consultant considered patients to be too unstable from a haemodynamic or ventilatory point for a BAL, a tracheal 
aspirate was done instead of a BAL. Towards the end of the study period, during February 2012, the PICU at RCWMCH introduced the 
VAP bundle of care and changes to the utilisation of ventilator circuits were made (Personal communication, A Argent).  
 
Event definitions: Bleeding was defined as an event if additional treatments were needed, during and immediately postsurgery, to 
restore haemodynamic compromise including intravenous colloid / crystalloid solutions; blood or blood products or increased inotrope 
support was required. Any coffee ground aspirates noted was recorded as a complication indicating possible gastritis. Coagulopathy 
was defined as measurements that were beyond normal for the patient age range within the clinical context of a bleeding / at risk patient 
(National Health Laboratory Service (NHLS), South Africa). Systolic blood pressure limits were determined individually for each 
patient and the decision to treat hypertension / hypotension was determined by the attending PICU physician, cardiothoracic surgeon or 
anaesthetist. 
 
Descriptors for organ dysfunction were based on the Pediatric Logistic Organ Dysfunction score (PELOD) definitions (Leteurtre, 
Martinot et al. 1999, Leteurtre, Duhamel et al. 2010). Organ failure focussed on renal, central nervous system and liver dysfunction. 
  
Underweight for age was defined according to WHO growth chart standards: < -2 (standard deviation) SD of mean. Severely 
underweight was defined according to WHO growth charts: < -3rd SD of mean. 
 
At RCWMCH PICU there was not a specific transfusion policy in place regarding blood transfusions in postoperative cardiac patients. 
The decision to transfuse was made by the attending physician (and cardiac surgeon) and generally depended on the blood loss and 
haemodynamic state of the patient and oxygenation requirements of the patient. 
 
CONSENT 
This study entailed observational research of a non-therapeutic and non-invasive nature and there was no increased risk and no 
interference with the mental or physical integrity of the patients involved in the study. The need for informed written consent was 
therefore waived by the University of Cape Town’s Faculty of Health Sciences Human Research Ethics Committee. 
 
DATA ANALYSIS 
Data were collected prospectively in a standardized manner and stored in an MS Access (2007) database (Microsoft, Redmond, WA). 
After data collection was complete, descriptive statistical analysis was conducted as well as appropriate tests for comparing continuous 
and categorical data between groups with and without different categories of HAI. 
 
Continuous variables were tested for normality using the Shapiro-Wilks W test. Univariate comparisons for continuous and categorical 
variables were performed using Mann-Whitney U and chi-square tests (or the Yates corrected chi-square test when cell values were < 
10) respectively, with STATISTICA, version 8 (StatSoft, Tulsa, USA). Potential risk factors identified in the univariate analysis were 
then entered into stepwise logistic regression models using an online statistical program (Logistic Regression, 








A total of 110 patients undergoing 126 cardiac surgical procedures were enrolled into the study. Patient characteristics, comorbid 
conditions and admission routes are presented in Table 10. 
Table 10. Study population characteristics of all patients 
Characteristics of study population n = 110 patients enrolled in study 
Male n (%) 47 (42.7%) 
Age (months) 19 (6 – 72) 
Weight (kilograms) 8 (5 – 16) 
Normal 57 (51.8%) 
Underweight (WHO growth charts: < -2 
SD of mean) 
40 (36.4%) 
Severely underweight (< -3rd SD of 
mean) 
13 (11.8%) 
Height   
Normal (WHO growth charts: > -2 SD of 
mean) 
99 (90%) 
Stunted (< -2 SD of mean) 11 (10%) 
Admitted   
From Mother’s room 13 (11.8%) 
Ward 82 (74.5%) 
Neonatal ICU at referral hospital 1 (1%) 
Home 5 (4.5%) 
PICU 8 (7.2%) 
Genetic syndromes and malformation syndromes 24 (22%) 
Pre-existing medical illness 47 (42.7%) 
Previous cardiac operation 28 (25.5%) 
Ventilated prior to cardiac operation 9 (8.1%) 
HIV status  
Exposed 13 (11.8%) 
 Infected 0 
Unknown 1 
History of prematurity 9 (8.2%) 
Continuous data are median (interquartile range); categorical data are n (%) 
HIV  Human immunodeficiency virus   WHO  World health organisation 





Genetic and congenital malformation syndromes in all patients admitted to the study 
Of the 24 (22%) patients with genetic / malformation syndromes: 12 (10.9%) had Trisomy 21; three (2.7%) foetal alcohol syndrome; 
two (1.8%) 22Qdeletion; two (1.8%) William syndrome and one patient each had the following syndromes: retinoic acid embryopathy, 
Beckwith-Wiedeman syndrome, Goldenhar syndrome, Dandy-walker syndrome and Turner’s syndrome. 
 
Other comorbid conditions in all patients admitted to the study 
Thirteen (11.8%) patients were HIV exposed, none were infected and HIV status was unknown in one patient. 
 
Forty-seven (42.7%) patients had an additional pre-existing medical condition at the time of surgery. The most common pre-existing 
medical conditions were cardiac failure (n = 27, 24.5 %), pulmonary hypertension (n = 22, 2%), pneumonia (n = 7, 6.4%), gastro-




Six (5.5%) patients were on omeprazole at the time of surgery. Diuretics were prescribed in forty-seven (42.7%) patients (furosemide, 
spironolactone and captopril). 
Seventeen (15.5%) patients were receiving antibiotics prior to surgery: cefotaxime n = 3; ampicillin and gentamycin n = 2; 
piptazobactam and amikacin n = 2; rimacticid n = 2; vancomycin n = 1; ertapenem n=2; amoxyl n = 1; cephalexin n = 1; cloxacillin and 
ceftriaxone n = 1; prophylactic penicillin n = 2. 
 
CARDIAC CONDITIONS 
Cardiac conditions of patients are listed in (Table 11). The most common conditions were Tetralogy of Fallot (n = 19, 17.3%), 
ventricular septal defect (VSD) (n = 15, 13.6%) and atrioventricular septal defect (AVSD) (n = 15, 13.6%). 
 
Table 11. Cardiac conditions in all patients admitted to the study 
Cardiac conditions in all patients admitted to 
the study 
n = 110 patients admitted to the study (%) 
Tetralogy of Fallot 19 (17.3%) 
VSD 15 (13.6%) 
AVSD 15 (13.6%) 
TGA 6 (5.5%) 
TA 6 (5.5%) 
Aortic coarctation 5 (4.5%) 
PDA 4 (3.6%) 
TAPVD 4 (3.6%) 
Aortic valve abnormalities 4 (3.6%) 




Truncus Arteriosus 2 (1.8%) 
Combinations of cardiac conditions: ASD, PDA, 
VSD 
11 (10%) 
Other cardiac conditions 15 (13.6%) 
ASD  Atrial septal defect 
PDA  Patent ductus arteriosus 
TA  Tricuspid atresia 
TGA  Transposition of the great arteries 
TAPVD Total anomalous pulmonary vein drainage 
 
Operation details and outcomes are itemised in Table 12. Five cardiothoracic surgeons and one cardiologist performed 126 procedures 
in different categories. Surgical incision sites included median sternotomy, thoracotomy and one combination of median sternotomy 
and thoracotomy. Forty-five (40.9%) patients received steroids intraoperatively: three received methyl prednisone and 42 received 
solumedrol. 
The complexity categories used to describe the cardiothoracic surgical procedures are outlined in Appendix 6. This method categorised 
procedures by severity of illness and technical complexity (Levy, Ovadia et al. 2003). 
 
Table 12. Operative details and patient outcomes of all patients admitted to the study  
Operative details of all patients n = 126 cardiac surgical procedures (%) 
Received steroids 45 (40.9%) 
Received adequate peri-operative antibiotics 81 (64.3%) 
Category 1 45 (35.7%) 
                2 20 (15.9%) 
                3 34 (27.0%) 
                4 25 (19.8%) 
Use of CPB 82 (65%) 
Duration of CPB (min),  105 (76 – 140) 
Aortic cross-clamp time (min) 63 (39 – 92) 
Endotracheal tube intubation Nasal 110 (87.3%) 
                                                Oral 13 (10.3%) 
 Tracheostomy in place 2 (1.6%) 
Delayed closure of sternum 6 (4.8%) 
Procedures with intra-operative events 40 (31.7%) 
Outcome of all patients n = 110 patients admitted to the study (%) 
Duration of ventilation (days),  2 (2 – 4) 









Continuous data are median (interquartile range, IQR), categorical data are n (%) 
CPB Cardiopulmonary bypass 
PICU Paediatric Intensive Care Unit 
 
INTRAOPERATIVE PROCEDURES AND EVENTS 
Fifty-nine (53.6%) patients received intraoperative blood products including patients who received blood used to prime the CPB 
machine and stabilise hemodynamic state. Fifty-seven intraoperative events occurred in 24 patients during 40 surgeries. The most 
common intraoperative events were bleeding (n = 19) and arrhythmias / conduction abnormalities (n = 16) (Table 13).  
 
Table 13. Intraoperative procedures and events 
Intraoperative blood products received in all 
operative procedures 
n = 59 patients received intraoperative blood 
products  (%) 
Red blood cells 40 (67.8%) 
Platelets 8 (13.6%) 
Platelets, red blood cells 6 (10.2%) 
FFP, platelets 2 (3.4%) 
FFP, platelets, red blood cells 1 (1.7%) 
FFP, red blood cells 1 (1.7%) 
FFP 1 (1.7% 
Intraoperative events during all operative 
procedures 
n = 57 intraoperative events (%) 
Bleeding 12 (21%) 
Arrhythmia / Conduction abnormality 9 (15.8%) 
Bleeding, arrhythmia 5 (8.8%) 
Pulmonary Hypertension 3 (5.3%) 
Hypokalaemia 2 (3.5%) 
CPB restarted 2 (3.5%) 
Endotracheal reintubation 2 (3.5%) 
Detachment of tricuspid valve 2 (3.5%) 
Other 20 (35%) 
CPB  Cardiopulmonary bypass 
FFP   Fresh frozen plasma 
Postoperative events 77 (70%) 
Mortality, n (%) 9 (8.2%) 
  Mortality, n (%) admitted from Mother’s room 2 (15.4%) 






POSTOPERATIVE EVENTS (Table 14) 
One hundred and sixty-six postoperative events occurred in 77 patients (70%). The most common events were reintubation, bleeding, 
pleural effusion, arrhythmia, cardiac arrest, and organ failure. The chest was re-opened in four patients. Three (14.3%) of the 21 
reintubation events were following accidental extubation of three (1.8%) patients in PICU.  
 
Table14. Postoperative procedures and events  
Postoperative events following all 
operative procedures 
n = 166 postoperative events (%) 
Reintubation  21 (12.7%) 
Bleeding 16 (9.6%) 
Pleural effusion needing drainage (including 
chylothorax / haemothorax) 
15 (9.0%) 
Arrhythmia 14 (8.4%) 
Cardiac arrest 11 (6.6%) 
Organ failure  12 (7.2%) 
Pulmonary Hypertension 10 (6.0%) 
Hypertension 7 (4.2%) 
Hypoglycaemia (< 3mmol/L) 7 (4.2%) 
Hypotension 6 (3.6%) 
Postextubation stridor 5 (3.0%) 
Coffee ground aspirates 4 (2.4%) 
Chest reopened  4 (2.4%) 
 In ICU 3 (75%) 
 In postoperative Cardiology ward E1 1 (25%) 
Hemi-diaphragmatic paresis  3 (1.8%) 
Seizure 3 (1.8%) 
Hyperglycaemia (> 12mmol/L) 3 (1.8%) 
Infective endocarditis 3 (1.8%) 
Accidental extubation 2 (1.2) 
Pericardial effusion 2 (1.2%) 






INTRAVASCULAR CENTRAL LINES, URINARY CATHETERS, PACING WIRES, INTERCOSTAL DRAINS (ICDS) 
(Table 15) 
CVP lines were inserted in 109 (99%) patients. Arterial lines were inserted in 108 (98.2%) patients. Pacing wires were inserted in 53 
(48%) patients. Mediastinal drains were inserted in 34 (30.9%) patients. One hundred and one ICDs were inserted in 68 (61.8%) 
patients. Some patients had more than one drain inserted. 
One hundred and nine (99%) patients had a urinary catheter inserted: nine (8.1%) patients had PAP lines and two patients had LAP 
lines (1.8%) inserted. 
 
Table 15. Intravascular central lines, urinary catheters, pacing wires and intercostal drains inserted in all study patients (n = 
109)  
CVP lines anatomic site of insertion n = 109 patients had CVP lines inserted (%) 
RIJV 85 (78.0%) 
RFV 10 (9.2%) 
  LFV 9 (8.3) 
LIJV   3 (2.8%) 
LSV 1 (1%) 
LBCV 1 (1%) 
Site of arterial line insertion n = 108 patients had arterial lines inserted (%) 
LFA 42 (38.9%) 
RFA 29 (26.9%) 
RRA 18 (16.7%) 
LRA 17 (15.7%) 
Pacing wire site n = 53 patients had pacing wires inserted (%) 
Ventricular 33 (62.3%) 
AV 18 (33.9%) 
Atrial 2 (1.9%) 
Pericardial and mediastinal drain site n = 54 patients had a pericardial and / or 
mediastinal drain inserted (%) 
Mediastinal 34 (65.4%) 
Pericardial 21 (40.4%) 
Intercostal drain site n = 101 intercostal drains were inserted (%) 
RICD 64 (63.4%) 
LICD 37 (3.7%) 
LBCV Left brachia-cephalic vein LFV Left femoral vein 
LFA Left femoral artery 
LICD Left intercostal drain 




LRA Left radial artery 
LSV Left subclavian vein 
RFA Right femoral artery 
RFV Right femoral vein 
RICD Right intercostal drain  
RIJV Right internal jugular vein 
RRA Right radial artery 
 
MICROBIAL ISOLATES (Table 16)  
One hundred and ten patients were collectively followed over 612 patient days. Microbial isolates of all study patients are presented in 
Table 16. 
 
Table 16. Microbial isolates for all patients (n = 75 microbial isolates for all 110 patients) 
Microbial isolates on all 
specimens 
Blood  
   (n = 10) 
Respiratory  
   (n = 53) 
Wound  
 (n = 10) 
Urine  
(n = 2) 
Total  
    (n = 75) 
Gram negative 7 31 3 2 43 (57.3%) 
Acinetobacter baumanii 3 9 1  13 
Klebsiella pneumoniae 2 7  1 10 
Haemophilus influenzae  5   5 
Moraxella catarrhalis  4   4 
Serratia marcescens 1 1 1  3 
Citrobacter species   1  1 
Pseudomonas  1   1 
Enterobacteriaceae coli  1   1 
Enterococcus faecium    1 1 
Serratia liquefacies  1   1 
Ralstonia mannitolyca  1   1 
Sphingomonas paucimobilis 1    1 
Stenotrophomonas  1   1 
Gram positive 3 4 6  13 (17.3%) 
Methicillin resistant Staph. 
aureus (MRSA) 
2 1 3  6 
Streptococcus pneumoniae  2   2 
Staphylococcus aureus  1 1  2 





Staphylococcus  haemolyticus 1    1 
Diptheroids   1  1 
Viral positive result on a 
multiplex PCR 
 17   17 (22.3%) 
Adenovirus  6   6 
RSV  6   6 
Rhinovirus A  4   4 
Parainfluenzae  1   1 
Fungal  1 1  2 (2.7%) 
Fungal spores  1   1 
Candida albicans   1  1 
 
 
INFECTIONS AND ANTIBIOTIC USE 
Sixty HAIs occurred in 43 (39%) patients admitted to PICU following cardiac surgery. These HAI consisted of pulmonary infections 
(including VAP and nosocomial pneumonia) in forty-one  (68.3%) patients; blood stream infection in eight  (13.3%); surgical site 
infections in eight (13.3%), including superficial SSIs, and deep SSI in four (6.7%) patients (two with mediastinitis and two with 
infective endocarditis); and urinary tract infections in three (5%) patients (Figure 1). The central line-associated bloodstream infection 
(CLABSI) rate was 12.7 per 1000 central line days. 
Ten (9%) patients had more than one infection site (Table 17). Four (3.6%) of these patients developed possible secondary BSIs, 
including two with SSI and two with VAP. 
Twelve (27.9%) patients developed infections within 48 hours after cardiac surgery, all of which were respiratory infections: two 
(4.7%) patients acquired infections prior to admission to a hospital facility (community acquired), nine (20.3 %) acquired while 
admitted to a hospital facility outside PICU and one (2.3%) acquired in a patient admitted to PICU twenty days prior to surgery and 
remained admitted to PICU throughout (Figure 2). Of the two patients with community acquired infection one went on to develop a 
new VAP and one developed a new nosocomial pneumonia. Three of the patients with infection acquired in hospital facility outside of 





Fig. 1. Sites of PICU acquired infection (60 infections in 43 patients)  
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The most common associated organisms with hospital acquired respiratory infections (n = 41, 68.3%) were gram negative (41%) and 
viral (23%) isolates. According to study criteria, 43 new VAP cases were diagnosed in 24 patients at median (IQR) of the eighth (4 – 
14) postoperative day. 
 
Seventeen (15.5%) patients were receiving antibiotics prior to cardiac surgery. Six patients (5.5%) receiving antibiotics prior to surgery 
were diagnosed with infection while in PICU. 
 
ISOLATES IN PATIENTS WITH LIKELY HAI 
Microbial isolates in all infections diagnosed in PICU following cardiac surgery 
 
Microbial isolates from patients with presumed PICU HAIs are presented in Table 18. Thirty-six percent of isolates were detected in 
the first two postoperative days before signs of infection developed, and these results were used to guide antimicrobial therapy (Figure 
3). In all other cases specimens were taken on the clinical suspicion of infection, and therefore the index specimen was considered 
likely to reflect the causative or associated pathogen. Data on isolates are only analysed for those patients who met the criteria for HAI. 
 
Table 18. Microbial isolates from patients with HAI of all sites diagnosed in PICU 
Microbial isolates Blood 
 (n = 10) 
Respiratory  
(n = 53) 
Wound / 
Tissue  
  (n = 10) 
Urine 
     (n = 2) 
Total  
(n = 75)  
 
Postoperative day of first 
isolate (median, IQR) 
10 (6-12) 3 (2 -5) Pus 
swab: 14 
(5 – 19) 
Tissue: 
24 (14 – 
34) 
3 (3 – 3)  
Gram negative 7 (8%) 31 (41.3%) 4 (5.3%) 2 (2.7%) 43 (57.3%) 
Acinetobacter baumanii 3 9 2  13 (29.5%) 
Klebsiella pneumoniae 2 7  1 10 (22.7%) 
Haemophilus influenzae  5   5 (11.4%) 
Moraxella catarrhalis  4   4 (9.1%) 
Serratia marcescens 1 1 1  3 
Citrobacter species   1  1 
Pseudomonas  1   1 
Enterobacteriaceae coli  1   1 
Enterococcus faecium    1 1 
Serratia liquefacies  1   1 






1    1 
stenotrophomonas  1   1 
Gram positive 3 (4%) 4 (5.3%) 5 (6.7%) 0 12 (16%) 
Methicillin resistant 
Staph. aureus (MRSA) 
2 1 3  6 (50%) 
Streptococcus 
pneumoniae 




  1  1 (8%) 
Staphylococcus  
haemolyticus 
1    1(8%) 
Diptheroids   1  1 
Viral positive result on a 
multiplex PCR 
0 17 (22.7%) 0 0 17 (22.7%) 
Adenovirus  6   6 
RSV  6   6 
Rhinovirus A  4   4 
Parainfluenzae  1   1 
Fungal  1 (1.3%) 1 (1.3%)  2 (2.7%) 
Fungal spores  1   1 
Candida albicans   1  1 











































PULMONARY POSTOPERATIVE INFECTION 
Fifty-three organisms were detected in respiratory specimens taken on 30 patients (27.3%); with ten organisms isolated on day one 
postoperatively (18.9% of organisms), nine organisms on day 2 (16.9%) and 26 organisms between day three and seven postoperatively 
(49%). Six organisms were cultured between day eight and 13 (11%) and three organisms were identified after 14 days (5.7%) (Figure 
4). 
 
Nineteen isolates were obtained from respiratory specimens in 17 patients taken in the first 48 hours after surgery, with subsequent 
signs of infection: Acinetobacter baumanii (n = 5, 26.3%), Adenovirus (n = 4, 21.1%), Haemophilus influenzae (n = 2, 10.5%), 
Klebsiella pn. (n = 2, 10.5%), RSV (n = 2, 10.5%), Moraxella catarrhalis (n = 1, 5.3%), Staphylococcus aureus (n = 1, 5.3%) and 
Streptococcus pn. (n = 1, 5.3%) and rhinovirus A (n = 1, 5.3%). 
 
Ten respiratory isolates were detected in nine patients within the first 48 hours after surgery, without any accompanying sign of clinical 
infection: Acinetobacter baumanii (n = 3), respiratory syncytial virus (n = 2), methicillin resistant staphylococcus aureus (MRSA) 
(n=1), Haemophilus influenzae (n = 1), Moraxella catarrhalis (n = 1), Adenovirus (n = 1) and Rhinovirus (n = 1). These subsequently 
were thought to indicate pre-existing infection or colonisation. 
 
VAP was diagnosed with CPIS in twenty-four patients. Eight (33.3%) patients were not treated with antimicrobials and five (21%) had 
no detectable organism; one (4.2%) patient had a viral isolate detected ≤ 48 hours post surgery indicating possible previous infection or 
colonisation, one (4.2%) patient had a viral isolate detected on day four post surgery after being discharged from PICU and one (4.2%) 
patient had MRSA isolated on day one post surgery indicating possible colonisation (Figure 5). Seventeen patients were diagnosed with 
nosocomial pneumonia according to CDC criteria and did not meet VAP criteria according to CPIS (Figure 5). Five (29.4%) patients 
had detectable organisms and were not treated with antimicrobials; of these two (11.8%) patients had viral isolates ≤ 48 hours post 
surgery, one (5.9%) patient had an Acinetobacter baumanii isolated on day one post surgery and two (11.8%) patients had isolates 
detected on day 3 post surgery (Acinetobacter baumanii and Adenovirus). All these isolates were thought to indicate possible 












































































Fig. 5. Pulmonary infections including VAP and nosocomial pneumonia 
 
ANALYSIS 
UNIVARIATE DATA ANALYSIS (Table 19 – 21) 
The differences in patient characteristics, course and outcome for those who developed HAI infection of any site in PICU and those 
who did not develop infection are presented in Table 19. Notably, a greater proportion of patients who developed HAI were 
underweight for age; experienced postoperative events; and had more reintubation episodes than those who did not develop infection.  
Patients with HAI had worse outcome in terms of prolonged PICU and hospital stay and duration of mechanical ventilation, but there 
was no difference in mortality between groups (Table 19). 
Patients who developed HAI in PICU had higher Aristotle scores, lower CPB temperature (Table 20), and longer duration of arterial 
lines, CVP lines, pacing wires, urinary catheters and intercostal drains (Table 21) than uninfected patients. 
Duration of hospital stay, in the wards or Mother’s room, prior to PICU admission was significantly longer in those who developed 
HAI vs. those who did not develop infection (Table 19). 
 
Table 19. Univariate analysis of patient characteristics, course and outcome data for those who developed or did not develop 
infection of any site 
 HAI (n = 43) No HAI (n = 67) P  
Male: Female 21:22 26:41 0.3 
Age (months) 10 (6.5-45.5) 31 (6-84) 0.1 
History of prematurity, n 
(%) 
6 (14.0%) 3 (4.5%) 0.2 
Weight (kg) 6 (4-11) 10 (5-17) 0.02 
EWA (%) 73 (64-90) 78 (68-88) 0.41 
UWA, n (%) 27 (62.8%) 26 (38.8%) 0.01 
Height (cm) 67 (54-92) 85 (59-113) 0.03 
EHA (%) 95 (90-99) 93(91-99) 0.99 
Stunted, n (%) 5 (11.6%) 6 (9.0%) 0.9 
Genetic and congenital 
malformation syndromes, n 
(%) 
6 (14.0%) 6 (9.0%) 0.6 
Previous operation, n (%) 11 (25.6%) 17 (25.4%) 0.98 


















Omeprazole, n (%) 2 (4.7%) 4 (6.0%) 0.9 
Preoperative antibiotics 
(excluding 
antimycobacterial and oral 
antifungal nystatin) 
6 (13.95%) 8 (11.9%) 0.99 
Admitted from ward, n (%) 32 (74.4%) 50 (74.6%) 0.98 
Admitted from Mother’s 
room, n (%) 
8 (61.5%) 5 (38.5%) 0.2 
Steroids intraoperatively, n 
(%) 
18 (41.9%) 27 (40.3%) 0.9 
Number of dressing 
changes 
1 (1-1) 1 (1-1) 0.37 
Number of reintubations 0 (0-1) 0 (0-0) 0.037 
RBC volume (ml) 12 (6-69) 12 (5-32) 0.64 
PLT volume (ml) 14 (5-26) 4 (3-29) 0.29 
 FFP volume (ml) 8 (4-78) 15 (12-34) 0.49 
Cryoprecipitate volume 
(ml) 
15 (4-32) 15.5 (6.5-40) 0.52 
Intraoperative events, n (%) 11 (25.6%) 32 (47.8%) 0.02 
Postoperative events, n (%) 38 (88.4%) 39 (58.2%) 0.02 
Duration of ventilation 
(days) 
4 (3-7) 2 (2-2) < 0.0001 
Duration of PICU stay 
(days) 
6 (4-13) 3 (2-5) < 0.0001 
Duration of stay prior to 
surgery (days)  
8 (2-20) 2 (1-8) 0.0007 
Duration of hospital stay 
(days) 
21 (9-38) 9 (7-13) < 0.0001 
Mortality, n (%) 6 (20.1%) 3 (4.5%) 0.16 
Unless otherwise stated, values expressed as median (interquartile range) 
EHA Estimated height for age 
EWA Estimated weight for age 
FFP Fresh frozen plasma  
HIV Human immunodeficiency virus  
PLT Platelets 
RBC Red blood cells 





Table 20. Operative details for those who developed and did not develop HAI in PICU 
 Operations leading 
to HAI  
(n = 56) 
Operations not 
leading to HAI  








42 (60.9%) 0.3 
Surgeon, n (%)                 
1 14 (25.0%) 28 (40.6%) 0.07 
2 8 (14.3%) 12 (14.4%) 0.8 
3 6 (10.7%) 6 (8.7%) 0.9 
4 24 (41%) 22 (31.9%) 0.3 
5 3 (5.4%) 1 (1.4%) 0.5 
6 1 (1.8%) 0  
Category    
1 16 (28.6%) 29 (42%) 0.1 
2 6 (10.7%) 14 (20.3%) 0.2 
3 19 (34%) 15 (21.7%) 0.1 
4 14 (7.1%) 11 (15.9%) 0.2 
Aristotle score 9 (8-9) 8 (6-9) 0.007 
Risk of Mortality  
[Paediatric index of 
mortality 2 score, 
(PIM2)] 
0.05 (0.03 – 0.11) 0.04 (0.03 – 0.08) 0.37 
CPB duration (min) 107 (79-143) 101 (70-140) 0.35 
Aortic Cross Clamp 
Duration (min) 
72.5 (40.5-93.0) 61 (39-91) 0.37 
CPB Temperature  29.3 (24-31.95) 31.9 (27.7-33) 0.02 
Delayed sternal 
closure, n (%) 
5 (8.9%) 1 (1.4%) 0.1 
Received RBC 20 (35.7%) 28 (40.6%) 0.6 
RBC volume (ml) 80 (40-160) 100 (45-200) 0.89 
Received PLT 5 (8.9%) 7 (10.1%) 0.8 
PLT volume (ml) 105 (50-250) 200 (50-300) 0.25 
Received FFP 2 (3.6%) 3 (4.3%)   0.80 
FFP volume (ml) 122.5 (45-200) 140 (80-200) 0.80 




Nasal 52 (92.9%) 58 (84%) 0.4 
Oral 4 (7.1%) 9 (13.0%) 0.4 
Tracheostomy 0 1 (1.44%)  
Incision site    
Median sternotomy 48 (85.7%) 58 (84.0%) 0.4 
    Thoracotomy 5 (8.9%) 11 (15.9%) 0.4 
Unless otherwise stated, values expressed as median (interquartile range) 
 
Table 21. Details of invasive catheters and lines related to HAI in PICU 
 HAI (n = 43) No HAI (n = 67) P  
A-line duration (days) 5 (3-8) 2 (2-3) <0.0001 
CVP duration (days) 4 (3-6) 2 (2-3) <0.0001 
CVP 2 duration 
(days) 
0 (0-1) 0 0.06 
Pacing wire duration 
(days) 
14 (7-20) 7 (5-9) 0.001 
Urinary catheter 
duration (days) 
3 (1-5) 2 (1-2) 0.003 
Mediastinal drain 
duration (days) 
2 (1.5-4.5) 2 (2-3) 0.61 
PA line duration 5 (1-6) 1 (1-1) 0.39 
ICD duration (days) 4 (1-6) 2 (1-3) 0.007 
ICD 2 duration (days) 5 (3-6) 2 (1.5-3) 0.005 
ICD 3 duration (days) 4.5 (1-9) 32 (32-32) < 0.0001 
Unless otherwise stated, values expressed as median (interquartile range) 
 
MULTIVARIATE DATA ANALYSIS (Table 22) 
The final stepwise multiple regression model is presented in Table 22. Being underweight for age, longer duration of A-line and longer 
duration of hospital stay prior to surgery were independently associated with development of HAI. 
 
Table 22. Final multiple regression model of associations with HAI  
Factors Adjusted odds ratio 95% Confidence 
interval 
P 
Underweight for age 2.77 1.04-7.36 0.04 
A-line duration 1.47 1.24-1.78 0.0001 
Duration of stay prior 
to surgery 






This study demonstrated that infections are common among paediatric postoperative cardiac patients admitted to PICU in this setting. 
The incidence of HAIs was 39%, similar to the 38% rate reported by Grisaru-Soen et al (Grisaru-Soen, Paret et al. 2009) in a similar 
setting with a similar patient profile; but higher than the 11% reported in an Argentinian study (Rosanova, Allaria et al. 2009). 
Rosanova et al reported that the presence of underlying diseases, longer hospitalisation and inotropic support were risk factors for 
infections. A study conducted in USA (Mastropietro, Barrett et al. 2013) reported a similar HAI incidence of 36% in a cohort of 
patients undergoing more complex cardiac surgery (Basic Aristotle score ≥ 7) with longer duration of intensive care unit stays ( ≥ 7 
days). A Dutch study also reported a high HAI incidence of 25% (Algra, Driessen et al. 2012). In this study (Algra, Driessen et al. 
2012) variables most predictive of a HAI were: age less than 6 months, postoperative PICU stay longer than 48 hours, and open 
sternum for longer than 48 hours. 
 
Lower HAI incidence rates can be achieved, as reported by a Pakistani study (Siddiqui, Mir et al. 2011), which reported a HAI rate of 
7.9%. These authors postulated that the low incidence may reflect strict implementation and adherence to their institutional infection 
control policy including strict visit regulations (one parent at a time), hand hygiene and a 1:1 nurse-to-patient ratio in high dependency / 
intensive care areas. A study conducted in Israel (Levy, Ovadia et al. 2003) reported a HAI frequency of 16.4%. Similar to our 
institution they had up to 360 cardiac admissions per year, however, it was a dedicated paediatric cardiac ICU consisting of a smaller 
six-bed intensive care and a 12-bed intermediate care suite, in contrast to our unit, which is multidisciplinary. Their complexity of 
cardiac surgeries was similar to our study but 8% of their patients had open chests compared to 4% of patients in this study. Longer 
duration of open chest postoperatively was found to be a risk factor for HAI in the study by Levy et al. (Levy, Ovadia et al. 2003) but 
was not a factor contributing to HAI in our cohort – this may relate to the small number of children with delayed sternal closure in our 
study.  
 
Several studies have examined the influence of a dedicated paediatric cardiac intensive care unit (PCICU) on patient outcomes. A 
study conducted in the USA (Eldadah, Leo et al. 2011) described a decrease in morbidity as evidenced by the decrease in wound 
infection and need for chest re-exploration when cardiac care was transitioned from the general PICU to care provided exclusively in 
the PCICU. The percentage of wound infection for their combined PICU dropped from 7.54% as compared with the dedicated CICU 
unit with only 0.82%. In addition, mortality declined from 3.5% to 0.8% and fewer children required resuscitation. An Indian study 
(Balachandran, Nair et al. 2011) similarly reported improved outcomes in terms of earlier extubation, and ICU discharge and reduced 
BSIs (9 % vs. 5 % p = 0.04) following establishment of a dedicated PCICU. The authors acknowledge that the cost-effectiveness of 
establishing a dedicated cardiac ICU was not analysed. The nurse-patient ratio was 1:1 and the nursing team worked in 8-hour shifts. 
This differs from Red Cross War Memorial Children’s Hospital PICU, which is multidisciplinary including medical, neurosurgical, 
trauma and cardiothoracic patients. The nursing staff work 12-hour shifts and the nurse-patient ratio is similar at 1:1. 
 
Causative organisms for HAIs in this study were mostly gram negative (58.7%), viral (22.7%), followed by gram positive (16%) and 
fungal (2.7%) isolates. The predominance of gram negative or gram positive organisms as causative organisms in HAIs differ between 
studies in this population group. Gram negative infections, most commonly A.baumanii and K.pneumoniae predominated in this study, 
contradicting other studies that reported a predominance of gram positive causative organisms (Siddiqui, Mir et al. 2011, Grisaru-Soen, 
Paret et al. 2009). Siddiqui et al reported a predominance of gram negative bacteria (62.5% of all isolates) with Acinetobacter sp. 
(12.5%), and Pseudomonas aeruginosa most prevalent (12.5%).  Levy et al reported a similar gram negative predominance in their 
CICU, the main causative organisms were Klebsiella spp., Enterobacter spp. and Pseudomonas spp. followed by Staphylococcus spp. 
Possible reasons for the predominance in this study were less than optimal infection control protocols such as inadequate screening of 
patients for viral / bacterial organisms both presurgery and during hospitalisation and inadequate cohorting of patients when viral / 





Ten patients had multiple infections during their PICU stay. According to CDC definitions, each HAI has to be diagnosed in the 
absence of another infection site, but at present there is also no defined time period during which only one infection of the same event 
type may be reported for the same patient. The CDC definitions for BSI and UTI do take into consideration additional sites of infection: 
BSI that does not meet the criteria for a primary BSI can meet one of the criteria of a possible secondary BSI. UTI can de diagnosed in 
patients that match the clinical criteria and have cultured microorganisms from blood compatible with urinary tract site of infection 
(http://www.cdc.gov/ncidod/dhqp/pdf/nnis/NosInfDefinitions.pdf). It can, therefore, be difficult to identify multiple HAIs and the 
additional risk each contributes to developing further infections in different sites in this population group is unknown. This study has 
included the patients with possible secondary BSI in the total numbers for BSI and HAIs in order that all infections were identified and 
adequately treated. 
 
A third of our study patients did not receive adequate perioperative antibiotics, however, this was not found to be a risk factor for 
developing HAI after multiple regression analysis. The poor adherence to antibiotic prophylaxis is concerning, and included incorrect 
doses, incorrect timing of antibiotic prophylaxis and doses not being prescribed. As mentioned above, this could be linked to the high 
number of varying anaesthetists, cardiothoracic surgeons and ICU medical staff. This could be the focus of a practice improvement 
initiative in the future. 
 
Eight (11.9%) patients were started on antimicrobial treatment in PICU following cardiac surgery, but subsequently were not diagnosed 
with a HAI. The signs and symptoms of bacteraemia in the PICU setting are often subtle and nonspecific, and therefore a high index of 
suspicion is required. It is for this reason that sepsis work-up and empiric antibiotic therapy are often initiated in these patients. 
Knowledge of the main sites of HAI and the main pathogens that cause HAIs are important for the selection of the most appropriate 
antibiotic therapy in this setting.  
 
Patients with HAI received more antibiotics than those who did not develop HAI, but there were cases that met the criteria for HAI, 
particularly VAP, who did not receive antibiotic therapy. It appears, therefore, that diagnosis based on clinical assessment or 
microbiological and lab indications of infections were treated appropriately. This has relevance in that if VAP is diagnosed exclusively 
on CPIS, overdiagnosis and inappropriate antibiotic use may occur. VAP scores remain an important tool for monitoring the trend of 
infection rates in an institution and may be an indicator of quality of care in the PICU. Our study identified 22.7% of infections in 
which viral isolates were associated. Viral associated infection would not need antibiotic treatment and could partly explain the reduced 
use of antibiotics in those with any HAI.  
 
Pulmonary nosocomial infections were found to be the most common HAI in this study, accounting for 68% of all infection cases. 
This is much higher than previous studies done in the US (21%) (Richards, Edwards et al. 1999), Switzerland (6.9%) (Fischer, Allen et 
al. 2000) and Israel (16.4%) (Grisaru-Soen, Paret et al. 2009).  During the period that this study was conducted implementation of a 
VAP bundle was initiated in our ICU. An audit of the VAP bundle of care revealed less than ideal rates of compliance, which could 
have contributed to the high rates of VAP. At the time of the study, the background PICU VAP rate was 22.4% (Morrow, Mowzer et al. 
2012) with more recent data reporting VAP rate 3 – 6 per 1000 ventilator days (personal communication, A Argent). 
 
This study has highlighted the challenges of diagnosing respiratory infections in this group of patients. VAP was diagnosed by a score 
of   ≥ 6 on the CPIS more than 48 hours after initiation of ventilation or an increase of  > 2 if the patient started with a high CPIS. When 
the patient met CDC criteria for nosocomial pneumonia more than 48 hours after initiation of ventilation and did not meet CPIS criteria 
for VAP that was diagnosed as nosocomial pneumonia.  Diagnosing VAP on CPIS alone yielded a very high number, when we 
focussed down to those who actually received antibiotic therapy it came down to a much lower number. The dilemma is that we did not 





Twelve (27.9%) patients had respiratory infections that developed within 48 hours after cardiac surgery, reflecting both community 
acquired infection and nosocomial infections acquired outside PICU. This highlights the importance of considering strict 
implementation and adherence of infection control in areas outside of PICU, including the home environment and the various hospital 
facilities that act as admitting wards for paediatric cardiac surgery patients. 
 
Although respiratory specimens were not taken in a standardised manner in all patients, the most commonly isolated organisms were 
gram negative bacilli (41.3%), viral isolates (22.7%), gram positive bacilli (5.3%) and fungi (1.3%).  Gram negative predominance has 
been reported by Tan (86.1%) in China (Tan, Sun et al. 2004), Rosanova in Argentina (Rosanova, Allaria et al. 2009) and Roeleveld 
(Roeleveld, Guijt et al. 2011) in the Netherlands. The type of organisms isolated differed between studies yet all included Acinetobacter 
species. Roeleveld reported the most common organisms as Haemophilus influenzae, Moraxella catarrhalis, and Pseudomonas 
aeruginosa. Rosanova detected Haemophilus influenzae non type b and Acinetobacter species. Tan reported the main gram negative 
bacilli were Acinetobacter baumanii (13.9 %) and Pseudomonas aeruginosa (12.7%).  The most commonly seen gram positive cocci in 
our study were Staphylococcus aureus (2.5%) and Staphylococcus epidermidis (2.5%) and the most common fungus was Candida 
albicans (6.3%). Subsequent to this study there has been a dramatic drop in the number of Acinetobacter isolates in the RCWMCH 
PICU following changes to utilisation of ventilator circuits (personal communication, A Argent). Changes to circuit utilisation were 1) 
utilisation of non-reusable ventilator circuits instead of multiple use circuits 2) reorganisation of the packing and cleaning of equipment 
used for intubation. At the same time circuit utilisation was changed, the VAP bundle of care was introduced in the PICU with initial 
compliance reported 40% in February 2012, increasing to 80% by November 2012 (Personal communication Heide Kunzmann). 
 
Viral isolates were the second most common respiratory isolates and this has not been frequently reported in this population group. 
Roeleveld et al. (Roeleveld, Guijt et al. 2011) found rhinovirus by PCR in 18.2% of isolates, although the authors were unclear of the 
role this played in the aetiology of VAP. Viruses have been found to be responsible for up to 22% of paediatric nosocomial infections, 
and between eight and 14% of nosocomial lower respiratory tract infections in various settings (Raymond, Aujard et al. 2000, Valenti, 
Menegus et al. 1980, Ghani, Morrow et al. 2012). An Indian study of VAP reported that nine of 13 (69%) children who died following 
a diagnosis of VAP showed signs of viral infection on post-mortem (Bavdekar, Bhosale et al. 2011). This high rate of viral- associated 
nosocomial lower respiratory tract infections has been noted in previous studies in the same PICU, albeit not specific to cardiac surgery 
patients (Morrow, Argent et al. 2009, Ghani, Morrow et al. 2012). The fact that our study period was conducted during summer months 
could have underestimated the contribution of viruses to HAI, as viruses are more prevalent during the winter months.   
 
The median day postoperatively of the first organism being detected from any respiratory specimen (NPA, TA, BAL) was three days. 
This finding could be an indication of pre-existing infection or colonisation in the patients undergoing cardiac surgery. Included in 
the number of patients with respiratory infections were nine patients with various microbial isolates detected ≤ 48 hours after cardiac 
surgery: Gram negative bacilli predominated including, Acinetobacter baumanii, Haemophilus influenzae and Moraxella catarrhalis. 
The second most frequent isolates were viral organisms consisting of RSV, adenovirus and rhinovirus. There are limited guidelines on 
the diagnosis of nosocomial viral infections. The challenges in diagnosing nosocomial viral infections using the CDC 48 hour rule are 
longer incubation periods of viral organisms and unknown duration of viral organism shedding after an original infection.  Patients 
undergoing cardiac surgery in our institution were not routinely screened for viral infection prior to surgery. The role these organisms 
played in the aetiology of VAP is unknown and may highlight the need to screen for infection in asymptomatic paediatric patients prior 
to cardiac surgery. If patients are screened and found to be negative for viral organisms on admission and prior to surgery, then 
subsequently become positive > 48hours after hospital admission, the detected viral organism would more likely be considered the 
causative organism of a nosocomial infection.  
 
Known associations with VAP in the PICU are extubation failure, duration of ventilation, and prolonged PICU and hospital length of 
stay (Shi, Zhao et al. 2008). Nine (8%) patients in this study were ventilated prior to undergoing a cardiac surgical procedure. Two 




as a risk factor for acquiring HAI (hospital acquired infection). We did not investigate duration ventilated prior to cardiac surgery as a 
specific risk variable. Of the nine patients, one patient developed VAP and one patient a HAI acquired outside of this PICU. Duration 
of ventilation was not found to be associated with HAI (or VAP specifically) on univariate analysis, as previously reported (Shin, Jhang 
et al. 2011, Alvarez, Fuentes et al. 2012).  In this study, reintubations were associated with developing HAI on univariate analysis, but 
not specifically associated with nosocomial respiratory infections. In this study, reintubations were not categorised into time periods 
indicating early or late reintubations. Time to reintubation was unfortunately not analysed and was beyond the scope of this study. 
 
Blood infections were found in 13%, with associated organisms being predominantly gram negative (Acinetobacter baumanii, 
Klebsiella pneumoniae) and gram positive isolates (MRSA). There were no fungal blood isolates. The incidence is similar to that 
reported by Richards et al (15%) (Richards, Edwards et al. 1999) and Mastropietro et al (12%) (Mastropietro, Barrett et al. 2013) but 
lower than the 65.8% reported by Grisaru-Soen et al (Grisaru-Soen, Paret et al. 2009).  
 
Previous studies (Odetola, Moler et al. 2003) have reported that BSI caused by gram negative organisms in the PICU were associated 
with many factors including transfer from another facility, the presence of congenital heart disease, failure to thrive, younger age (≤30 
days), administration of prednisone and blood transfusion. Many of these factors that they reported are commonly seen in postoperative 
cardiac cases and could have played a role in this study. Other types of HAI also may increase the risk of BSI development, particularly 
with gram negative organisms (Abou Elella, Najm et al. 2010). In a study (Asembergiene, Gurskis et al. 2009) conducted in a general 
PICU population, secondary bacteremia occurred in 10.6% of children with a diagnosis of HAI with skin wound infection, pneumonia, 
and urinary tract infection the main primary sources of secondary bacteremia associated with HAI.  
 
Consistent with findings from previous studies (Richards, Edwards et al. 1999, Grisaru-Soen, Paret et al. 2009, Bezzio, Scolfaro et al. 
2009), the duration of central vascular catheters in situ was linked to the development of infection in both univariate and multivariate 
analyses. Bezzio et al. suggested that interventions to improve the adoption of sterile common barriers could reduce the rate of BSIs. 
This hypothesis was supported by the fact that the shortage of nurses in hospitals did not always allow for optimal medical assistance 
(because of high workloads and a patient-to-nurse ratio of 2:1), and the time required for assistance increased by the use of the various 
sterile barriers (Bezzio, Scolfaro et al. 2009).  Their study reported no significant risk associated with BSI in lines inserted in the 
operating room or in the PICU. In our institution the majority of children have central lines placed in theater by the anaesthetists at the 
time of surgery. Compliance with the catheter related blood stream infection bundle of care was not assessed in our study. 
 
Abou Elella et al. (Abou Elella, Najm et al. 2010) identified a lower rate of 8.6% BSI in all patients undergoing cardiac surgery with a 
similar report of gram negative organism predominance in their study. The predominant gram negative organisms were Pseudomonas 
and Enterobacter. The study differed in various aspects to our study in that it was conducted in a dedicated paediatric cardiac intensive 
care unit and perioperative antibiotics were administered at a higher dosage and for longer duration; all patients undergoing cardiac 
surgery were treated with intravenous cefazolin at a dose of 100 mg/kg/day in three divided doses, starting 30 min before surgery and 
continued until the chest tubes were removed after surgery. For the patients with an open chest postoperatively, intravenous ceftazidime 
and vancomycin were used as prophylaxis and continued until the chest was closed (48–72 hours postoperatively). 
 
In our study gram positive organisms with most frequently isolated organisms MRSA and Staphylococcus epidermidis predominantly 
caused SSIs. Previous studies in this population group (Allpress, Rosenthal et al. 2004, Ben-Ami, Levy et al. 2008) have reported gram 
positive predominance with Staphylococcus aureus and coagulase negative Staphylococcus the most frequently detected isolates from 
wound sites. This differs from a study conducted by Hafez et al (Hafez, Saied et al. 2012) who reported gram negative predominance 
with Klebsiella sp. being the most frequently isolated organisms. The incidence of wound (12%) and tissue (3%) infections is lower 
than reported by the Egyptian study (Hafez, Saied et al. 2012), in which SSIs occurred in 187 (17%) of patients with complete follow-
up, of which 106 (57%) occurred in-hospital and 81 (43%) occurred after discharge. Increased risk of SSI was found in those with 




≤ 24 hours before surgery (OR 2.54; 95% CI 1.63-3.94). This study incorporated both adult and paediatric patients. Problems 
associated with stratifying an adult study to the paediatric population include the added comorbidities such as smoking and diabetes 
mellitus in the adult patients. 
 
This study was conducted in a multidisciplinary twenty bed PICU with open bays with no physical walls separating patients. A 
Canadian study conducted by Bowman et al in an eighteen bed PICU (Bowman, Rebeyka et al. 2013) reported a trend toward increased 
SSIs in patients undergoing delayed sternal closure in beds in the open bay of their PICU. 
 
We did not include assessment of pre-surgical skin decontamination measures. In our institution it is policy that all children receive 
chlorhexidine baths prior to surgery, however, implementation was not consistently monitored. Less than adequate skin 
decontamination could have contributed to the SSI rate. This requires prospective investigation. Hafez et al found a high risk of SSIs in 
patients who received an antiseptic preoperative shower one day before surgery. The use and the timing of preoperative showers to 
reduce SSIs continue to be controversial. A Cochrane Review of six randomized controlled trials found no clear benefit of using 4% 
chlorhexidine gluconate for preoperative showers for SSI prevention (Hafez, Saied et al. 2012). These authors concluded that 
developing a clear policy for preoperative showering is crucial given that this procedure has organizational and economic implications 
and involves both the nursing staff and hospital administrators. 
 
Chaudhuri et al (adult study) (Chaudhuri, Shekar et al. 2012) reported that early microbiological diagnosis of deep sternal wound 
infections (DSWI) could improve outcomes by allowing targeted antibiotic treatment. Superficial sternal wound swabs predicted the 
pathogen 75% of the time. Specific to Staphylococcus aureus, the positive predictive value of a superficial sternal swab was found to 
approach 100%. Colonisation with multi-resistant organisms was 100% predictive of the pathogen in DSWI. The multiresistant 
organism screen, which included nasal and perineal swabs, predicted the pathogen of DSWI in all cases that had a positive screen. The 
inclusion of blood cultures predicted the pathogen 82% of the time across all types of bacterial infections. The authors concluded that 
routine testing and reporting of these samples could enable early and targeted antimicrobial therapy in DSWI to improve outcomes.  
 
Delayed sternal closure was not found to have an impact on infections in this study in contradiction to previous studies by Das et al. 
(Das, Rubio et al. 2011) and Johnson et al. (Johnson, Jaggers et al. 2010)Das et al reported (Das, Rubio et al. 2011) a significantly 
higher rate of BSIs in patients with delayed sternal closure. Their population had a mean age of 4 days, mean weight 3 kg and was post 
stage 1 Norwood surgery which could indicate a more vulnerable population undergoing more complex surgery. Similarly Johnson et al 
also used a cohort of neonatal post Norwood procedure patients and reported a longer duration of stay and higher infection rates in 
patients undergoing delayed sternal closure (Johnson, Jaggers et al. 2010). 
 
Urinary tract infections occurred in 5% of the study population with all causative organisms being gram negative bacilli 
(Enterococcus faecium, Klebsiella pneumoniae). All were associated with having catheters in situ. Siddiqui et al reported a similar 
incidence (3.8%) (Siddiqui, Mir et al. 2011) of urinary tract infections; whilst Doyle et al reported an incidence of 18% with E. coli and 
Candida spp.  Richards et al reported UTI incidence of 15% (Richards, Edwards et al. 1999). All studies concluded associated risk of 
UTI with use of an invasive device.  
 
The mortality rate in this study population was 8.2% and not significantly associated with acquiring HAIs. The high mortality rate in 
our institution during the study period could be due to the relatively small study population with the resultant bias. Other reasons could 
include delayed presentation for diagnosis with relatively high complexity scores and subsequently experiencing complications such as 
pulmonary hypertension. Factors mentioned in previous studies include long waiting lists that add to complications such as failure to 
thrive that may increase patient risk of acquiring HAIs and subsequent increased mortality (Grisaru-Soen, Paret et al. 2009, Rosanova, 





Siddiqui et al (Siddiqui, Mir et al. 2011) reported a lower HAI rate; however, the case fatality rate was 19.2%. The authors did not 
associate increased mortality risk with higher complexity score (RACHS->3) and BSI. An Argentinian study (Rosanova, Allaria et al. 
2009) with a setting similar to our institution reported an overall mortality rate of 11% not associated with nosocomial infections in 
postoperative paediatric cardiac patients. This differs from several previous studies such as Tantawy et al (Tantawy, Seliem et al. 2012) 
who observed a mortality rate during their study period of 30.8%. The authors reported patients with nosocomial infection had 
significant mortality of 25%. Factors associated with mortality risk were younger age, higher complexity score for congenital cardiac 
lesions, prolonged CPB and ischemic times, HAI, prolonged mechanical ventilation, prolonged central line insertion and the use of total 
parenteral nutrition (Tantawy, Seliem et al. 2012). Grisaru-Soen (Grisaru-Soen, Paret et al. 2009) reported a similar mortality rate of 
9.7%, however, the crude mortality rate for patients with nosocomial infection was 23.7%, compared with 2.2% for patients without NI 
(P < 0.001). These mortality rates are higher than reported in developed countries such as Saudi Arabia (2.9%) (Abou Elella, Najm et 
al. 2010) and Netherlands (2.6%) (Roeleveld, Guijt et al. 2011). A USA review of heart surgery databases conducted by Barket et al 
(Barker, O'Brien et al. 2010) reported mortality risk was greater (22.2%) in those with HAIs than in those without HAIs (3%) with 
major infections (mediastinitis, septicemia and endocarditis) (p = < 0.001) being significantly associated with risk. 
 
Univariate analysis identified being underweight for age, fewer intraoperative events, more postoperative events, and longer duration of 
PICU and hospital stay as being associated with infection.  Further associations identified were higher Aristotle score and long duration 
of arterial lines, CVP lines, pacing wires, urinary catheters and intercostal drains. However, on multivariate analysis only increased 
duration of A-line, being underweight for age, and increased duration of stay prior to surgery were identified as being 
independently associated with HAI. 
 
 Previous studies have found that longer duration of central lines was associated with the development of HAIs (Abou Elella, Najm et 
al. 2010, Bezzio, Scolfaro et al. 2009). Similarly to the study conducted by Abou Elella et al (Abou Elella, Najm et al. 2010) this study 
reported a high use of intravascular catheter devices. The authors postulated that extensive use of invasive devices, and the relative 
malnourished status of many of their patients contributed to their findings. Also, the device utilisation ratio (the number of days of 
individual device use divided by the total days of stay) corresponds to the rate of PICU nosocomial infections (Slonim, Kurtines et al. 
2001). Our study population had a high CLABSI rate of 12.7 per 1000 central line days. At the time of the study, the background 
central line associated BSI rate for the PICU was 9.6 per 1000 central line days (Personal communication Heide Kunzmann). Because 
of the design of this study, we could not determine if the patients required prolonged arterial catheter use monitoring because of their 
HAI (to enable continuous blood pressure monitoring or routine blood sampling), or if they were prone to HAI due to prolonged 
catheter use. In a study conducted by Ben-Ami et al (Ben-Ami, Levy et al. 2008) the authors postulated that the mean dwell time for 
CVCs in their study population was identical to the mean time of SWI onset (10 days), which supported the assumption that it was the 
duration of catheterisation that was a causative factor for the infection.  
 
Being underweight for age has previously been associated with increased risk of acquiring HAI (Ades, Dominguez et al. 2010). 
Contributing factors in this population group may include poor socio-economic background, chronic illness, late presentation or 
malnutrition. During this study a full nutritional assessment was not conducted on each patient. Weight measured was a reflection at 
one point during the study period and UWA was defined according to WHO criteria of less than -2SD of mean. We are thus unable to 
report if being UWA was due to inadequate diet or a reflection of severity of the existing cardiac condition.  
 
A few studies have previously reported duration of stay prior to surgery being associated with the development of HAIs (Hafez, 
Saied et al. 2012, Allpress, Rosenthal et al. 2004). Allpress et al and Hafez et al reported an increased incidence of SSIs in paediatric 
cardiac patients with longer presurgery hospital stays. Possible reasons for this could include an increased exposure to hospital acquired 
organisms and a worse clinical state prior to cardiac surgery. This study did not find a significant association with HAIs and increased 





Previous studies have found that HAIs did not correlate with length of stay (Bezzio, Scolfaro et al. 2009, Richards, Edwards et al. 
1999). An Argentinian study (Rosanova, Allaria et al. 2009) with a setting similar to our institution associated postoperative stay longer 
than 12 days with increased risk of acquiring HAIs. These authors were unable to report if the prolonged stay was cause or 
consequence of developing HAIs. Prolonged length of stay in the PICU and prolonged hospital stay are reported more frequently in 
critically ill patients who may have more risk factors for infection (Grisaru-Soen, Paret et al. 2009, Levy, Ovadia et al. 2003). Grisaru et 
al reported a relatively prolonged length of stay in PICU and a higher number of multiple surgeries in the patients who developed HAIs 
(Grisaru-Soen, Paret et al. 2009). Consequently, the length of hospitalisation might be a consequence instead of a cause of HAI. Indeed, 
this variable was no longer a risk factor for HAI on multivariate analysis in our study. 
 
Postoperative events have frequently been associated with HAI and have emerged as a predictor for mortality in patients with HAI after 
paediatric cardiovascular surgery (Grisaru-Soen, Paret et al. 2009).  Intraoperative events occurred in 24 patients (22%) and 
postoperative events occurred in 77 patients (70%) during this study. Postoperative and intraoperative events reported included all 
events of bleeding and arrhythmia requiring intervention to restore hemodynamic stability in the intra- and postoperative cardiac 
patient. These are events that due to the nature of cardiac surgery and patient profile may be considered expected events and not 
necessarily adverse events due to surgical / anaesthetic / medical incidents. This may account for the high incidence reported. On 
univariate analysis our study found an association with increased postoperative events and the development of infection, however, this 
was not found to be a significant association on multivariate analysis.  
 
Barker et al (Barker, O'Brien et al. 2010) reported that mortality and postoperative length of stay were greater in those with major 
infection (mortality, 22.2% versus 3.0%; length of stay > 21 days, 69.9% versus 10.7%). Young age, high complexity, previous 
cardiothoracic operation, preoperative length of stay more than 1 day, preoperative ventilator support, and presence of a genetic 
abnormality were associated with major infection after backward selection (P < 0.001) (Barker, O'Brien et al. 2010). 
 
Genetic and congenital malformation syndromes were not found to be significantly associated with acquiring HAI; this may be due to 
the small sample of patients included. McDonald et al (McDonald, Dodgen et al. 2012) previously reported on the impact of 22q11.2 
deletion on the postoperative course of children after cardiac surgery. The findings revealed an increased incidence of fungal infection 
and wound infection in the del22q11 group, more days of positive blood and urine cultures indicating prolonged infections. 
 
The use of blood and blood products were not significantly associated with HAIs as previously reported by Salvin et al (Salvin, 
Scheurer et al. 2011). In this institution all RBC concentrates are leukocyte depleted. The administration of blood is at the discretion of 
the anaesthetist / surgeon / perfusionist intra-operatively and the paediatric intensivist postoperatively. RBC transfusions are generally 
given with the goal of improving oxygen delivery or blood volume. Our study population differed from the Salvin (Salvin, Scheurer et 
al. 2011) study in that their patients requiring RBC transfusion were younger (age < 28 days), more likely to have single ventricle 
physiology, required more complicated cardiac surgery, and were more acutely ill. 
 
Corticosteroids have been used in cardiac surgery with the aim of reducing inflammatory response after CPB. Various studies have 
produced mixed results. Similar to Pasquali et al. (Pasquali, Li et al. 2012), no association was found between the use of 
corticosteroids and HAIs. In this study two types of steroids were used and dosing differed between patients and surgeries. Solumedrol 
was used in the majority of patients who received steroids intraoperatively (93.3%, 42 of 45 patients). This is consistent with previous 






An observational analysis including multiple US centres was unable to demonstrate a significant benefit and actually demonstrated an 
increased morbidity associated with steroid use, longer duration of hospital stay, and greater infection risk (Pasquali, Hall et al. 2010). 
A further analysis by Pasquali (Pasquali, Li et al. 2012) showed no significant mortality or length-of-stay benefit associated with any 
methylprednisolone regimen versus no steroids, and no difference in postoperative infection. In subgroup analysis by surgical risk 
group, there was a significant association of methylprednisolone with infection consistent across all regimens in the lower-surgical-risk 
group. Mastropietro et al reported that increased cumulative corticosteroid exposure was a significant risk factor for infection in 
complex paediatric cardiac surgery patients (Mastropietro, Barrett et al. 2013). All patients in the study received intraoperative 
methylprednisolone 30mg/kg, 48% received postoperative hydrocortisone, and 86% received periextubation dexamethasone. This study 
did not evaluate cumulative steroid exposure in the post cardiac surgery patients. 
 
Clarizia et al (Clarizia, Manlhiot et al. 2011) demonstrated that intraoperative steroid use was associated with shorter durations of stay 
in intensive care and hospital. Their use of an additional preoperative dose resulted in further improvements, especially reduction in 
duration of mechanical ventilation. Patients in the cohort who received steroids were younger, had longer CPB and aortic cross-clamp 
times, and had higher incidence of delayed sternal closure. The finding that they also experienced better outcomes suggests that 
targeted use of steroids for younger, more complex patients may provide the most benefit. 
 
This study found no association with CPB duration, CPB temperature and aortic cross clamp duration with HAIs. It has been well 
documented that open heart surgery with CPB can result in systemic inflammatory response, impaired immune reaction, and organ 
dysfunction in children. Clinical consequences of bypass-induced injury are more significant in high-risk operations such as those on 
neonatal patients and those requiring prolonged use of CPB, especially with the use of deep hypothermic circulatory arrest (Clarizia, 
Manlhiot et al. 2011). Moderate hypothermia at 28⁰ C has been shown to offer better protection from systemic inflammatory response 
syndrome (SIRS) postoperative than normothermia (37⁰ C) during CPB in the experimental setting (Stocker, Shekerdemian et al. 
2011). Stocker et al in a double blind randomized controlled trial found no evidence that SIRS is influenced by CPB temperature. In 
this study temperatures achieved during CPB varied significantly ranging from deep hypothermia to normothermia in various severities 
of cardiac condition. I can therefore not say with certainty that lower CPB temperature was a reflection of a sicker patient or associated 
with more severe underlying cardiac lesion. Lower CPB temperature may merely relate to a different surgical challenge. 
 
The Aristotle Basic Complexity (ABC) score system was developed by consensus to compare outcomes of congenital cardiac 
surgery. In this study, the ABC score was not associated with increased HAI. A study done by Al-Radi (Al-Radi, Harrell et al. 2007) 
adjusted ABC by including age at operation in predictive models with ABC. The predictive value of such models improved and a 
strong association with in-hospital mortality and length of stay was demonstrated. 
 
INTERVENTIONS INFLUENCING ICU INFECTION EPIDEMIOLOGY 
Hand hygiene is the single most important measure to reduce transmission of microorganisms between patients (Doyle, Buising et al. 
2011). The use of alcohol-based hand rubs has led to markedly improved hand hygiene compliance, and particularly reduces 
transmission of MRSA. Sustained improvement in hand hygiene has been shown to be associated with a fall in ICU-acquired infection 
rates (Doyle, Buising et al. 2011). 
 
Chlorhexidine body washes have been increasingly used in ICUs and other settings to prevent bacterial acquisition, colonisation, and 
infection. In ICUs, chlorhexidine bathing has been shown to substantially decrease MRSA acquisition, colonisation, and infection (at 
times with intranasal Mupirocin), bacteraemia, and MRSA ventilator pneumonia, and to reduce A. baumannii skin colonisation and 
bloodstream infections (with whole body washes with 4% chlorhexidine gluconate) (Doyle, Buising et al. 2011). Daily bathing with 2% 




the ICU (Bleasdale, Trick et al. 2007). As mentioned above, in our institution chlorhexidine bathing is done prior to surgery, however, 
the compliance with this protocol was not assessed.  
 
BUNDLES OF CARE   
A bundle is a set of a small number of evidence-based prevention practices that improve patient outcomes when performed collectively 
and consistently (Institute for Healthcare Improvement (IHI) Updated 2014). The CVC bundle includes the use of aseptic techniques, 
including maximal barrier precautions, hand washing, chlorhexidine insertion site antisepsis, and daily review and removal of 
unnecessary catheters (Berenholtz, Pronovost et al. 2004, McKee, Berkowitz et al. 2008). This bundle has achieved significant 
decreased bacteraemia, and is associated with cultural change in the ICU, and nearly eliminates CLABSIs (O'Grady, Alexander et al. 
2002). Similar bundles are used to prevent VAP and catheter associated UTI (Muscedere, Dodek et al. 2008, Fuhrman, Zimmerman et 
al. 2011). 
 
ANTIMICROBIAL USE IN THE ICU 
Antimicrobial use in the ICU is an important factor influencing the epidemiology of infections in the ICU.  It is known that frequent 
antibiotic use promotes selection of resistant microorganisms. A balance has to be met in the ICU with policies that promote early use 
of broad spectrum empirical antibiotics, followed by de-escalation to narrower spectrum antibiotics, or shortening the duration of 
treatment in response to investigation results or clinical improvement – in keeping with the Surviving Sepsis Guidelines (Dellinger, 
Levy et al. 2008). 
 
LIMITATIONS 
There are several limitations to this study. This study was conducted in a single tertiary centre with a relatively small sample size and 
short period of study (6 months), which may limit its generalisability. The follow-up was limited to the duration of hospital stay due to 
resource limitations. SSIs according to CDC criteria require 30 day follow up postoperatively, therefore SSIs that developed post 
hospital discharge would have been missed. However, a study done by Sarvikivi et al (Sarvikivi, Lyytikainen et al. 2008) designed to 
detect SSIs within 30 days after surgery, concluded that postdischarge SSI surveillance might not have clinical relevance in pediatric 
cardiac surgery patients. 
 
Due to this study being observational I did not intervene in patient management. I can therefore not be sure that all specimens were 
taken for appropriate reasons according to the study protocols. I recorded the results of all specimens collected from the study patients 
during their PICU admission. The implication hereof was that specimens may have been collected in patients who did not strictly meet 
criteria for infection which inturn has implications for unnecessary investigation expenses, additional utilisation of antibiotics and 
challenges in the clinical interpretation of postive microbial detection. 
 
The definition of pulmonary infections, including VAP, was based on clinical and microbiological criteria not included in the Infectious 
Diseases Society of America definition. Pulmonary infections included those diagnosed by CPIS VAP score ≥ 6 that were not treated 
with antimicrobials and no organism isolated.  The diagnosis of respiratory infections could, therefore, have been over-estimated by 
using the CPIS scoring system. Diagnosing VAP using a modification of the CPIS was previously validated in this institution in a 
general PICU population and not in a cardiac surgery population (Morrow, Argent et al. 2009, Morrow, Mowzer et al. 2012). 
 
The incidence of intraoperative events may have been under reported, as this relied on documentation in the patient records by the 





Patients being treated for infection with antimicrobials prior to cardiac surgery were not excluded from the study and the effect of pre-
existing infection was not investigated in this study. The effects of co-existing HAIs in the same post cardiac surgery paediatric patient 
were not investigated. As an example raised inflammatory markers in a patient with BSI could influence using CPIS to diagnose VAP. 
It remains unclear whether one HAI predisposes to developing a secondary / additional HAI. This is the dilemma created by including 
patients with different types of HAIs in the same study instead of focussing on a specific HAI in a cohort of patients. 
 
It is reasonable to suggest that longer duration of A-line and hospital stay may reflect increased disease severity in a cardiac patient.  
In this study, indices of disease severity  and cardiac surgery comlexity were not found to be significantly different between the group 
of patients that developed HAIs versus those who did not. The study population may have been too small to demonstrate this.  The HAI 
group had younger infants, longer duration of CPB and more patients requiring delayed sternal closure which could indicate increased 
disease severity, however, this was not found to be significant on univariate analysis. The categories of surgery, PIM 2 scoring and 
Aristotle scores were not significantly different on final analysis.  However, it is important to note that this study was not designed to 
investigate the relationship between specific causal-consequence factors increasing risk of acquiring HAIs in this population group.  
 
 Despite these limitations this study has revealed definite points of reference for HAIs in postoperative cardiac surgery patients and 








CONCLUSION AND RECOMMENDATIONS 
 
Gram negative and viral isolates were the most common organisms associated with HAIs developing in PICU after paediatric cardiac 
surgery. The incidence of HAI in this population was high with identified factors associated with risk being underweight for age, 
prolonged duration of A-lines and prolonged duration of stay prior to surgery. This study has shown that various issues may be related 
to the development of HAI in this group of patients. 
 
Previous studies have found that longer duration of central lines was associated with the development of HAIs (Abou Elella, Najm et 
al. 2010, Bezzio, Scolfaro et al. 2009). Similarly to the study conducted by Abou Elella et al (Abou Elella, Najm et al. 2010) this study 
reported a high use of intravascular catheter devices. The authors postulated that extensive use of invasive devices, and the relative 
malnourished status of many of their patients contributed to their findings. Because of the design of this study, we could not determine 
if the patients required prolonged arterial catheter use monitoring because of their HAI (to enable continuous blood pressure monitoring 
or routine blood sampling), or if they were prone to HAI due to prolonged catheter use. Further delineation of the causal relationship 
between prolonged use of invasive devices (CVP lines, A-lines, pacing wires, ICDs and urinary catheters), severity of cardiac disease 
and risk of developing HAIs in this population group is needed. 
 
Being underweight for age has previously been associated with increased risk of acquiring HAI (Ades, Dominguez et al. 2010). 
Contributing factors in this population group may include poor socio-economic background, chronic illness, late presentation or 
malnutrition. During this study a full nutritional assessment was not conducted on each patient. Weight measured was a reflection at 
one point during the study period and UWA was defined according to WHO criteria of less than -2SD of mean. We are thus unable to 
report if being UWA was due to inadequate diet or a reflection of severity of the existing cardiac condition.  
 
A few studies have previously reported duration of stay prior to surgery being associated with the development of HAIs (Hafez, Saied 
et al. 2012, Allpress, Rosenthal et al. 2004). Possible reasons for this could include an increased exposure to hospital acquired 
organisms and a worse clinical state prior to cardiac surgery. This study did not find a significant association with HAIs and increased 
severity of illness scores (PIM2), increased complexity of surgery scores (Aristotle score) or multiple previous surgeries. 
 
Perioperative factors such as intra- and postoperative complications and duration of stay prior to surgery, together with postoperative 
outcomes such as durations of ventilation, PICU and hospital stay are both indicators of severity of disease and proven risk factors for 
developing HAIs in this population group. Distinguishing cause from consequence would require further prospective, randomised and 
controlled clinical trials. This study’s findings may be used to inform suggestions for further studies into the management of paediatric 
cardiac patients with the aim to reduce durations of ventilation and durations of stay in PICU in an attempt to reduce risk of acquiring 
HAIs. 
 
There is an urgent need for better biomarkers for risk stratification, therapeutic monitoring and to differentiate systemic inflammatory 
response syndrome (SIRS) from infection in this population. Improved understanding is needed of the impact of different CHD, and in 
particular, the effects of CPB, on the subsequent risk for HAIs. Understanding of the epidemiology, pathogen distribution, and 
antibiotic resistance profile may promote the rational use of antibiotics. This is crucial to reduce drug resistance, mortality, and hospital 
costs. Antimicrobial agents selected for treatment of HAIs should be effective against any likely pathogen but should not promote the 





Possible exposure to infectious organisms prior to surgery whether viral or bacterial organisms provide challenges in diagnosing 
nosocomial infection if pre-existing infection or colonisation is not detected prior to surgery. Further studies are needed to develop 
strategies for preventing and optimising the management of HAIs in postoperative paediatric cardiac patients (Wheeler, Jeffries et al. 
2011). The strategies this institution would need to consider are: 
 Pre-operative measures, such as optimising nutrition, active screening for colonisation and pre-existing infections 
 Intra-operative measures, such as consistent steroid use and appropriate individually specific prophylactic antibiotic use 
(considering vancomycin use if MRSA colonised) 
 Postoperative measures, such as policy implementation of HAI bundles of Care, for VAP, CRBSIs, CAUTIs, and SSIs, early 
extubation of mechanically ventilated patients, and early removal of arterial and venous central catheters, cohorting of patients 
with similar infective organisms  





















APPENDIX 1. REFERENCES 
ABOU ELELLA, R., NAJM, H.K., BALKHY, H., BULLARD, L. and KABBANI, M.S., 2010. Impact of bloodstream infection on the 
outcome of children undergoing cardiac surgery. Pediatric cardiology, 31(4), pp. 483-489. 
ADES, A.M., DOMINGUEZ, T.E., NICOLSON, S.C., GAYNOR, J.W., SPRAY, T.L., WERNOVSKY, G. and TABBUTT, S., 2010. 
Morbidity and mortality after surgery for congenital cardiac disease in the infant born with low weight. Cardiology in the young, 20(1), 
pp. 8-17. 
ALGRA, S.O., DRIESSEN, M.M., SCHADENBERG, A.W., SCHOUTEN, A.N., HAAS, F., BOLLEN, C.W., HOUBEN, M.L. and 
JANSEN, N.J., 2012. Bedside prediction rule for infections after pediatric cardiac surgery. Intensive care medicine, 38(3), pp. 474-481. 
ALLEN, M.L., HOSCHTITZKY, J.A., PETERS, M.J., ELLIOTT, M., GOLDMAN, A., JAMES, I. and KLEIN, N.J., 2006. 
Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery. Critical Care Medicine, 34(10), pp. 2658-
2665. 
ALLPRESS, A.L., ROSENTHAL, G.L., GOODRICH, K.M., LUPINETTI, F.M. and ZERR, D.M., 2004. Risk factors for surgical site 
infections after pediatric cardiovascular surgery. The Pediatric infectious disease journal, 23(3), pp. 231-234. 
AL-RADI, O.O., HARRELL, F.E.,Jr, CALDARONE, C.A., MCCRINDLE, B.W., JACOBS, J.P., WILLIAMS, M.G., VAN 
ARSDELL, G.S. and WILLIAMS, W.G., 2007. Case complexity scores in congenital heart surgery: a comparative study of the 
Aristotle Basic Complexity score and the Risk Adjustment in Congenital Heart Surgery (RACHS-1) system. The Journal of thoracic 
and cardiovascular surgery, 133(4), pp. 865-875. 
ALVAREZ, P., FUENTES, C., GARCIA, N. and MODESTO, V., 2012. Evaluation of the duration of the antibiotic prophylaxis in 
paediatric postoperative heart surgery patients. Pediatric cardiology, 33(5), pp. 735-738. 
ANDREASSON, S., GOTHBERG, S., BERGGREN, H., BENGTSSON, A., ERIKSSON, E. and RISBERG, B., 1993. Hemofiltration 
modifies complement activation after extracorporeal circulation in infants. The Annals of Thoracic Surgery, 56(6), pp. 1515-1517. 
ASEMBERGIENE, J., GURSKIS, V., KEVALAS, R. and VALINTELIENE, R., 2009. Nosocomial infections in the pediatric intensive 
care units in Lithuania. Medicina (Kaunas, Lithuania), 45(1), pp. 29-36. 
BAKSHI, K.D., VAIDYANATHAN, B., SUNDARAM, K.R., ROTH, S.J., SHIVAPRAKASHA, K., RAO, S.G., NAIR, S.G., 
CHENGODE, S. and KUMAR, R.K., 2007. Determinants of early outcome after neonatal cardiac surgery in a developing country. The 
Journal of thoracic and cardiovascular surgery, 134(3), pp. 765-771. 
BALACHANDRAN, R., NAIR, S., GOPALRAJ, S., VAIDYANATHAN, B. and KUMAR, R., 2011. Dedicated pediatric cardiac 
intensive care unit in a developing country: Does it improve outcome? Annals of Pediatric Cardiology, 4(2), pp. 122-126. 
BARKER, G.M., O'BRIEN, S.M., WELKE, K.F., JACOBS, M.L., JACOBS, J.P., BENJAMIN, D.K.,Jr, PETERSON, E.D., 
JAGGERS, J. and LI, J.S., 2010. Major infection after pediatric cardiac surgery: a risk estimation model. The Annals of Thoracic 
Surgery, 89(3), pp. 843-850. 
BAVDEKAR, S., BHOSALE, A. and VAIDEESWAR, P., 2011. Viral ventilator-associated pneumonia: Uncovering tip of the iceberg. 
Indian Journal of Pathology and Microbiology, (54), pp. 339. 
BAYER, A., DOGAN, O., ERSOY, F. and ERSOY, U., 2009. The effect of open heart surgery on circulating lymphocytes and 
lymphocyte subsets in pediatric patients. Türk Göğüs Kalp Damar Cer Derg, 17(1), pp. 13-17. 
BEGHETTI, M., RIMENSBERGER, P.C., KALANGOS, A., HABRE, W. and GERVAIX, A., 2003. Kinetics of procalcitonin, 
interleukin 6 and C-reactive protein after cardiopulmonary-bypass in children. Cardiology in the young, 13(2), pp. 161-167. 
BEN-AMI, E., LEVY, I., KATZ, J., DAGAN, O. and SHALIT, I., 2008. Risk factors for sternal wound infection in children 
undergoing cardiac surgery: a case-control study. The Journal of hospital infection, 70(4), pp. 335-340. 
BERENHOLTZ, S.M., PRONOVOST, P.J., LIPSETT, P.A., HOBSON, D., EARSING, K., FARLEY, J.E., MILANOVICH, S., 
GARRETT-MAYER, E., WINTERS, B.D., RUBIN, H.R., DORMAN, T. and PERL, T.M., 2004. Eliminating catheter-related 
bloodstream infections in the intensive care unit. Critical Care Medicine, 32(10), pp. 2014-2020. 
BEZZIO, S., SCOLFARO, C., BROGLIA, R., CALABRESE, R., MIGNONE, F., ABRUZZESE, P.A., AIDALA, E., VALORI, A., 
GRASSITELLI, S., RIZZO, A., IANNANDREA, S. and TOVO, P.A., 2009. Prospective incidence study of bloodstream infection in 
infants and children with central venous catheters after cardiac surgery in Italy. Infection control and hospital epidemiology : the 




BLEASDALE, S.C., TRICK, W.E., GONZALEZ, I.M., LYLES, R.D., HAYDEN, M.K. and WEINSTEIN, R.A., 2007. Effectiveness 
of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Archives of 
Internal Medicine, 167(19), pp. 2073-2079. 
BOWMAN, M.E., REBEYKA, I.M., ROSS, D.B., QUINONEZ, L.G. and FORGIE, S.E., 2013. Risk factors for surgical site infection 
after delayed sternal closure. American Journal of Infection Control, 41(5), pp. 464-465. 
BRATZLER, D.W., HOUCK, P.M. and SURGICAL INFECTION PREVENTION GUIDELINE WRITERS WORKGROUP, 2005. 
Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. American 
Journal of Surgery, 189(4), pp. 395-404. 
CARCILLO, J.A., 2005. Reducing the global burden of sepsis in infants and children: a clinical practice research agenda. Pediatric 
critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical 
Care Societies, 6(3 Suppl), pp. S157-64. 
CENTERS FOR DISEASE CONTROL AND PREVENTION, January 2014, 2014-last update, CDC's National Healthcare Safety 
Network definitions for Nosocomial infections. [Homepage of CDC], [Online]. Available: 
http://www.cdc.gov/nhsn/PDFs/pscManual/17pscNosInfDef_current.pdf [January, 2014]. 
CHASTRE, J. and FAGON, J.Y., 2002. Ventilator-associated pneumonia. American journal of respiratory and critical care medicine, 
165(7), pp. 867-903. 
CHAUDHURI, A., SHEKAR, K. and COULTER, C., 2012. Post-operative deep sternal wound infections: making an early 
microbiological diagnosis. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-
thoracic Surgery, 41(6), pp. 1304-1308. 
CLARIZIA, N.A., MANLHIOT, C., SCHWARTZ, S.M., SIVARAJAN, V.B., MARATTA, R., HOLTBY, H.M., GRUENWALD, 
C.E., CALDARONE, C.A., VAN ARSDELL, G.S. and MCCRINDLE, B.W., 2011. Improved outcomes associated with intraoperative 
steroid use in high-risk pediatric cardiac surgery. The Annals of Thoracic Surgery, 91(4), pp. 1222-1227. 
COSTELLO, J.M., GRAHAM, D.A., MORROW, D.F., MORROW, J., POTTER-BYNOE, G., SANDORA, T.J., PIGULA, F.A. and 
LAUSSEN, P.C., 2010. Risk factors for surgical site infection after cardiac surgery in children. The Annals of Thoracic Surgery, 89(6), 
pp. 1833-41; discussion 1841-2. 
DAS, S., RUBIO, A., SIMSIC, J.M., KIRSHBOM, P.M., KOGON, B., KANTER, K.R. and MAHER, K., 2011. Bloodstream 
infections increased after delayed sternal closure: cause or coincidence. The Annals of Thoracic Surgery, 91(3), pp. 793-797. 
DELLINGER, R.P., LEVY, M.M., CARLET, J.M., BION, J., PARKER, M.M., JAESCHKE, R., REINHART, K., ANGUS, D.C., 
BRUN-BUISSON, C., BEALE, R., CALANDRA, T., DHAINAUT, J.F., GERLACH, H., HARVEY, M., MARINI, J.J., MARSHALL, 
J., RANIERI, M., RAMSAY, G., SEVRANSKY, J., THOMPSON, B.T., TOWNSEND, S., VENDER, J.S., ZIMMERMAN, J.L., 
VINCENT, J.L., INTERNATIONAL SURVIVING SEPSIS CAMPAIGN GUIDELINES COMMITTEE, AMERICAN 
ASSOCIATION OF CRITICAL-CARE NURSES, AMERICAN COLLEGE OF CHEST PHYSICIANS, AMERICAN COLLEGE OF 
EMERGENCY PHYSICIANS, CANADIAN CRITICAL CARE SOCIETY, EUROPEAN SOCIETY OF CLINICAL 
MICROBIOLOGY AND INFECTIOUS DISEASES, EUROPEAN SOCIETY OF INTENSIVE CARE MEDICINE, EUROPEAN 
RESPIRATORY SOCIETY, INTERNATIONAL SEPSIS FORUM, JAPANESE ASSOCIATION FOR ACUTE MEDICINE, 
JAPANESE SOCIETY OF INTENSIVE CARE MEDICINE, SOCIETY OF CRITICAL CARE MEDICINE, SOCIETY OF 
HOSPITAL MEDICINE, SURGICAL INFECTION SOCIETY and WORLD FEDERATION OF SOCIETIES OF INTENSIVE AND 
CRITICAL CARE MEDICINE, 2008. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic 
shock: 2008. Critical Care Medicine, 36(1), pp. 296-327. 
DOYLE, S., BUISING, L., THURSKY, K., WORTH, L. and RICHARDS, M., 2011. Epidemiology of Infections Acquired in Intensive 
Care Units. Seminars in respiratory and critical care medicine, 32(2), pp. 115-138. 
DUDECK, M.A., HORAN, T.C., PETERSON, K.D., ALLEN-BRIDSON, K., MORRELL, G., POLLOCK, D.A. and EDWARDS, 
J.R., 2011. National Healthcare Safety Network (NHSN) Report, data summary for 2010, device-associated module. American Journal 
of Infection Control, 39(10), pp. 798-816. 
EDWARDS, F.H., ENGELMAN, R.M., HOUCK, P., SHAHIAN, D.M., BRIDGES, C.R. and SOCIETY OF THORACIC 
SURGEONS, 2006. The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part I: 
Duration. The Annals of Thoracic Surgery, 81(1), pp. 397-404. 
ELDADAH, M., LEO, S., KOVACH, K., RICARDO ARGUETA MORALES, I., PEPE, J., FAKIOGLU, H. and DECAMPLI, W., 
2011. Influence of a dedicated paediatric cardiac intensive care unit on patient outcomes. Nursing in critical care, 16(6), pp. 281-286. 
ELDADAH, M., LEO, S., KOVACH, K., RICARDO ARGUETA MORALES, I., PEPE, J., FAKIOGLU, H. and DECAMPLI, W., 
2011. Influence of a dedicated paediatric cardiac intensive care unit on patient outcomes. Nursing in critical care, 16(6), pp. 281-286. 
ELLIOTT, M.J., 1993. Ultrafiltration and modified ultrafiltration in pediatric open heart operations. The Annals of Thoracic Surgery, 




FISCHER, J.E., ALLEN, P. and FANCONI, S., 2000. Delay of extubation in neonates and children after cardiac surgery: impact of 
ventilator-associated pneumonia. Intensive Care Medicine, (26), pp. 942-949. 
FUHRMAN, B., ZIMMERMAN, J., CARCILLO, J.A., R, C., RELVAS, M., ROTTA, A., THOMPSON, A. and TOBIAS, J., 2011. 
Pediatric critical care. 4th edn. USA: Elsevier. 
GANGAHAR, D.M., MCGOUGH, E.C. and SYNHORST, D., 1981. Secondary sternal closure: a method of preventing cardiac 
compression. The Annals of Thoracic Surgery, 31(3), pp. 281-282. 
GARCIA, I.J., GARGALLO, M.B., TORNE, E.E., LASAOSA, F.J., VINAS, A.T., TOLOSA, C.V. and RICO, A.P., 2012. 
Procalcitonin: A useful biomarker to discriminate infection after cardiopulmonary bypass in children. Pediatric critical care medicine : 
a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 13(4), 
pp. 441-445. 
GARNER, J., JARVIS, W.R., EMORI, T. and HUGHES, J., 1996. CDC Definitions of Nosocomial Infections. APIC Infection Control 
and Applied Epidemiology: Principles and Practice, , pp. A-1-A-20. 
GHANI, A., MORROW, B.M., HARDIE, M. and ARGENT, A., 2012. An investigation into the prevalence and outcome of 
patients admitted to a pediatric intensive care unit with viral respiratory tract infections in Cape Town, South Africa. Pediatric 
Critical Care Medicine, 13(5), pp. 275. 
GRAHAM, E.M., ATZ, A.M., BUTTS, R.J., BAKER, N.L., ZYBLEWSKI, S.C., DEARDORFF, R.L., DESANTIS, S.M., REEVES, 
S.T., BRADLEY, S.M. and SPINALE, F.G., 2011. Standardized preoperative corticosteroid treatment in neonates undergoing cardiac 
surgery: results from a randomized trial. The Journal of thoracic and cardiovascular surgery, 142(6), pp. 1523-1529. 
GRAVLEE, G., 2008. Cardiopulmonary bypass: Principles and practice. 3rd edn. Philadelphia: Wolters Kluwer Health / Lippincott 
William & Wilkins. 
GRISARU-SOEN, G., PARET, G., YAHAV, D., BOYKO, V. and LERNER-GEVA, L., 2009. Nosocomial infections in pediatric 
cardiovascular surgery patients: a 4-year survey. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine 
and the World Federation of Pediatric Intensive and Critical Care Societies, 10(2), pp. 202-206. 
HAFEZ, S., SAIED, T., HASAN, E., ELNAWASANY, M., AHMAD, E., LLOYD, L., EL-SHOBARY, W., HOUSE, B. and 
TALAAT, M., 2012. Incidence and modifiable risk factors of surveillance of surgical site infections in Egypt: a prospective study. 
American Journal of Infection Control, 40(5), pp. 426-430. 
HARDER, E.E., GAIES, M.G., YU, S., DONOHUE, J.E., HANAUER, D.A., GOLDBERG, C.S. and HIRSCH, J.C., 2013. Risk 
factors for surgical site infection in pediatric cardiac surgery patients undergoing delayed sternal closure. The Journal of thoracic and 
cardiovascular surgery, 146(2), pp. 326-333. 
HATHERILL, M., TIBBY, S.M. and SYKES, K.E.A., 1999. Diagnostic markers of infection: Comparison of procalcitonin with C 
reactive protein and leucocyte count. Arch Dis Child, (81), pp. 417-421. 
HEWITSON, J., BRINK, J. and ZILLA, P., 2002. The challenge of pediatric cardiac services in the developing world. Seminars in 
thoracic and cardiovascular surgery, 14(4), pp. 340-345. 
HOOSEN, E., CILLIERS, A., HUGO-HAMMAN, C., BROWN, S., HARRISBERG, J., TAKAWIRA, F., GOVENDRAGELOO, K. 
and LAWRENSON, J AND HEWITSON, J., 2010. Audit of paediatric cardiac services in South Africa. SAHeart, 7, pp. 4-5-9. 
HOOSEN, E.G., CILLIERS, A.M., HUGO-HAMMAN, C.T., BROWN, S.C., LAWRENSON, J.B., ZUHLKE, L. and HEWITSON, J., 
2011. Paediatric cardiac services in South Africa. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 101(2), 
pp. 106-107. 
INSTITUTE FOR HEALTHCARE IMPROVEMENT (IHI), Updated 2014-last update, What is a bundle?. Available: 
www.ihi.org/resources/Pages/ImprovementStories/What IsaBundle.aspx. 
JOGI, P. and WERNER, O., 1985. Hemodynamic effects of sternum closure after open-heart surgery in infants and children. 
Scandinavian journal of thoracic and cardiovascular surgery, 19(3), pp. 217-220. 
JOHNSON, J.N., JAGGERS, J., LI, S., O'BRIEN, S.M., LI, J.S., JACOBS, J.P., JACOBS, M.L., WELKE, K.F., PETERSON, E.D. and 
PASQUALI, S.K., 2010. Center variation and outcomes associated with delayed sternal closure after stage 1 palliation for hypoplastic 
left heart syndrome. The Journal of thoracic and cardiovascular surgery, 139(5), pp. 1205-1210. 
KATO, Y., SHIME, N., HASHIMOTO, S., NOMURA, M., OKAYAMA, Y., YAMAGISHI, M. and FUJITA, N., 2007. Effects of 





KILGER, E., WEIS, F., BRIEGEL, J., FREY, L., GOETZ, A.E., REUTER, D., NAGY, A., SCHUETZ, A., LAMM, P., KNOLL, A. 
and PETER, K., 2003. Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early 
outcome in a risk group of patients after cardiac surgery. Critical Care Medicine, 31(4), pp. 1068-1074. 
LETEURTRE, S., DUHAMEL, A., GRANDBASTIEN, B., PROULX, F., COTTING, J., GOTTESMAN, R., JOFFE, A., WAGNER, 
B., HUBERT, P., MARTINOT, A., LACROIX, J. and LECLERC, F., 2010. Daily estimation of the severity of multiple organ 
dysfunction syndrome in critically ill children. CMAJ : Canadian Medical Association journal = journal de l'Association medicale 
canadienne, 182(11), pp. 1181-1187. 
LETEURTRE, S., MARTINOT, A., DUHAMEL, A., GAUVIN, F., GRANDBASTIEN, B., NAM, T.V., PROULX, F., LACROIX, J. 
and LECLERC, F., 1999. Development of a pediatric multiple organ dysfunction score: use of two strategies. Medical decision making 
: an international journal of the Society for Medical Decision Making, 19(4), pp. 399-410. 
LEVY, I., KATZ, J., SOLTER, E., SAMRA, Z., VIDNE, B., BIRK, E., ASHKENAZI, S. and DAGAN, O., 2005. Chlorhexidine-
impregnated dressing for prevention of colonization of central venous catheters in infants and children: a randomized controlled study. 
The Pediatric infectious disease journal, 24(8), pp. 676-679. 
LEVY, I., OVADIA, B., EREZ, E., RINAT, S., ASHKENAZI, S., BIRK, E., KONISBERGER, H., VIDNE, B. and DAGAN, O., 2003. 
Nosocomial infections after cardiac surgery in infants and children: incidence and risk factors. The Journal of hospital infection, 53(2), 
pp. 111-116. 
MASTROPIETRO, C.W., BARRETT, R., DAVALOS, M.C., ZIDAN, M., VALENTINE, K.M., DELIUS, R.E. and WALTERS, 
H.L.,3rd, 2013. Cumulative corticosteroid exposure and infection risk after complex pediatric cardiac surgery. The Annals of Thoracic 
Surgery, 95(6), pp. 2133-2139. 
MAUERMANN, W., SAMPATHKUMAR, P. and THOMPSON, R., 2008. Sternal wound infections. Best Practice and research, 
22(3), pp. 423-436. 
MCDONALD, R., DODGEN, A., GOYAL, S., GOSSETT, J.M., SHINKAWA, T., UPPU, S.C., BLANCO, C., GARCIA, X., 
BHUTTA, A.T., IMAMURA, M. and GUPTA, P., 2012. Impact of 22q11.2 Deletion on the Postoperative Course of Children After 
Cardiac Surgery. Pediatric cardiology, . 
MCELHINNEY, D.B., REDDY, V.M., PARRY, A.J., JOHNSON, L., FINEMAN, J.R. and HANLEY, F.L., 2000. Management and 
outcomes of delayed sternal closure after cardiac surgery in neonates and infants. Critical Care Medicine, 28(4), pp. 1180-1184. 
MCKEE, C., BERKOWITZ, I., COSGROVE, S.E., BRADLEY, K., BEERS, C., PERL, T.M., WINNER, L., PRONOVOST, P.J. and 
MILLER, M.R., 2008. Reduction of catheter-associated bloodstream infections in pediatric patients: experimentation and reality. 
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive 
and Critical Care Societies, 9(1), pp. 40-46. 
MCMASTER, P., PARK, D.Y., SHANN, F., COCHRANE, A., MORRIS, K., GRAY, J., COTTRELL, S. and BELCHER, J., 2009. 
Procalcitonin versus C-reactive protein and immature-to-total neutrophil ratio as markers of infection after cardiopulmonary bypass in 
children. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric 
Intensive and Critical Care Societies, 10(2), pp. 217-221. 
MORROW, B.M., ARGENT, A.C., JEENA, P.M. and GREEN, R.J., 2009. Guideline for the diagnosis, prevention and treatment of 
paediatric ventilator-associated pneumonia. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 99(4 Pt 2), pp. 
255-267. 
MORROW, B.M., MOWZER, R., PITCHER, R. and ARGENT, A.C., 2012. Investigation into the effect of closed-system suctioning 
on the frequency of pediatric ventilator-associated pneumonia in a developing country. Pediatric critical care medicine : a journal of 
the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 13(1), pp. e25-32. 
MROWCZYNSKI, W., WOJTALIK, M., ZAWADZKA, D., SHARMA, G., HENSCHKE, J., BARTKOWSKI, R., PAWELEC-
WOJTALIK, M., WODZINSKI, A. and WESTERSKI, P., 2002. Infection risk factors in pediatric cardiac surgery. Asian 
cardiovascular & thoracic annals, 10(4), pp. 329-333. 
MUSCEDERE, J., DODEK, P., KEENAN, S., FOWLER, R., COOK, D., HEYLAND, D. and VAP GUIDELINES COMMITTEE 
AND THE CANADIAN CRITICAL CARE TRIALS GROUP, 2008. Comprehensive evidence-based clinical practice guidelines for 
ventilator-associated pneumonia: diagnosis and treatment. Journal of critical care, 23(1), pp. 138-147. 
NAHUM, E., LIVNI, G., SCHILLER, O., BITAN, S., ASHKENAZI, S. and DAGAN, O., 2012. Role of C-reactive protein velocity in 
the diagnosis of early bacterial infections in children after cardiac surgery. Journal of intensive care medicine, 27(3), pp. 191-196. 
NAHUM, E., SCHILLER, O., LIVNI, G., BITAN, S., ASHKENAZI, S. and DAGAN, O., 2012. Procalcitonin level as an aid for the 
diagnosis of bacterial infections following pediatric cardiac surgery. Journal of critical care, 27(2), pp. 220.e11-220.e16. 
NATEGHIAN, A., TAYLOR, G. and ROBINSON, J., 2004. Risk factors for surgical site infections following open-heart surgery in a 




NGUYEN, T.H., NGUYEN, T.L., LEI, H.Y., LIN, Y.S., LE, B.L., HUANG, K.J., LIN, C.F., DO, Q.H., VU, T.Q., LAM, T.M., YEH, 
T.M., HUANG, J.H., LIU, C.C. and HALSTEAD, S.B., 2005. Association between sex, nutritional status, severity of dengue 
hemorrhagic fever, and immune status in infants with dengue hemorrhagic fever. The American Journal of Tropical Medicine and 
Hygiene, 72(4), pp. 370-374. 
NGUYEN-VERMILLION, A., JUUL, S.E., MCPHERSON, R.J. and LEDBETTER, D.J., 2011. Time course of C-reactive protein and 
inflammatory mediators after neonatal surgery. The Journal of pediatrics, 159(1), pp. 121-126. 
ODETOLA, F.O., MOLER, F.W., DECHERT, R.E., VANDERELZEN, K. and CHENOWETH, C., 2003. Nosocomial catheter-related 
bloodstream infections in a pediatric intensive care unit: risk and rates associated with various intravascular technologies. Pediatric 
critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical 
Care Societies, 4(4), pp. 432-436. 
O'GRADY, N.P., ALEXANDER, M., BURNS, L.A., DELLINGER, E.P., GARLAND, J., HEARD, S.O., LIPSETT, P.A., MASUR, 
H., MERMEL, L.A., PEARSON, M.L., RAAD, I.I., RANDOLPH, A.G., RUPP, M.E., SAINT, S. and HEALTHCARE INFECTION 
CONTROL PRACTICES ADVISORY COMMITTEE (HICPAC) (APPENDIX 1), 2011. Summary of recommendations: Guidelines 
for the Prevention of Intravascular Catheter-related Infections. Clinical infectious diseases : an official publication of the Infectious 
Diseases Society of America, 52(9), pp. 1087-1099. 
O'GRADY, N.P., ALEXANDER, M., DELLINGER, E.P., GERBERDING, J.L., HEARD, S.O., MAKI, D.G., MASUR, H., 
MCCORMICK, R.D., MERMEL, L.A., PEARSON, M.L., RAAD, I.I., RANDOLPH, A., WEINSTEIN, R.A. and HEALTHCARE 
INFECTION CONTROL PRACTICES ADVISORY COMMITTEE, 2002. Guidelines for the prevention of intravascular catheter-
related infections. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of 
America, 23(12), pp. 759-769. 
OZKER, E., SARITAS, B., VURAN, C., YORUKER, U., ULUGOL, H. and TURKOZ, R., 2012. Delayed sternal closure after 
pediatric cardiac operations; single center experience: a retrospective study. Journal of cardiothoracic surgery, 7, pp. 102-8090-7-102. 
PASQUALI, S.K., HALL, M., LI, J.S., PETERSON, E.D., JAGGERS, J., LODGE, A.J., MARINO, B.S., GOODMAN, D.M. and 
SHAH, S.S., 2010. Corticosteroids and outcome in children undergoing congenital heart surgery: analysis of the Pediatric Health 
Information Systems database. Circulation, 122(21), pp. 2123-2130. 
PASQUALI, S.K., HE, X., JACOBS, M.L., HALL, M., GAYNOR, J.W., SHAH, S.S., PETERSON, E.D., HILL, K.D., LI, J.S. and 
JACOBS, J.P., 2013. Hospital variation in postoperative infection and outcome after congenital heart surgery. The Annals of Thoracic 
Surgery, 96(2), pp. 657-663. 
PASQUALI, S.K., LI, J.S., HE, X., JACOBS, M.L., O'BRIEN, S.M., HALL, M., JAQUISS, R.D., WELKE, K.F., PETERSON, E.D., 
SHAH, S.S., GAYNOR, J.W. and JACOBS, J.P., 2012. Perioperative methylprednisolone and outcome in neonates undergoing heart 
surgery. Pediatrics, 129(2), pp. e385-91. 
POLLOCK, E.M., FORD-JONES, E.L., REBEYKA, I., MINDORFF, C.M., BOHN, D.J., EDMONDS, J.F., LIGHTFOOT, N.E., 
COLES, J., WILLIAMS, W.G. and TRUSLER, G.A., 1990. Early nosocomial infections in pediatric cardiovascular surgery patients. 
Critical Care Medicine, 18(4), pp. 378-384. 
RAJA, S.G. and DREYFUS, G.D., 2005. Modulation of systemic inflammatory response after cardiac surgery. Asian cardiovascular & 
thoracic annals, 13(4), pp. 382-395. 
RAO, S.G., 2007. Pediatric Cardiac Surgery in Developing Countries. Pediatric cardiology, 28, pp. 144-148. 
RAYMOND, J., AUJARD, M. and THE EUROPEAN STUDY GROUP, 2000. Nosocomial Infections in Pediatric Patients: A 
European, Multicenter Prospective Study. Infection control and hospital epidemiology : the official journal of the Society of Hospital 
Epidemiologists of America, 21(4),. 
REY, C., LOS ARCOS, M., CONCHA, A., MEDINA, A., PRIETO, S., MARTINEZ, P. and PRIETO, B., 2007. Procalcitonin and C-
reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children. Intensive care medicine, 
33(3), pp. 477-484. 
RICHARDS, M., EDWARDS, M., CULVER, D., GAYNES, R. and AND THE NATIONAL NOSOCOMIAL INFECTIONS 
SURVEILLANCE SYSTEM, 1999. Nosocomial Infections in Pediatric Intensive Care Units in the United states. Pediatrics, 103(4), 
pp. 1-7. 
ROBERTSON-MALT, S., AFRANE, B. and EL BARBARY, M., 2007. Prophylactic steroids for pediatric open heart surgery. 
Cochrane database of systematic reviews (Online), (4)(4), pp. CD005550. 
ROELEVELD, P.P., GUIJT, D., KUIJPER, E.J., HAZEKAMP, M.G., DE WILDE, R.B. and DE JONGE, E., 2011. Ventilator-




ROSANOVA, M.T., ALLARIA, A., SANTILLAN, A., HERNANDEZ, C., LANDRY, L., CEMINARA, R. and BERBERIAN, G., 
2009. Risk factors for infection after cardiovascular surgery in children in Argentina. The Brazilian journal of infectious diseases : an 
official publication of the Brazilian Society of Infectious Diseases, 13(6), pp. 414-416. 
SAFDAR, N. and MAKI, D.G., 2004. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central 
venous catheters. Intensive care medicine, 30(1), pp. 62-67. 
SALVIN, J.W., SCHEURER, M.A., LAUSSEN, P.C., WYPIJ, D., POLITO, A., BACHA, E.A., PIGULA, F.A., MCGOWAN, F.X., 
COSTELLO, J.M. and THIAGARAJAN, R.R., 2011. Blood transfusion after pediatric cardiac surgery is associated with prolonged 
hospital stay. The Annals of Thoracic Surgery, 91(1), pp. 204-210. 
SARVIKIVI, E., LYYTIKAINEN, O., NIEMINEN, H., SAIRANEN, H. and SAXEN, H., 2008. Nosocomial infections after pediatric 
cardiac surgery. American Journal of Infection Control, 36(8), pp. 564-569. 
SAXENA, A., 2009. Congenital cardiac surgery in the less privileged regions of the world. Expert review of cardiovascular therapy, 
7(12), pp. 1621-1629. 
SEGUELA, P.E., JORAM, N., ROMEFORT, B., MANTEAU, C., ORSONNEAU, J.L., BRANGER, B., GOURNAY, V., ROZE, J.C. 
and GRAS-LE GUEN, C., 2011. Procalcitonin as a marker of bacterial infection in children undergoing cardiac surgery with 
cardiopulmonary bypass. Cardiology in the young, 21(4), pp. 392-399. 
SHI, S., ZHAO, Z., LIU, X., SHU, Q., TAN, L., LIN, R., SHI, Z. and FANG, X., 2008. Perioperative risk factors for prolonged 
mechanical ventilation following cardiac surgery in neonates and young infants. Chest, 134(4), pp. 768-774. 
SHIN, H.J., JHANG, W.K., PARK, J.J. and YUN, T.J., 2011. Impact of delayed sternal closure on postoperative infection or wound 
dehiscence in patients with congenital heart disease. The Annals of Thoracic Surgery, 92(2), pp. 705-709. 
SIDDIQUI, N.U., MIR, F., SHAKIL, O., AMANULLAH, M. and HAQUE, A., 2011. Health-care associated infections in children 
after cardiac surgery in a pediatric cardiac intensive care unit (PCICU). Journal of infection in developing countries, 5(10), pp. 748-
750. 
SINGH-NAZ, N., SPRAGUE, B.M., PATEL, K.M. and POLLACK, M.M., 1996. Risk factors for nosocomial infection in critically ill 
children: a prospective cohort study. Critical Care Medicine, 24(5), pp. 875-878. 
SLATER, A., SHANN, F. and PEARSON, G., 2003. PIM2: a revised version of the Paediatric Index of Mortality.. Intensive Care 
Med, 29, pp. 278-285. 
SLONIM, A.D., KURTINES, H.C., SPRAGUE, B.M. and SINGH, N., 2001. The costs associated with nosocomial bloodstream 
infections in the pediatric intensive care unit. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and 
the World Federation of Pediatric Intensive and Critical Care Societies, 2(2), pp. 170-174. 
SOHN, A.H., SCHWARTZ, J.M., YANG, K.Y., JARVIS, W.R., GUGLIELMO, B.J. and WEINTRUB, P.S., 2010. Risk factors and 
risk adjustment for surgical site infections in pediatric cardiothoracic surgery patients. American Journal of Infection Control, 38(9), 
pp. 706-710. 
STATISTICS SOUTH AFRICA, 2011. Mid-year population estimates . http://www.statssa.gov.za/publications/P0302/P03022011.pdf,. 
STOCKER, C.F., SHEKERDEMIAN, L.S., HORTON, S.B., LEE, K.J., EYRES, R., D'UDEKEM, Y. and BRIZARD, C.P., 2011. The 
influence of bypass temperature on the systemic inflammatory response and organ injury after pediatric open surgery: a randomized 
trial. The Journal of thoracic and cardiovascular surgery, 142(1), pp. 174-180. 
SUOMINEN, P.K., DICKERSON, H.A., MOFFETT, B.S., RANTA, S.O., MOTT, A.R., PRICE, J.F., HEINLE, J.S., MCKENZIE, 
E.D., FRASER, C.D.,Jr and CHANG, A.C., 2005. Hemodynamic effects of rescue protocol hydrocortisone in neonates with low 
cardiac output syndrome after cardiac surgery. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and 
the World Federation of Pediatric Intensive and Critical Care Societies, 6(6), pp. 655-659. 
TAN, L., SUN, X., ZHU, X., ZHANG, Z., LI, J. and SHU, Q., 2004. Epidemiology of nosocomial pneumonia in infants after cardiac 
surgery. Chest, 125(2), pp. 410-417. 
TANTAWY, A., SELIEM, Z., AGHA, H., EL-KHOLY, A. and ABDELAZIZ, D., 2012. Epidemiology of nosocomial infections and 
mortality following congenital cardiac surgery in Cairo University, Egypt. Journal of the Egyptian Public Health Association, 87, pp. 
79-84. 
URREA, M., PONS, M., SERRA, M., LATORRE, C. and PALOMEQUE, A., 2003. Prospective incidence study of nosocomial 
infections in a pediatric intensive care unit. The Pediatric infectious disease journal, 22(6), pp. 490-494. 
VALENTI, W.M., MENEGUS, M.A., HALL, C.B., PINCUS, P.H. and DOUGLAS, R.G.,Jr, 1980. Nosocomial viral infections: I. 




VAN KEULEN, J.G., POLDERMAN, K.H. and GEMKE, R.J., 2005. Reliability of PRISM and PIM scores in paediatric intensive 
care. Archives of Disease in Childhood, 90(2), pp. 211-214. 
WALD, E., PREZE, E., EICKHOFF, J. and BACKER, C., 2011. The effect of cardiopulmonary bypass on the hypothalamic-pituitary-
adrenal axis in children*. Pediatric Critical Care Medicine, 12(2), pp. 190-196. 
WHEELER, D.S., JEFFRIES, H.E., ZIMMERMAN, J.J., WONG, H.R. and CARCILLO, J.A., 2011. Sepsis in the Pediatric Cardiac 
Intensive Care Unit. World journal for pediatric & congenital heart surgery, 2(3), pp. 393-399. 
WOODWARD, C.S., SON, M., CALHOON, J., MICHALEK, J. and HUSAIN, S.A., 2011. Sternal wound infections in pediatric 























APPENDIX 3. DATA COLLECTION FORMS 
PATIENT 000       FOLDER # 
Date of hospital admission  
Date of PICU admission 1                 Time  Date of PICU1 discharge                 Time 
Date of PICU admission 1                 Time Date of PICU1 discharge                 Time 
Age / Gestational age  
sex Male Female 
height  Estimated 













Cardiac lesion  
Previous surgical history  
Admitted from home / ward / mother’s room  
Genetic Syndromes (e.g. Trisomy21, 22 Q 
deletion) 
 

















DATE    
Type – complexity 
score 
    
Surgeon     
CPB duration     
Cross clamp time     
Chest left open Y             N    
Antibiotics: time     
Blood products: 
volume, type 






    





    
Bleeding:  blood 
transfusion, blood 
product transfusion  
volume, same donor, 
leukocyte depleted 








    
Chest re-opened  
 
 





SURGICAL WOUNDS DATE   
Mediastinotomy                   Dressing change    
Y        N    
    
Thoracotomy                        Dressing change    
Y         N    
 
CATHETERS/ LINES    
CVP                                           Site 
 
   
                                                  Date inserted 
 
   
                                                  Date removed    
                                                  Dressing change    
Arterial line                              Site 
 
   
                                                  Date inserted    
                                                  Date removed    
                                                  Dressing change    
Pacing wires                            Site 
 
   
                                                  Date inserted    
                                                  Date removed    
                                                  Dressing change    
Urinary catheter                    Date inserted    
                                                  Date removed    
Mediastinal drain                   Site    
                                                  Date inserted    
                                                  Date removed    
                                                  Dressing change    
Intercostal chest drain          Site 
 
   
                                                  Date inserted    
                                                  Date removed    




VAP identification: Clinical Pulmonary Infection Score (CPIS).  
Please tick appropriate box (worst value over previous 24 hours) 






<36.0 or >39.0 2 
 
Leukocyte count  
(X 109/l) 
4.0-11 0 
≤3.9 ≥11.1 and no bands 
or ≥ 11.1 ≤17.0 and no differentiation done 
1 
≥11.1 with bands  
or no differentiation done and leukocytes ≥17.1 
2 
Chest radiography 
No CXR taken or no infiltrate 0 
Diffuse or patchy infiltrate 1 
Localised infiltrate 2 
Pulmonary 
secretions 
Absent or minimal 0 
Present and non purulent 1 
Present and purulent 2 
PaO2 (mmHg)/FiO2 
>240 0 
≤ 240 2 
Organism isolated 
on BAL 
No or Not Done 0 
Yes 2 
 TOTAL SCORE   
















worst value over 
previous 24 hours 
DATE    
White cell count     
Bands     
Hb     
Platelets     
PCT     
Blood glucose     
T°                LOW 
                    HIGH 
    
    
CXR findings             
Pulmonary secretions     
PaO2 (mmHg)/FiO2  
e.g. PaO₂  8, FiO₂  
30% (8 x 7.5 / 0.3) 




BAL   
 
 
   
Urine     
Blood     
Pus 
Swab 
    
Clinician           
opinion to treat 
infection 
Y        N     N/A Y        N     N/A Y        N     N/A Y        N     N/A 
Suspected infection 
site 
    







ANTIMICROBIALS     
Type 
 
    
Date      initiated 
 
    
ended     
Dosage 
 




DATE    
Blood transfusion, 
blood product 
transfusion  volume, 
same donor, leukocyte 
depleted 
    
Cardiac arrest 
 
    
Reintubation 
 
    
Chest re-opened 
 
    
Organ failure   liver: 
AST, ALT, TSB, INR  
Renal: urea, creatinine 
    














   
 
     




       
                
          
 
 


















Do Blood culture 
If + Nitrates / 
leucocytes 
Do Urine dipstix 
(bladder catheter / 
suprapubic 
aspiration)   
Send uMCS to lab 
Assess Clinical Pulmonary Infection Score (CPIS) Review: WCC, diff, secretions, Blood gas, CXR, 
BAL 
Do Pus swab with aseptic 
technique of fluid / pus at 
incision site. Send for MCS. 
Pain, tenderness, 
localised swelling, 
redness, heat, pus 
Check all wound 
sites 
Pyrexia > 38°C, Hypotension, Hypothermia 





APPENDIX 5. CDC DEFINITIONS OF INFECTIONS (Centers for Disease Control and Prevention 2014) 
Laboratory confirmed blood stream infections (BSI), urinary tract infections (UTI), and surgical site infections 
Present on Admission (POA) Infections 
If all of the elements used to meet a CDC site specific infection criterion are present during the two calendar days before the day of 
admission, the first day of admission (day 1) and/or the day after admission (day 2) and are documented in the medical record, the 
infection is considered POA. Infections that are POA should not be reported as HAIs. 
 
Healthcare-associated infections (HAI)  
A healthcare-associated infection (HAI) is a localised or systemic condition resulting from an adverse reaction to the presence of an 
infectious agent(s) or its toxin(s) that was not present on admission to the acute care facility.  An infection is considered an HAI if all 
elements of a CDC/NHSN site-specific infection criterion were not present during the POA time period but were all present on or after 
the 3rd calendar day of admission to the facility (the day of hospital admission is calendar day 1).  
 
Bloodstream infection (BSI) 
Table 1. Laboratory-Confirmed Bloodstream Infection Criteria 
Criterion 
 
Laboratory-Confirmed Bloodstream Infection (LCBI) 
Comments and reporting instructions that follow the site-
specific criteria provide further explanation and are integral to 
the correct application of the criteria. 
Must meet one of the following criteria: 
LCBI 1 Patient has a recognized pathogen cultured from one or more 
blood cultures 
and 
organism cultured from blood is not related to an infection at 


























Patient has at least one of the following signs or symptoms: 
fever (>38oC), chills, or hypotension 
and 
positive laboratory results are not related to an infection at 
another site (See Appendix 1 Secondary BSI Guide) 
and 
the same common commensal (i.e., diphtheroids 
[Corynebacterium spp. not C. diphtheriae], Bacillus spp. [not B. 
anthracis], Propionibacterium spp., coagulase-negative 
staphylococci [including S. epidermidis], viridans group 
streptococci, Aerococcus spp., and Micrococcus spp.) is cultured 
from two or more blood cultures drawn on separate occasions 
(see comment 3a below). Criterion elements must occur within a 
timeframe that does not exceed a gap of 1 calendar day between 




(See complete list of common commensals at 
http://www.cdc.gov/nhsn/XLS/master-organism-Com-
Commensals- Lists.xlsx) 
NOTE: The matching common commensals represent a single 
element; therefore, the collection date of the first common 





Patient ≤ 1 year of age has at least one of the following signs or 
symptoms: fever (>38oC core), hypothermia (<36oC core), 
apnea, or bradycardia 
and 
positive laboratory results are not related to an infection at 
another site (See Appendix 1 Secondary BSI Guide) 
and 
the same common commensal (i.e., diphtheroids 
[Corynebacterium spp. not C. diphtheriae], Bacillus spp. [not B. 
anthracis], Propionibacterium spp., coagulase-negative 
staphylococci [including S. epidermidis], viridans group 
streptococci, Aerococcus spp., Micrococcus spp.) is cultured 
from two or more blood cultures drawn on the same or 
consecutive days and separate occasions (see Comment 3a 
below). Criterion elements must occur within a timeframe that 
does not exceed a gap of 1 calendar day between two adjacent 
elements. (See complete list of common commensals at 
http://www.cdc.gov/nhsn/XLS/master- organism-Com-
Commensals-Lists.xlsx#common) 
NOTE: The matching common commensals represent a single 
element; therefore, the collection date of the first common 




1. Report organisms cultured from blood as BSI–LCBI 
when no other site of infection is evident (see Appendix 
1. Secondary Bloodstream Infection [BSI] Guide).  
2. Catheter tip cultures are not used to determine whether a 
patient has a primary BSI.  
3. When there is a positive blood culture and clinical signs 
or symptoms of localised infection at a vascular access 
site, but no other infection can be found, the infection is 
considered a primary BSI.  
4. Purulent phlebitis confirmed with a positive 
semiquantitative culture of a catheter tip, but with either 
negative or no blood culture is considered a CVS-VASC, 




5. Occasionally a patient with both peripheral and central IV 
lines develops a primary bloodstream infection (LCBI) 
that can clearly be attributed to the peripheral line (e.g., 
pus at the insertion site and/or matching pathogen from 
pus and blood). In this situation, enter “Central Line = 
No” in the NHSN application. You should, however, 
include the patient’s central line days in the summary 
denominator count.  
6. If your state or facility requires that you report healthcare-
associated BSIs that are not central line-associated, enter 
“Central Line = No” in the NHSN application when 
reporting these BSIs. You should, however, include all of 
the patient’s central line days in the summary 




Lower respiratory tract infection (LRTI), other than pneumonia 
BRON-Bronchitis, tracheobronchitis, bronchiolitis, tracheitis, without evidence of pneumonia 
Tracheobronchial infections must meet at least 1 of the following criteria: 
1. Patient has no clinical or imaging test evidence of pneumonia 
and  patient has at least 2 of the following signs or symptoms: fever (>38°C), cough*, new or increased sputum production*, rhonchi*, 
wheezing*  and  at least 1 of the following: 
a. positive culture obtained by deep tracheal aspirate or bronchoscopy 
b. positive laboratory test on respiratory secretions. * With no other recognized cause 
2. Patient ≤1 year of age has no clinical or imaging test evidence of pneumonia 
and  patient has at least 2 of the following signs or symptoms: fever (>38°C core), cough*, new or increased sputum production*, 
rhonchi*, wheezing*, respiratory distress*, apnea*, or bradycardia* and  at least 1 of the following: 
a. organisms cultured from material obtained by deep tracheal aspirate or bronchoscopy  b. positive laboratory test on respiratory 
secretions  c. diagnostic single antibody titer (IgM) or 4-fold increase in paired sera (IgG) for pathogen. 
* With no other recognized cause 
 
Pneumonia 
There are 3 specific types of pneumonia: clinically-defined pneumonia (PNU1), pneumonia with specific laboratory findings (PNU2), 
and pneumonia in immunocompromised patients (PNU3). Listed below are general comments applicable to all specific types of 
pneumonia, along with abbreviations used in the algorithms and reporting instructions. 
Table 11 shows threshold values for cultured specimens used in the surveillance diagnosis of pneumonia. 
General comments 
5. Physician diagnosis of pneumonia alone is not an acceptable criterion for healthcare-associated pneumonia.  
6. Although specific criteria are included for infants and children, pediatric patients may meet any of the other pneumonia specific 




7. When assessing a patient for presence of pneumonia, it is important to distinguish between changes in clinical status due to 
other conditions such as myocardial infarction, pulmonary embolism, respiratory distress syndrome, atelectasis, malignancy, 
chronic obstructive pulmonary disease, hyaline membrane disease, bronchopulmonary dysplasia, etc. Also, care must be taken 
when assessing intubated patients to distinguish between tracheal colonization, upper respiratory tract infections (e.g., 
tracheobronchitis), and early onset pneumonia. Finally, it should be recognized that it may be difficult to determine healthcare-
associated pneumonia in the elderly, infants, and immunocompromised patients since such conditions may mask typical signs 
or symptoms associated with pneumonia. Alternate specific criteria for the elderly, infants, and immunocompromised patients 
have been included in this definition of healthcare-associated pneumonia.  
8. Healthcare–associated pneumonia can be characterized by its onset: early or late. Early-onset pneumonia occurs during the first 
4 days of hospitalization and is often caused by Moraxella catarrhalis, H influenzae, and S pneumoniae. Causative agents of 
late-onset pneumonia are frequently Gram-negative bacilli or S aureus, including methicillin-resistant S aureus. Viruses (e.g., 
influenza A and B or respiratory syncytial virus) can cause early- and late-onset nosocomial pneumonia, whereas yeasts, fungi, 
legionellae, and Pneumocystis carinii are usually pathogens of late-onset pneumonia.  
9. Pneumonia due to gross aspiration (for example, in the setting of intubation in the emergency room or operating room) is 
considered healthcare associated if it meets any specific criteria and the infection itself was not clearly present at the time of 
admission to the hospital.  
10. Multiple episodes of healthcare-associated pneumonia may occur in critically ill patients with lengthy hospital stays. When 
determining whether to report multiple episodes of healthcare–associated pneumonia in a single patient, look for evidence of 
resolution of the initial infection. See Note following HAI definition in Chapter 2. The addition of or change in pathogen alone 
is not indicative of a new episode of pneumonia.  
11. Positive Gram’s stain for bacteria and positive KOH (potassium hydroxide) mount for elastin fibers and/or fungal hyphae from 
appropriately collected sputum specimens are important clues that point toward the etiology of the infection. However, sputum 
samples are frequently contaminated with airway colonizers and therefore must be interpreted cautiously. In particular, 
Candida is commonly seen on strain, but infrequently causes healthcare-associated pneumonia, especially in immunocompetent 
patients.  
Abbreviations 
BAL–bronchoalveolar lavage  EIA–enzyme immunoassay  FAMA–fluorescent-antibody staining of membrane antigen IFA–
immunofluorescent antibody  LRT–lower respiratory tract  PCR–polymerase chain reaction  PMN–polymorphonuclear leukocyte 
RIA–radioimmunoassay 
Reporting instructions 
• There is a hierarchy of specific categories within the major type pneumonia (PNEU). Even if a patient meets criteria for more than 1 
specific site, report only 1: 
o If a patient meets criteria for both PNU1 and PNU2, report PNU2. o If a patient meets criteria for both PNU2 and PNU3, report 
PNU3. o If a patient meets criteria for both PNU1 and PNU3, report PNU3. 
12. Report concurrent lower respiratory tract infection (e.g., abscess or empyema) and pneumonia with the same organism(s) as 
PNEU.  
13. Lung abscess or empyema without pneumonia is classified as LUNG.  













Two or more serial chest radiographs with at least one of the 
following: 
 New or progressive and persistent infiltrate  
 Consolidation  
 Cavitation  
 Pneumatoceles, in infants ≤1 year old   NOTE: In 
patients without underlying pulmonary or cardiac 
disease (e.g., respiratory distress syndrome, 
bronchopulmonary dysplasia, pulmonary edema, or 
chronic obstructive pulmonary disease), one definitive 
chest radiograph is acceptable.  
 
FOR ANY PATIENT, at least one of the following: 
•     Fever (>38°C or >100.4°F)  
 Leukopenia (<4000 WBC/mm ) or leukocytosis 
(≥12,000 WBC/mm )  • For adults ≥70 years old, 
altered mental status with no other recognized cause and 
  at least two of the following: 
 New onset of purulent sputum, or change in character of 
sputum, or   increased respiratory secretions, or 
increased suctioning requirements  
 New onset or worsening cough, or dyspnea, or tachypnea  
 Rales or bronchial breath sounds  
 Worsening gas exchange (e.g., O2 desaturations (e.g., 
PaO2/FiO2  ≤ 240),   increased oxygen requirements, or 
increased ventilator demand)  
ALTERNATE CRITERIA, for infants <1 year old: 
Worsening gas exchange (e.g., O2 desaturations [e.g., pulse 
oximetry <94%], increased oxygen requirements, or increased 
ventilator demand)  and  at least three of the following: 
• Temperature instability 
 Leukopenia (<4000 WBC/mm3) or leukocytosis 
(≥15,000 WBC/mm3) and left   shift (≥10% band forms)  
 New onset of purulent sputum or change in character of 
sputum, or   increased respiratory secretions or 
increased suctioning requirements  
 Apnea, tachypnea , nasal flaring with retraction of chest 
wall or grunting  
 Wheezing, rales, or rhonchi  
 Cough  
 Bradycardia (<100 beats/min) or tachycardia (>170 
beats/min)  
ALTERNATE CRITERIA, for child >1 year old or  ≤12 years 
old, at least three of the following: 
 Fever (>38.4°C or >101.1°F) or hypothermia (<36.5°C 
or <97.7°F)  
 Leukopenia (<4000 WBC/mm3) or leukocytosis 




 New onset of purulent sputum, or change in character of 
sputum, or   increased respiratory secretions, or 
increased suctioning requirements  
 New onset or worsening cough, or dyspnea, apnea, or 
tachypnea.  
 Rales or bronchial breath sounds  
 Worsening gas exchange (e.g., O2 desaturations [e.g., 
pulse oximetry <94%],   increased oxygen requirements, 
or increased ventilator demand)  
 
 
Table 3. Specific Site Algorithms for Pneumonia with Common Bacterial or Filamentous Fungal Pathogens and Specific 
Laboratory Findings (PNU2) 
Radiology  Signs/Symptoms  Laboratory  
Two or more serial chest radiographs with 
at least one of the following:  
• New or progressive and persistent 
infiltrate  
 
• Consolidation  
 
• Cavitation  
 
• Pneumatoceles, in infants ≤1 year old  
 
NOTE: In patients without underlying 
pulmonary or cardiac disease (e.g., 
respiratory distress syndrome, 
bronchopulmonary dysplasia, pulmonary 
edema, or chronic obstructive pulmonary 
disease), one definitive chest radiograph is 
acceptable. 
At least one of the following:  
• Fever (>38°C or >100.4°F)  
• Leukopenia (<4000 WBC/mm3) or 
leukocytosis (≥12,000 WBC/mm3)  
• For adults ≥70 years old, altered mental 




at least one of the following:  
 
• New onset of purulent sputum, or change 
in character of sputum, or increased 
respiratory secretions, or increased 
suctioning requirements  
• New onset or worsening cough, or 
dyspnea or tachypnea 
• Rales or bronchial breath sounds  
• Worsening gas exchange (e.g., O2 
desaturations [e.g., PaO2/FiO2 ≤240], 
increased oxygen requirements, or 
increased ventilator demand)  
 
At least one of the following:  
• Positive growth in blood culture not 
related to another source of infection  
 
• Positive growth in culture of pleural 
fluid  
 
• Positive quantitative culture from 
minimally contaminated LRT specimen 
(e.g., BAL or protected specimen 
brushing)  
 
• ≥5% BAL-obtained cells contain 
intracellular bacteria on direct 
microscopic exam (e.g., Gram’s stain)  
 
• Histopathologic exam shows at least one 
of the following evidences of pneumonia:  
o Abscess formation or foci of 
consolidation with intense PMN 
accumulation in bronchioles and alveoli  
o Positive quantitative culture of lung 
parenchyma  
o Evidence of lung parenchyma invasion 






Table 4. Specific Site Algorithms for Viral, Legionella, and other Bacterial Pneumonias with Definitive Laboratory Findings 
(PNU2) 
Radiology  Signs/Symptoms  Laboratory  
Two or more serial chest radiographs with 
at least one of the following:  
• New or progressive and persistent 
infiltrate  
 
• Consolidation  
 
• Cavitation  
 
• Pneumatoceles, in infants ≤1 year old  
 
NOTE: In patients without underlying 
pulmonary or cardiac disease (e.g., 
respiratory distress syndrome, 
bronchopulmonary dysplasia, pulmonary 
edema, or chronic obstructive pulmonary 
disease), one definitive chest radiograph is 
acceptable.  
At least one of the following:  
• Fever (>38°C or >100.4°F)  
• Leukopenia (<4000 WBC/mm3) or 
leukocytosis (≥12,000 WBC/mm3)  
• For adults ≥70 years old, altered mental 
status with no other recognized cause  
 
and  
at least one of the following:  
 
• New onset of purulent sputum, or change 
in character of sputum, or increased 
respiratory secretions, or increased 
suctioning requirements  
• New onset or worsening cough or 
dyspnea, or tachypnea 
• Rales or bronchial breath sounds  
• Worsening gas exchange (e.g., O2 
desaturations [e.g., PaO2/FiO2 ≤240], 
increased oxygen requirements, or 
increased ventilator demand)  
 
At least one of the following: 
• Positive culture of virus or Chlamydia 
from respiratory secretions 
• Positive detection of viral antigen or 
antibody from respiratory secretions (e.g., 
EIA, FAMA, shell vial assay, PCR) 
• Fourfold rise in paired sera (IgG) for 
pathogen (e.g., influenza viruses, 
Chlamydia) 
• Positive PCR for Chlamydia or 
Mycoplasma 
• Positive micro-IF test for Chlamydia 
• Positive culture or visualization by 
micro-IF of Legionella spp, from 
respiratory secretions or tissue. 
• Detection of Legionella pneumophila 
serogroup 1 antigens in urine by RIA or 
EIA 
• Fourfold rise in L. pneumophila 
serogroup 1 antibody titer to ≥1:128 in 
paired acute and convalescent sera by 
indirect IFA. 
 
Footnotes to Algorithms:  
Occasionally, in nonventilated patients, the diagnosis of healthcare-associated pneumonia may be quite clear on the basis of symptoms, 
signs, and a single definitive chest radiograph. However, in patients with pulmonary or cardiac disease (for example, interstitial lung 
disease or congestive heart failure), the diagnosis of pneumonia may be particularly difficult. Other noninfectious conditions (for 
example, pulmonary edema from decompensated congestive heart failure) may simulate the presentation of pneumonia. In these more 
difficult cases, serial chest radiographs must be examined to help separate infectious from noninfectious pulmonary processes. To help 
confirm difficult cases, it may be useful to review radiographs on the day of diagnosis, 3 days prior to the diagnosis and on days 2 and 7 
after the diagnosis. Pneumonia may have rapid onset and progression, but does not resolve quickly. Radiographic changes of 
pneumonia persist for several weeks. As a result, rapid radiographic resolution suggests that the patient does not have pneumonia but 









Surgical Site Infection (SSI) 
DIP/DIS-Deep incisional surgical site infection  
Deep incisional SSI must meet the following criterion:  
Infection occurs within 30 or 90 days after the NHSN operative procedure (where day 1 = the procedure date) according to the list in 
Table 12  
and  
involves deep soft tissues of the incision (e.g., fascial and muscle layers)  
and  
patient has at least one of the following:  
a. purulent drainage from the deep incision  
b. a deep incision that spontaneously dehisces or is deliberately opened by a surgeon, attending physician** or other designee and is 
culture-positive or not cultured  
and  
patient has at least one of the following signs or symptoms: fever (>38°C); localised pain or tenderness. A culture-negative finding does 
not meet this criterion.  
c. an abscess or other evidence of infection involving the deep incision that is detected on direct examination, during invasive 
procedure, or by histopathologic examination or imaging test.  
 
** The term attending physician for the purposes of application of the NHSN SSI criteria may be interpreted to mean the surgeon(s), 
infectious disease, other physician on the case, emergency physician or physician’s designee (nurse practitioner or physician’s 
assistant).  
Comments  
There are two specific types of deep incisional SSIs:  
1. Deep Incisional Primary (DIP) – a deep incisional SSI that is identified in a primary incision in a patient that has had an operation 
with one or more incisions (e.g., C-section incision or chest incision for CBGB)  
2. Deep Incisional Secondary (DIS) – a deep incisional SSI that is identified in the secondary incision in a patient that has had an 
operation with more than one incision (e.g., donor site [leg] incision for CBGB)  
 
Reporting instructions  
• The type of SSI (superficial incisional, deep incisional, or organ/space) reported should reflect the deepest tissue layer involved in the 
infection: o Report infection that involves the organ/space as an organ/space SSI, whether or not it also involves the superficial or deep 
incision sites.  
o Report infection that involves the superficial and deep incisional sites as a deep incisional SSI.  










Organ/space surgical site infection 
Organ/Space SSI must meet the following criterion: 
Infection occurs within 30 or 90 days after the NHSN operative procedure (where day 1 = the procedure date)  
and 
infection involves any part of the body, excluding the skin incision, fascia, or muscle layers, that is opened or manipulated during the 
operative procedure 
and 
patient has at least 1 of the following: 
a. purulent drainage from a drain that is placed into the organ/space 
b. organisms isolated from an aseptically-obtained culture of fluid or tissue in the organ/space 
c. an abscess or other evidence of infection involving the organ/space that is detected on direct examination, during invasive procedure, 
or by histopathologic examination or imaging test 
and 
meets at least one criterion for a specific organ/space infection site  
Comments 
Because an organ/space SSI involves any part of the body, excluding the skin incision, fascia, or muscle layers, that is opened or 
manipulated during the operative procedure, the criterion for infection at these body sites must be met in addition to the organ/space 
SSI criteria. For example, an appendectomy with subsequent subdiaphragmatic abscess would be reported as an organ/space SSI at the 
intraabdominal specific site (SSI-IAB) when both organ/space SSI and IAB criteria are met.  
Reporting instructions 
• If a patient has an infection in the organ/space being operated on, subsequent continuation of this infection type during the remainder 
of the surveillance period is considered an organ/space SSI, if organ/space SSI and site-specific infection criteria are met. 
• Report mediastinitis following cardiac surgery that is accompanied by osteomyelitis as SSI-MED rather than SSI-BONE. 
• If meningitis (MEN) and a brain abscess (IC) are present together after operation, report as SSI-IC. Similarly, if meningitis and spinal 
abscess (SA) are present together after an operation, report as SSI-SA. 
• Report CSF shunt infection as SSI-MEN if it occurs within 90 days of placement; if later or after manipulation/access, it is considered 
CNS-MEN and is not reportable under this module. 
• The term attending physician for the purposes of application of the NHSN SSI criteria may be interpreted to mean the surgeon(s), 
infectious disease, other physician on the case, emergency physician or physician’s designee (nurse practitioner or physician’s 
assistant). 
 
SIP/SIS-Superficial incisional surgical site infection 
Superficial incisional SSI must meet the following criterion: 
Infection occurs within 30 days after any NHSN operative procedure (where day 1 = the procedure date), including those coded as 
‘OTH’* 
and 
involves only skin and subcutaneous tissue of the incision 
and 




a. purulent drainage from the superficial incision 
b. organisms isolated from an aseptically-obtained culture of fluid or tissue from the superficial incision 
c. superficial incision that is deliberately opened by a surgeon, attending physician** or other designee and is culture-positive or not 
cultured 
and 
patient has at least one of the following signs or symptoms of infection: pain or tenderness; localised swelling; redness; or heat. A 
culture negative finding does not meet this criterion 
d. diagnosis of superficial incisional SSI by the surgeon or attending physician** or other designee (see reporting instructions). 
*http://www.cdc.gov/nhsn/XLS/ICD-9-cmCODEScurrent.xlsx 
** The term attending physician for the purposes of application of the NHSN SSI criteria may be 
interpreted to mean the surgeon(s), infectious disease, other physician on the case, emergency 
physician or physician’s designee (nurse practitioner or physician’s assistant). 
Comments 
There are two specific types of superficial incisional SSIs: 
1. Superficial Incisional Primary (SIP) – a superficial incisional SSI that is identified in the primary incision in a patient that has had an 
operation with one or more incisions (e.g., C-section incision or chest incision for CBGB) 
2. Superficial Incisional Secondary (SIS) – a superficial incisional SSI that is identified in the secondary incision in a patient that has 
had an operation with more than one incision (e.g., donor site [leg] incision for CBGB) 
 
Urinary Tract Infection (UTI) 
Table 5. Urinary Tract Infection Criteria 
Criterion Urinary Tract Infection (UTI)  
 
 Symptomatic Urinary Tract Infection (SUTI)  
Must meet at least 1 of the following criteria:  
1a Patient had an indwelling urinary catheter in place for >2 calendar days, with day of device placement being 
Day 1, and catheter was in place on the date of event  
and  
at least 1 of the following signs or symptoms: fever (>38°C); suprapubic tenderness*; costovertebral angle 
pain or tenderness*  
and  
a positive urine culture of ≥105 colony-forming units (CFU)/ml with no more than 2 species of 
microorganisms. Elements of the criterion must occur within a timeframe that does not exceed a gap of 1 
calendar day between two adjacent elements.  
-----------------------------------------------------------OR--------------------------------------------  
Patient had an indwelling urinary catheter in place for >2 calendar days and had it removed the day of or the 
day before the date of event  
and  




tenderness*; costovertebral angle pain or tenderness*  
and  
a positive urine culture of ≥105 colony-forming units (CFU)/ml with no more than 2 species of 
microorganisms. Elements of the criterion must occur within a timeframe that does not exceed a gap of 1 
calendar day between two adjacent elements.  
*With no other recognized cause  
1b Patient did not have an indwelling urinary catheter that had been in place for >2 calendar days and in place at 
the time of or the day before the date of event  
and  
has at least 1 of the following signs or symptoms: fever (>38°C) in a patient that is ≤65 years of age; 
urgency*; frequency*; dysuria*; suprapubic tenderness*; costovertebral angle pain or tenderness*  
and  
a positive urine culture of ≥105 CFU/ml with no more than 2 species of microorganisms. Elements of the 
criterion must occur within a timeframe that does not exceed a gap of 1 calendar day between elements two 
adjacent elements.  
*With no other recognized cause  
2a Patient had an indwelling urinary catheter in place for >2 calendar days, with day of device placement being 
Day 1, and catheter was in place on the date of event  
and  
at least 1 of the following signs or symptoms: fever (>38°C); suprapubic tenderness*; costovertebral angle 
pain or tenderness*  
and  
at least 1 of the following findings:  
a. positive dipstick for leukocyte esterase and/or nitrite  
b. pyuria (urine specimen with ≥10 white blood cells [WBC]/mm3 of unspun urine or >5 WBC/high power 
field of spun urine)  
c. microorganisms seen on Gram’s stain of unspun urine  
 
and  
a positive urine culture of ≥103 and <105 CFU/ml with no more than 2 species of microorganisms. Elements 
of the criterion must occur within a timeframe that does not exceed a gap of 1 calendar day between two 
adjacent elements.  
----------------------------------------------------------OR---------------------------------------------  
Patient with an indwelling urinary catheter in place for >2 calendar days and had it removed the day of or the 
day before the date of event  
and  
at least 1 of the following signs or symptoms: fever (>38°C); urgency*; frequency*; dysuria*; suprapubic 





at least 1 of the following findings:  
a. positive dipstick for leukocyte esterase and/or nitrite  
b. pyuria (urine specimen with ≥10 WBC/mm3 of unspun urine or >5 WBC/high power field of spun urine  
c. microorganisms seen on Gram’s stain of unspun urine  
and  
a positive urine culture of ≥103 and <105 CFU/ml with no more than 2 species of microorganisms. Elements 
of the criterion must occur within a timeframe that does not exceed a gap of 1 calendar day between two 
adjacent elements.  
*With no other recognized cause  
2b Patient did not have an indwelling urinary catheter, that had been in place for >2 calendar days and in place at 
the time of, or the day before the date of event  
and  
has at least 1 of the following signs or symptoms: fever (>38°C) in a patient that is ≤65 years of age; 
urgency*; frequency*; dysuria*; suprapubic tenderness*; costovertebral angle pain or tenderness*  
and  
at least 1 of the following findings:  
a. positive dipstick for leukocyte esterase and/or nitrite  
b. pyuria (urine specimen with ≥10 WBC/mm3 of unspun urine or >5 WBC/high power field of spun urine  
c. microorganisms seen on Gram’s stain of unspun urine  
 
and  
a positive urine culture of ≥103 and <105 CFU/ml with no more than 2 species of microorganisms. Elements 
of the criterion must occur within a timeframe that does not exceed a gap of 1 calendar day between two 
adjacent elements.  
*With no other recognized cause  
3 Patient ≤1 year of age with** or without an indwelling urinary catheter has at least 1 of the following signs or 
symptoms: fever (>38°C core); hypothermia (<36°C core); apnea*; bradycardia*; dysuria*; lethargy*; 
vomiting*  
and  
a positive urine culture of ≥105 CFU/ml with no more than 2 species of microorganisms. Elements of the 
criterion must occur within a timeframe that does not exceed a gap of 1 calendar day between two adjacent 
elements.  
*With no other recognized cause  
** Patient had an indwelling urinary catheter in place for >2 calendar days, with day of device placement 
being Day 1, and catheter was in place on the date of event  
4 Patient ≤1 year of age with** or without an indwelling urinary catheter has at least 1 of the following signs or 






at least 1 of the following findings:  
a. positive dipstick for leukocyte esterase and/or nitrite  
b. pyuria (urine specimen with ≥10 WBC/mm3 of unspun urine or >5 WBC/high power field of spun urine  
c. microorganisms seen on Gram’s stain of unspun urine  
and  
a positive urine culture of between ≥103 and <105 CFU/ml with no more than two species of 
microorganisms. Elements of the criterion must occur within a timeframe that does not exceed a gap of 1 
calendar day between two adjacent elements.  
*With no other recognized cause  
** Patient had an indwelling urinary catheter in place for >2 calendar days, with day of device placement 
being Day 1, and catheter was in place on the date of event.  
 
Infection-related Ventilator-Associated Complication (IVAC) 
Patient meets criteria for VAC  
and  
on or after calendar day 3 of mechanical ventilation and within 2 calendar days before or after the onset of worsening oxygenation, the 
patient meets both of the following criteria:  
1. Temperature > 38 °C or < 36°C, OR white blood cell count ≥ 12,000 cells/mm3 or ≤ 4,000 cells/mm3.  
 
and  
2. A new antimicrobial agent(s)* is started, and is continued for ≥ 4 calendar days.  
 
*See Table 15 for eligible agents.  
Possible VAP – Possible Ventilator-Associated Pneumonia  
Patient meets criteria for VAC and IVAC  
and  
on or after calendar day 3 of mechanical ventilation and within 2 calendar days before or after the onset of worsening oxygenation, 
ONE of the following criteria is met:  
1) Purulent respiratory secretions (from one or more specimen collections)  
• Defined as secretions from the lungs, bronchi, or trachea that contains > 25 neutrophils and < 10 squamous epithelial cells per low 
power field [lpf, x100].  
• If the laboratory reports semi-quantitative results, those results must be equivalent to the above quantitative thresholds.  
• See additional instructions for using the purulent respiratory secretions criterion in the VAE Protocol.  
 
OR  
2) Positive culture (qualitative, semi-quantitative or quantitative) of sputum*, endotracheal aspirate*, bronchoalveolar lavage*, lung 





*Excludes the following:  
• Normal respiratory/oral flora, mixed respiratory/oral flora or equivalent  
• Candida species or yeast not otherwise specified  
• Coagulase-negative Staphylococcus species  
• Enterococcus species  
 
 Probable VAP 
Patient meets criteria for VAC and IVAC  
and  
On or after calendar day 3 of mechanical ventilation and within 2 calendar days before or after the onset of worsening oxygenation, 
ONE of the following criteria is met:  
1) Purulent respiratory secretions (from one or more specimen collections—and defined as for possible VAP)  
and  
one of the following:  
• Positive culture of endotracheal aspirate*, ≥ 105 CFU/ml or equivalent semi-quantitative result  
• Positive culture of bronchoalveolar lavage*, ≥ 104 CFU/ml or equivalent semi-quantitative result  
• Positive culture of lung tissue, ≥ 104 CFU/g or equivalent semi-quantitative result  
• Positive culture of protected specimen brush*, ≥ 103 CFU/ml or equivalent semi-quantitative result  
*Same organism exclusions as noted for Possible VAP.  
OR  
2) One of the following (without requirement for purulent respiratory secretions):  
• Positive pleural fluid culture (where specimen was obtained during thoracentesis or initial placement of chest tube and NOT from an 
indwelling chest tube)  
• Positive lung histopathology  
• Positive diagnostic test for Legionella spp.  
• Positive diagnostic test on respiratory secretions for influenza virus, respiratory syncytial virus, adenovirus, parainfluenza virus, 
rhinovirus, human metapneumovirus, coronavirus 
 
Secondary Bloodstream Infection (BSI) Guide (not applicable to Ventilator-associated Events)  
What is the meaning of the statement “not related to infection at another site” in relation to a positive blood culture?  
The purpose of using the CDC/NHSN infection criteria is to identify and consistently categorize infections that are healthcare-
associated into major and specific infection sites or types. LCBI criteria include the caveat that the organism(s) cultured from the blood 
cannot be related to infection at another site (i.e., must be a primary BSI). One must be sure that there is no other CDC-defined primary 
site of infection that may have seeded the bloodstream secondarily; otherwise the bloodstream infection may be misclassified as a 
primary BSI or erroneously associated with the use of a central line, i.e., called a CLABSI. For locations participating in in-plan VAE 
surveillance, refer to the VAE chapter for specific guidance on assigning a secondary BSI to a VAE.  
Below are listed several scenarios that may occur with guidance on how to distinguish between the primary or secondary nature of a 




1. Blood and site-specific specimen cultures match for at least one organism: In a patient suspected of having an infection, blood 
and a site-specific specimen are collected for culture and both are positive for at least one matching organism. If the site-specific 
culture is an element used to meet the infection site criterion, then the BSI is considered secondary to that site-specific infection. a. 
Example: Patient meets HAI criteria for a symptomatic urinary tract infection (suprapubic tenderness and >105 CFU/ml of E. coli) and 
blood culture from the same date grows E. coli. This is an HAI SUTI with a secondary BSI and the reported organism is E. coli.  
b. Example: Patient meets HAI criteria for a symptomatic urinary tract infection (suprapubic tenderness and >105 CFU/ml of E. coli) 
and blood culture from the same date grows E. coli and P. aeruginosa. This is an HAI SUTI with a secondary BSI and the reported 
organisms are E. coli and P. aeruginosa, since P. aeruginosa is a logical pathogen for this site of infection.  
c. Example: Patient meets HAI criteria for a symptomatic urinary tract infection (suprapubic tenderness and >105 CFU/ml of E. coli) 
and blood culture from the same date grows E. coli and S. epidermidis. This is an HAI SUTI with a secondary BSI and the reported 
organism is only E. coli, since the single common commensal S. epidermidis positive blood culture by itself does not meet BSI criteria.  
 
2. Blood and site-specific specimen cultures do not match: There are two scenarios that can occur when a patient suspected of 
having an infection has blood and a site-specific specimen cultured but the organisms do not match. a. If the site-specific culture is an 
element used to meet the infection site criterion and the blood isolate is also an element used to meet another criterion at the same 
infection site, then the BSI is considered secondary to that site-specific infection. i. Example: Postoperative patient becomes febrile and 
complains of nausea and abdominal pain. Blood and an aseptically-obtained T-tube drainage specimen are collected for culture. A CT 
scan done that day shows fluid collection suggestive of infection. Culture results show Escherichia coli from the purulent drainage 
specimen but the blood grows Bacteroides fragilis. Because the patient meets IAB criteria by positive site-specific culture (IAB 
criterion 3a) and by positive blood culture as an element of a different criterion of the same infection site (IAB 3c), the blood is 
considered a secondary BSI to an IAB and both organisms would be listed as the IAB infection pathogens. No primary BSI would be 
reported.  
 
b. If the site-specific culture is an element used to meet the infection site criterion and the blood isolate is not, then the BSI is 
considered a primary infection.  
 
i. Example: Postoperative patient has an intraabdominal abscess (IAB) noted during reoperation and purulent material is obtained at 
that time which grows Escherichia coli. The patient spikes a fever two days later and blood culture shows Bacteroides fragilis. Because 
the organisms from the site and blood cultures do not match, and no site-specific criterion that includes positive blood culture as an 
element is met, both a site-specific infection (criteria 1 and 2) and a primary BSI would be reported.  
ii. Example: Unconscious ICU patient with a Foley catheter and central line for past 4 days spikes a fever; blood, urine and sputum 
specimens are collected for culture. The urine culture grows >100,000 CFU/ml of Escherichia coli, blood culture grows Enterococcus 
faecium, and sputum shows oral flora only. Because the organisms from the urine and blood cultures do not match, and a UTI criterion 
that includes positive blood culture as an element is not met, both a SUTI (SUTI criterion 1a) and a primary BSI would be reported. 
This infection does not meet the ABUTI criterion since that requires at least one matching uropathogen organism in urine and blood in 
an asymptomatic patient.  
 
3. No site-specific specimen culture, only a positive blood culture: In a patient suspected of having an infection, if the only specimen 
cultured is blood and it grows a logical pathogen for the suspected body site of infection, and a site-specific infection criterion is met, 
an element of which may or may not include a positive blood culture, the BSI is considered secondary to that site-specific infection. a. 
Example: Postoperative patient has an abscess in the small bowel noted during reoperation. The only specimen cultured is blood which 
grows B. fragilis. Because gastrointestinal tract infection (GIT) criterion 1 is met with the surgically-identified abscess alone and 
because B. fragilis is a logical pathogen for this site of infection, the BSI is considered secondary to a GIT and B. fragilis is listed as the 




b. Example: Patient has a positive blood culture with E. coli proximal in time with fever, abdominal pain, and CT scan evidence of 
intraabdominal abscess (IAB). This patient meets IAB criterion 3c, which includes a positive blood culture as one of its elements. The 
BSI is considered secondary to the IAB and E. coli is listed as the IAB infection pathogen.  
 
4. Negative site-specific specimen culture with positive blood culture: In a patient suspected of having an infection, if a specimen 
from the suspected site of infection is cultured and yields no growth, but a blood specimen collected as part of the infection work-up is 
positive, that BSI is only considered a secondary BSI if another of the site-specific criteria that includes positive blood culture as an 
element is met. Otherwise, the BSI is considered a primary BSI, even if another criterion for that site is met and the blood isolate is a 
logical pathogen for the infection. a. Example: Patient has purulent material from the IAB space cultured and it yields no growth. The 
patient also has fever, abdominal pain, a positive blood culture with Pseudomonas aeruginosa, and radiographic evidence of IAB 
infection. This patient does not meet IAB criterion 1 (positive culture from purulent material) but does meet IAB criterion 3c, an 
element of which is a positive blood culture (signs/symptoms plus positive blood culture plus radiographic evidence). This BSI is 
considered secondary to the IAB and P. aeruginosa is listed as the IAB infection pathogen.  
b. Example: Postoperative knee replacement patient with a central line spikes a fever; blood and knee joint fluid are cultured. Only the 
blood cultures from at least two separate blood draws are positive for S. epidermidis. No other JNT infection criteria are met. This BSI 
should be reported as a CLABSI.  
c. Example: Patient has a central line in place for 10 days. Patient complains of knee joint tenderness and limited range of motion. CT 
scan findings suggest joint (JNT) infection but culture of a needle-aspirated joint fluid is negative. However, a blood culture from the 
same time period grows S. aureus. While this patient does not meet JNT criterion 1 (positive joint fluid culture), he does meet JNT 
criterion 3d (signs/symptoms plus positive laboratory test on blood [blood culture]). Since a positive blood culture is part of the 
criterion met for JNT infection, this BSI is considered secondary to the JNT infection and not reported as a CLABSI. S. aureus is 
reported as the pathogen for the JNT infection.  
A matching organism is defined as one of the following:  
1. If genus and species are identified in both cultures, they must be the same. a. Example: A blood culture reported as Enterobacter 
cloacae and an intraabdominal specimen of Enterobacter cloacae are matching organisms.  
b. Example: A blood culture reported as Enterobacter cloacae and an intraabdominal specimen of Enterobacter aerogenes are NOT 
matching organisms as the species are different.  
 
2. If the organism is less definitively identified in one culture than the other, the identifications must be complementary. a. Example: A 
surgical wound growing Pseudomonas spp. and a blood culture growing Pseudomonas aeruginosa are considered a match at the genus 
level and therefore the BSI is reported as secondary to the SSI.  
b. Example: A blood culture reported as Candida albicans and a urine culture reported as yeast are considered to have matching 










APPENDIX 6. COMPLEXITY CATEGORIES OF CARDIOTHORACIC SURGICAL PROCEDURES 



























APPENDIX 7. SYSTEMS OF ASSESSING QUALITY OF CARE IN PAEDIATRIC PATIENTS FOR CARDIAC SURGERY 
Several groups have proposed systems of assessing quality of care by assigning surgical cardiac operations risk score or grouping 
operations of similar risk into categories. Two such systems, namely the Aristotle Basic Complexity (ABC) score and the Risk 
Adjustment for Congenital Heart Surgery (RACHS-1), were developed. Briefly, the Aristotle score reflects the potential for mortality, 
potential for morbidity, and technical difficulty for each operation.  
 
Scoring systems such as the Paediatric Index of Mortality (PIM) score allows the assessment of severity of illness and mortality risk 
adjustment in heterogeneous groups of patients in an objective manner.  The PIM scoring system has been developed and carefully 
validated in tertiary PICUs (van Keulen, Polderman et al. 2005, Slater, Shann et al. 2003). 
 
Our institution (RCWMCH) uses two scoring systems in cardiac surgery patients. The cardiothoracic team assign an Aristotle score to 
each operation and when admitted to PICU a PIM2 score is assigned. These scoring systems may then be used to conduct audits into 
quality of care of cardiac surgery patients in the PICU. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
